Pathophysiological effects of the excess of sodium in renal and vascular tissues by Della Penna, Silvana Lorena
  
 University of Groningen
Pathophysiological effects of the excess of sodium in renal and vascular tissues
Della Penna, Silvana Lorena
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Della Penna, S. L. (2013). Pathophysiological effects of the excess of sodium in renal and vascular tissues.
Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Pathophysiological effects of the 















Silvana Lorena Della Penna 
PhD Thesis 
 
This PhD Project was financially supported by: 
University Medical Center Groningen 
Research Institute – GUIDE 
Jan Kornelis de Cock Foundation 
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires – FFyB UBA 
Consejo Nacional de Investigaciones Científicas y Técnicas de la República 
Argentina – CONICET 
 
The printing of this Thesis was financially supported by: 
Research Institute – GUIDE 
University Library – University of Groningen 
 
Cover: Puerto Madryn Sunset, Patagonia Argentina - by Silvana Lorena Della Penna 
Lay-out by: Silvana Lorena Della Penna 
Printed by: GVO drukkers vormgevers B. V. 
 
Copyright: Silvana Lorena Della Penna 2013 
All rights reserved. No part f this publication may be reproduced, stored in a retrieval 
system or transmitted in any form without explicit prior permission of the author. 
 
ISBN (Printed): 978-90-367-6546-6 







Pathophysiological effects of the excess 






ter verkrijging van het doctoraat in de 
Medische Wetenschappen 
aan de Rijksuniversiteit Groningen 
op gezag van de 
Rector Magnificus, dr. E. Sterken, 
in het openbaar te verdedigen op 
woensdag 4 december 2013 








Silvana Lorena Della Penna 
geboren op 31 augustus 1979 
te Buenos Aires, Argentina 
Promotores:   Prof. dr. H. van Goor 
    Prof. dr. B.E. Fernández 
 
Copromotor:   Dr. W.W. Bakker 
 
Beoordelingscommissie:  Prof. dr. W.J. van Son  
    Prof. dr. J-L. Hillebrands 
    Prof. dr. K. Poelstra 
Paranimfen:   A. López Angarita 
    A-R. Frenay 
    V. Ayala Núñez  















Effects of acute hypertonic sodium overload on the expression of aquaporins 1 








Different protective actions of losartan and tempol on the renal inflammatory 





High-sodium diet promotes a profibrogenic reaction in normal rat kidneys: 











A slight increase of salt induces down regulation of CD39 and type-1 




Summary, General Discussion and Future Perspectives 
 
165 
Nederlandse Samenvatting 179 
Resumen en Español 183 





 General Introduction 
& 
Aim of this Thesis 
Della Penna S. L. et al. 
 
 




~ 11 ~ 
 
Salt consumption and diseases related to excess of salt 
Salt has played a vital role since the beginning of time. It has served as a spiritual 
icon and to preserve and improve the taste of food. Roman soldiers were paid partly 
in salt, their salarium, today’s “salary”. Around 2.700 years B.C., the earliest known 
treatise on pharmacology was published in China, where a major portion of this 
writing was devoted to descriptions of more than 40 kinds of salt, including methods 
of extracting and putting it in usable form
1
. Nowadays, the average individual 
dietary salt intake worldwide largely exceeds its physiological need. According to 
the new guidelines on sodium intake issued by the World Health Organization, 
adults are advised to consume less than 2 grams of sodium (Na) or 5 grams of salt 
(NaCl) per day. Sodium is found naturally in a variety of foods, for example milk 
and cream (50 mg Na/100g approx.). It is also found in much higher concentrations 
in processed foods such as bacon (1.500mg.100g
-1
 approx.), snacks (e.g. pretzels, 
cheese puffs, popcorn) and condiments
2
. The body uses Na to control blood pressure 
and to maintain circulating volume. The ingestion of excess dietary salt is strongly 
correlated with morbidity, mortality of cardiovascular diseases and atherosclerosis
3
. 
Excess salt intake is also regarded as a major contributing factor to the pathogenesis 
of hypertension and kidney diseases by increasing water and sodium retention, 
which results in blood volume expansion, vascular abnormalities and 




Aquaporins in Water Balance Disorders 
Water constitutes around 70% of our body mass, and every day our kidneys filter 
and reabsorb around 180 litres of water. Thus, the appropriate distribution of water 
is required to maintain fluid balance within different anatomic compartments
5
. In 
contrast to the classic view of simple diffusion through the lipid bilayer of cell 
membranes, several studies have shown the existence of a membrane-protein-
mediated water movement in certain membranes, called Aquaporins (AQPs)
5
. AQPs 
are transmembrane proteins formed by 6 α-helixes which have a narrow opening in 
the interior from where water molecules can pass. Four of these proteins (subunits) 
are arranged in parallel forming a fifth pore in the centre of the tetramer (Fig. 1). 
These specialized proteins do not allow anions and the majority of big cations to 
pass through. There are cationic amino acids acting as “doors”, preventing the 
passage of small cations like H3O
+
. Although recent experiments have indicated 






 and tetramethylammonium, through 
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the central pore of the AQP-1 tetramer. It has also been suggested that the central 
pore could conduct certain gases (G) such as CO2 or NO
6
 in certain AQPs. 
 
Figure 1. Simplified figure of an Aquaporin. Aquaporins (AQPs) are transmembrane proteins formed by 4 
subunits forming tetramers. Each subunit has 6 α-helixes which have a narrow opening in the interior 
from where water molecules can pass. These tetramers form a central pore, which may conduct certain 
gases (G) such as CO2 or NO. 
 
To date, 13 AQPs have been identified in different mammal tissues (AQP-0 to AQP-
12)
7
. AQP water permeability is essential in several situations, such as in kidney 
collecting duct, for example, when water movement is driven across a barrier by a 
continuous osmotic gradient, or for active, near-isosmolar fluid absorption/secretion, 
as in kidney proximal tubule
8
. The main AQPs expressed in kidney are: i) AQP-1 in 
the luminal and basolateral membranes of the proximal tubules, in the epithelial 
cells of the thin descending limb of Henle and in endothelial cells of the descending 
vasa recta
6-7
, which reabsorbs 80% of the glomerular filtrate; and ii) AQP-2, a 
vasopressin-regulated water channel, found in collecting-duct apical membrane and 
intracellular vesicles, which reabsorbs the 20% left of the tubular fluid
9
. Unlike ion 
channels and solute transporters, the AQPs do not show gating, saturation, or 
membrane potential-dependence behaviour
9
. The importance of AQPs resides in the 
responses to physiological or pathological changes, as they can be activated or 
deactivated by different regulatory mechanisms. For example, vasopressin 
(antidiuretic hormone) translocates AQP-2 from the intracellular vesicles to the 
apical plasmatic membrane in the renal tubular cells, and stimulates the transcription 
of AQP-2 gene (Fig. 2)
10
, resulting in water reabsorption. Moreover, it has been 
recently demonstrated that Angiotensin II (Ang II) regulates the activity of the main 
AQPs in the kidney
11
. It has also been shown that Ang II could regulate the 
addressing of AQP-2 to the plasmatic membrane in the cells of the collecting duct of 
the internal membrane, through the activation of its receptor AT1
12
, and that the 
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Figure 2. Simplified schematic regulation of AQP-2 trafficking and expression in collecting duct principal 
cells. Vasopressin (AVP) acts on V2 receptors (V2R) in the basolateral plasma membrane (1). 
Angiotensin II (Ang II) is able to stimulate the release of aldosterone and thus inducing this step. 
Adenylyl cyclase (AC) is activated, which accelerates the production of cAMP, activating the catalytic 
subunit of protein kinase A (PKA) (not shown). PKA phosphorylates AQP-2 in intracellular vesicles (3) 
and in the nuclei, activating transcription factors (4), thus increasing gene transcription of AQP-2, 
synthesis and trafficking to the apical plasma membrane (3 and 5). In parallel, AQP-3 synthesis and 
trafficking to the basolateral plasma membrane takes place (6). In this way, water is reabsorbed. AQP-2 is 
then excreted into urine (7) or recycled from the apical plasma membrane (8). 
 
AQPs are involved in several human disease conditions involving fluid transport 
such as brain edema, lung edema, dry eye, congestive heart failure and nephrogenic 
diabetes insipidus (NDI)
8
. NDI caused by AQP-2 mutation is characterized by 
severe polyuria and polydipsia, refractory to antidiuretic hormone. People who lack 
functional AQP-1 are phenotypically normal but manifest defective urinary 
concentrating function when deprived of water, similar to AQP-1-null mice. AQPs 
are involved in cell migration as well, having implications in tumor angiogenesis, 
local invasion, and metastasis. AQP-facilitated cell migration appears to be a general 
phenomenon relevant not only to angiogenesis but also to wound healing or tumor 





Della Penna S. L. et al. 
 
 
~ 14 ~ 
 
The kidney and the Renin-Angiotensin-Aldosterone-System 
The main hormonal regulator of sodium homeostasis is the Renin-Angiotensin-
Aldosterone System (RAAS) which contributes to a large extent to the regulation of 
blood pressure. The juxtaglomerular (JG) cells of the kidney release renin into the 
circulation stimulated by changes in renal perfusion pressure, sodium content in the 
tubules, and the renal sympathetic nerve activity. The liver produces 
angiotensinogen which is cleaved in the blood by renin to an inactive decapeptide 
named Angiotensin I (Ang I). Then, the angiotensin-converting enzyme (ACE) 
converts Ang I into the active form of Ang II. The main source of ACE is the 
pulmonary endothelium, although it exists in several other tissues such as the 




Figure 3. Angiotensin peptide formation. Renin, released by the kidney cleaves the precursor protein 
angiotensinogen (Ao) to angiotensin I (Ang I), which is further processed to the biologically active 
peptides Angiotensin II (Ang II) by angiotensin converting enzyme (ACE) and Angiotensin-(1-7) by 
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Ang II signals are mediated by the stimulation of two types of receptors: Ang II type 
1 (AT1R) and Ang II type 2 (AT2R). The RAAS mediates the majority of its effects 
via Ang II and its AT1R, conferring the most classical actions, such as 
vasoconstriction, aldosterone release from the adrenal gland, salt retention in the 
renal proximal tubules, and stimulation of the sympathetic nervous system in the 
brain. In addition, there is the ACE2–Ang-(1–7)–Mas axis. A homolog of ACE, 
ACE2, degrades Ang II into Ang-(1-7) which binds to the Mas receptor which 
counter-regulates the actions of the classical RAAS (Fig. 4)
14
. Apart from the 
systemic RAAS, there is a local RAAS present in the nephrons of the kidneys. Ang 
II is locally converted and secreted, reaching a concentration 100-fold higher in the 
lumen compared with the plasma
15-17
. In this way, the Ang II formed in the kidney 
could have an important role in sodium retention and blood pressure regulation
16
. In 
pathological conditions, Ang II can contribute to renal diseases by inducing sodium 
retention, inflammation, fibrosis
18-19
, and down-regulation of water channels in the 
kidney (aquaporins, AQPs)
20-21
. These processes can occur in spite of the 




In the kidney, AT1R mediates vasoconstriction of glomerular microvasculature, 
modifying the glomerular filtration rate, the tubuloglomerular feedback and cell 
growth
15
. Moreover, Ang II modifies through this receptor, the activity of different 




 interchanger (NHE), ENaCs, NKCC2 and 
NCC co-transporters
15, 22
. Overall, these actions contribute to an increased capacity 
of the kidney to preserve sodium and keep blood pressure within normal values. 
AT2R is localized in glomerular epithelial cells, proximal tubules, collecting ducts 
and renal vasculature. It is considered as a functional antagonist of AT1R and is 
associated with vasodilation, apoptosis, antiproliferation, and increase of natriuresis, 
by stimulation of nitric oxyde/cGMP/protein-kinase G pathway
23
 (Fig. 4). 
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Figure 4. Angiotensin peptides metabolism and main functions. Angiotensin-(1-7) is metabolized by ACE 
to form Ang-(1-5). Angiotensin II (Ang II) is processed by aminopeptidase A (APA) to form Angiotensin 
III, which is further hydrolyzed by aminopeptidase N (APN) to form Angiotensin IV. Ang II can be 
directly cleaved by dipeptidyl aminopeptidase IV (DAP) to Ang IV. Ang-(1-7) binds to Mas receptor to 
produce anti-inflammatory effects. Ang II can bind to either AT2R or AT1R. By binding to AT2R, eNOS 
is stimulated to produce nitric oxide (NO) for vasodilation. When Ang II binds to AT1R, it stimulates 
NADPH oxidase to produce oxygen radicals (ROS) such us superoxide anion (O2
-). Ang II type 1 
receptor blockers (ARBs) inhibit Ang II effects by binding to the AT1R. 
 
Angiotensin II Signal Blockage 
The development of renal injury and hypertension is closely related to inappropriate 
regulation of the RAAS. Hypertensive patients with renal disease are recommended 
as first-line therapy to use ACE inhibitors (ACEIs) or Angiotensin II type I Receptor 
Blockers (ARBs) (Fig. 4)
15
. These inhibitors attenuate renal disease in both pre-
clinical and clinical studies, and are effective and well tolerated, improving 
morbidity and mortality associated to cardiovascular diseases
24-25
. They not only 
exert their effect at a systemic level reducing elevated values of blood pressure but 
also increase nitric oxide (NO) bioavailability. NO is a potent vasoactive molecule 
essential for the maintenance of cardiovascular health, which has proved to be 
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Kidney inflammation and fibrosis 
In addition to the cardiovascular system, the kidney is highly affected by the excess 
of salt. Sodium filters freely through the glomeruli, being reabsorbed 99% of the 
filtered load along the nephron (mainly in the proximal tubules) by an integrated 
system of channels, interchangers and ionic transporters. Sodium reabsorption is a 
determinant factor of the renal oxygen consumption
27-28
. 
A renal pro-inflammatory response, secondary to the excess of sodium (Fig. 5), 
favours further sodium retention and thus the development of arterial hypertension
29-
30
. The molecular mechanisms of the inflammatory response to salt-sensitive 
hypertension remain to be completely characterized. The increase in sodium 
reabsorption in the renal tubules leads to elevated blood flow and thus to glomerular 
hyper-filtration. This process intensifies the metabolic demand of oxygen, which 
results in a decrease in tissue oxygen tension (pO2)
31
. The rise in oxygen 
consumption leads to relative hypoxia. The latter then triggers a cascade of events, 
magnifying the production of reactive oxygen species (ROS) that follows a rise of 
the expression of nuclear pro-inflammatory transcription factors such as activator 
protein-1 (AP-1) and nuclear factor-kappa B (NF-B). NF-B activates genes 
involved in the inflammatory and fibrotic responses, resulting in the accumulation of 
cells responding to inflammation in the kidney as well as the release of adhesion 
molecules (V-CAM 1, I-CAM 1), chemokines (MCP-1, RANTES) and cytokines 
(transforming growth factor-beta1, TGF-1), as well as Ang II14. Ang II signalling 
through AT1R stimulates the enzyme NADPH oxidase which produces more ROS, 
in turn activating NF-B, and stimulating the expression of pro-inflammatory genes, 
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Figure 5. Inflammation markers triggered by excess of salt. High salt increases sodium tubular 
reabsorption and thus oxygen consumption. Higher oxygen demand leads to reduced O2 availability 
(hypoxia). Hypoxia, together with an increase of flow due to greater sodium transport, stimulates the 
formation of oxygen radicals. Angiotensin II production is up-regulated in the kidney and stimulates 
NADPH oxidase to produce more oxygen radicals (ROS). It follows an activation cascade of adhesion 
molecules, chemokines, cytokines and nuclear factors, leading to inflammation, fibrosis, angiogenesis, 
and erythropoyesis, closing a positive feedback. 
 
In previous studies, we have provided in vivo evidence that there is early over-
expression of the main pro-inflammatory and pro-fibrotic markers produced by 
acute infusions of hypertonic NaCl in anaesthetised Sprague Dawley rats. The 
cascade of events observed includes hypoxia, oxidative stress, tubular inflammation, 
and interstitial fibrosis, evidenced by the increased expression of: TGF-1, 
RANTES, HIF-1, -SMA, NF-B, and Ang II33. These processes were prevented 
within the acute period, by the administration of atrial natriuretic peptide
34
. On the 




Damaged cells release ATP under local inflammation and intravascular 
microthrombus formation. The ATP is converted into adenosine by ectonucleases 
lining the endothelium of various cell surfaces
37-40
. Examples of this type of integral 
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membrane enzymes are ecto-nucleotide diphosphohydrolase (E-NTPDase, also 
Ectoapyrase or CD39) and ecto-5-nucleotidase (Ecto-5’-NTase, also CD73). E-
NTPDase converts pro-aggregatory ATP into ADP and less efficiently into anti-
aggregatory adenosine (Fig. 6). Ecto-5’-NTase converts ADP into adenosine. These 
actions limit the extent of intravascular platelet aggregation
41
. E-NTPDase has a role 
in water handling as well. Over-expression of this enzyme in transgenic mice results 
in down-regulation of the water channel aquaporin-2, leading to impaired urine 
concentration
42
. E-NTPDase is highly sensitive for ROS
43-44
 leading to diminished 
expression of this ecto enzyme in ischemic conditions as observed in vascular 
endothelium of subjects with preeclampsia
45-46
, and in the glomerular 
microvasculature in chronic kidney graft rejection
47
. ROS have been implicated in 
the signalling cascade induction related to vascular remodelling, cell growth, 
extracellular matrix protein deposition, inflammation, endothelial dysfunction, and 







Figure 6. E-NTPDase. In pathological events, such as inflammation, there is accumulation and secretion 
of ATP from the injured cell, a pro-inflammatory molecule. E-NTPDase transforms these ATP molecules 
to ADP, and adenosine, although less efficiently. Ecto-5’Ntase converts ADP into adenosine. Adenosine, 
on the contrary, exerts a potent anti-inflammatory effect. Reactive oxygen species, such as ·O-2, have a 
direct negative influence on E-NTPDase, by down-regulating its expression. 
Della Penna S. L. et al. 
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Inflammation is a crucial event prior to the development of fibrosis, which is the 
final common pathway to end stage renal disease. It has been demonstrated that 
TGF-β1 activated by Ang II stimulates collagen and fibronectin synthesis and 
participates in the development of kidney damage, controlling the deposition of 
extracellular matrix and its remodelling
16, 24
. Up regulation of TGF-1 is found in 
the majority of fibrotic kidney diseases, in patients as well as in animal models. On 
the contrary, the suppression of TGF-1 signalling significantly slows the 
progression of interstitial kidney fibrosis in animals
49
. TGF-1 is the main stimulant 
of the phenotypic activation of myofibroblasts. Myofibroblasts are the primary 
source of extracellular matrix products in active fibrotic sites. In response to tissue 
damage, these cells undergo a process of activation in order to turn into -SMA-
positive myofibroblasts, an intermediate phenotype between fibroblasts and muscle 
cells
50
. The interstitial -SMA-positive myofibroblasts are responsible for the 
continuous accumulation and deposition of extracellular matrix in the interstitial 





Endothelial dysfunction under salt excess. Role of Nitric Oxide 
The vascular endothelium not only serves as a passive barrier to diffusion between 
the circulating blood and underlying vascular smooth muscle cells, but also regulates 
vessel diameter, inhibits blood clot formation, and impairs the multiplication of cells 
involved in plaque formation. Endothelial dysfunction is considered to play an 
important role in the pathogenesis of vascular disease. Two of the main 
characteristics are impaired NO availability and increased levels of ROS
51-52
. 
NO has numerous beneficial effects including the regulation of vascular tone, 
permeability, inflammation, cellular proliferation, angiogenesis, and vascular 
remodelling. NO is produced via the oxidative L-arginine pathway catalyzed by a 
family of three isoforms of nitric oxide synthases: nNOS (neuronal), iNOS 
(inducible) and eNOS (endothelial)
53-54
. Endothelial cell activation, in response to 
agonists and mechanical stimuli, leads to NO formation by stimulating eNOS (Fig. 
7)
55
. Endothelium-derived NO diffuses to the underlying vascular smooth muscle 
cells (VSMC) and stimulates soluble guanylyl cyclase to produce cGMP, causing 
relaxation
56
. Recent data have suggested the involvement of aquaporin-1 (AQP-1) in 
NO transport out of the endothelium and into VSMC
57-58
. However, more recently, it 
has been demonstrated that VSMC also express all three NOS isoforms, which may 
represent an alternative mechanism whereby local NOS expression modulates 
Introduction 
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vascular functions in an endothelium-independent manner
59-60
. Previous studies have 
demonstrated that a high salt diet leads to impaired vascular relaxation to 
acetylcholine and elevated production of superoxide by NADPH oxidase and 
xantine-xantine oxidase in aorta and mesenteric resistance arteries
61-64
. By 
incubating the vessels with tempol, apocynin or oxypurinol, the higher superoxide 
levels are reduced and NO levels are increased, suggesting that the increase of 
superoxide in animals fed a high salt diet interfere with NO availability and thus, it 
could play a critical role in reducing endothelium-dependent vascular relaxation, and 
inducing vascular remodelling, cell growth, and extracellular matrix protein 
production
65
. However, at the present time, the effect of elevated superoxide levels 
on eNOS expression in smooth muscle layer from arteries of rats fed high salt diet 
have not been determined. 
 
 
Figure 7. Production and destruction of Reactive Oxygen Species and Nitric Oxide. NADPH oxidase 
stimulated by mechanical stretch, vasoactive peptides, growth hormones and cytokines, converts 
NAD(P)H into NAD(P)+ and H+, releasing an electron that converts the oxygen (O2) into an oxygen 
radical, the superoxide anion (·O2
-). The superoxide anion is transformed into H2O2
 by the Superoxyde 
Dismutase (SOD) enzyme and into water and oxygen again by Catalase or Peroxidase. The Nitric Oxide 
Synthase (endothelial, eNOS) produces the vasodilator Nitric Oxide (NO) by metabolizing L-arginine. 
NO can also bind to ·O2
- and generate peroxinitrite (ONOO-), another oxygen radical that produces 
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Oxidative Stress 
It has been described that a high salt diet increases oxidative stress in kidneys of 
salt-sensitive rats, for example, by producing superoxide anion or via lipidic 
peroxidation
66-67
. ROS are involved in vasoconstriction and anti-natriuresis in the 
kidneys in vivo
68
 and increase sodium transport in vitro
69
, suggesting that this anion 
plays a pathophysiological role in the kidney, contributing to the development of 
hypertension. Moreover, Ang II can increase the production of ROS through the 
activity of the enzyme NADPH oxidase (Fig. 7)
70
. On the other hand, superoxide 
anion activates the transcription of the nuclear factor NF-kB, which regulates the 
induction of genes involved in the inflammatory and fibrogenic responses through 





Reducing Oxidative Stress 
Tempol (4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl) is a small cell-
permeable molecule, mimetic of the superoxide dismutase enzyme (SOD), 
commonly used for the study of oxidative stress in different animal models of salt 
sensitive-hypertension (Fig. 7). The acute or chronic intravenous administration has 
also been effective in reducing blood pressure
72
. This effect is accompanied by an 
increase in sodium excretion and a decrease in oxygen consumption in the kidney. 
The mechanisms by which tempol improves renal oxygenation are not well 
established. One possibility is that tempol increases NO bioavailability, which 
competes with the oxygen in the mitochondrion respiratory chain, thus reducing the 
use of oxygen by the mitochondria and inhibiting the luminal entrance of sodium
73
. 
In this regard, Welch et al. demonstrated that tempol improves pO2 in the renal 
cortex and the relation sodium transport/oxygen consumption, previously reduced by 
prolonged infusion of Ang II
74
. In addition, the oral administration of tempol to 
Dahl-sensible rats (a model of salt-sensitive hypertension) fed a diet rich in sodium, 
prevents the intrarenal increase of angiotensingen
75
 and thus, the production of Ang 
II
15, 75
. However, Silva et al. observed that the increase of NaCl in the thick 
ascending limb of Henle in the kidney medulla is capable by itself to diminish the 
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Aim and scope of the thesis 
The aim of this thesis is to deepen the present knowledge of the effects of excess salt 
on the kidney in vivo and on the vascular endothelium in vitro, especially in regard 
to water balance disorders, and inflammatory and fibrotic responses. 
In the first part of this thesis, we focused on the regulation of water channels in the 
kidney and the alterations they undergo when exposed to high sodium. In Chapter 1, 
we investigated the expression of the main two AQPs in renal tubules of normal rats 
under a high salt diet. We evaluated the role of tubular Ang II signalling by 
administering losartan (AT1R blocker), and the participation of oxidative stress and 
NO by inhibiting ROS production with tempol (mimetic of the superoxide dismutase 
enzyme). We measured systolic blood pressure and renal function as well as the 
intrarenal levels of the AQPs together with inflammatory markers. Our next aim was 
to assess the expression of these AQPs and the inflammatory markers in an acute 
model of hypernatremia, together with their regulation by the RAAS and oxidative 
stress (Chapter 2). In this study, we utilized an acute sodium overload treatment in 
anesthetized as well as in anaesthetized rats. In the second part of the thesis, we 
studied the effects of salt on inflammation and fibrotic markers in different models 
in vivo and in vitro. We first utilized an in vivo model of acute sodium overload in 
normal rats (Chapter 2 and 3), in which we measured mean arterial pressure and 
renal functional parameters. We evaluated the role of tubular Ang II signalling by 
administering losartan, and the participation of oxidative stress with tempol. We also 
studied the regulation of pro-inflammatory cytokines and chemokines and nuclear 
factors. We then proposed to study the aforementioned processes in a chronic model, 
as a way to correlate it with salt intake in humans. We used concentrations of salt 
higher than in regular high salt intake in humans in order to enhance the effects. For 
this purpose, animals were subjected to a diet with “normal salt” or “high salt” 
content (Chapters 4, 5 and 6). In Chapter 4, we hypothesized that the oxidative stress 
induced by chronic salt overload could stimulate inflammatory and fibrogenic 
signalling pathways in kidneys of normal rats. To prove this hypothesis, we 
administered tempol in the drinking water of rats fed a high salt diet. In Chapter 5, 
we investigated a possible adaptive mechanism which attenuates the deleterious 
effects of oxidative stress and hypoxia that are produced in response to a chronic 
sodium overload. In Chapter 6, we tested the direct in vitro effect of salt on the 
endothelium and the potential involvement of ROS in the mechanism of damage, by 
producing an in vitro co-culture with a monolayer of endothelial cells and a 
supernatant with peripheral blood mononuclear cells (PBMC). 
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The purpose of this study was to investigate the expression of aquaporin-1 (AQP-1) 
and aquaporin-2 (AQP-2) in the renal tubule of rats fed a high-salt diet and its 
modulation by the AT1 receptor blocker losartan. 
The experiments were performed in four groups of rats fed for 3 weeks with the 
following diets: regular rat chow (NS), high-salt (8% NaCl) chow (HS), NS plus 
losartan (NS-L) and HS plus losartan (HS-L). Losartan (40 mg.kg
−1
) was 
administered in the drinking water. Systolic blood pressure (SBP) and renal function 
were evaluated. The intrarenal levels of angiotensin II (Ang II), TGF-β1, α-smooth 
muscle actin (α-SMA), endothelial nitric oxide synthase (eNOS), AQP-1 and AQP-2 
were determined by immunohistochemistry. AQP-1 and AQP-2 protein levels were 
measured by western blot analysis. 
A high-sodium diet down-regulated AQP-1 and AQP-2 expression levels in the 
proximal tubule and collecting duct, respectively. The high-sodium diet also induced 
Ang II, TGF-β1 and α-SMA over-expression and decreased eNOS expression in the 
renal cortex and medulla. Losartan increased the diuresis and natriuresis, favouring 
urinary sodium concentration. Additionally, losartan prevented the pro-ﬁbrogenic 
response, decreasing Ang II, TGF-β1 and α-SMA levels and normalizing AQP-2 
expression in the HS-L group. AQP-1 expression was upregulated by losartan in 
both the NS-L and HS-L groups. 
These results show that increased intrarenal Ang II in rats fed a high-salt diet down-
regulates renal AQP-1 and AQP-2 expressions. In addition, although losartan 
increased diuresis and natriuresis, it prevented the down-regulation of aquaporins, 
favouring urinary sodium concentration. 
Chapter 1 
 




Diverse factors like AQP-1, AQP-2, Ang II and vasopressin can alter the ability of 
the kidney to recover water from the tubular ﬂuid. AQP-1 mediates the reabsorption 
of already 80% of the ﬂuid from the glomerular ﬁltrate, being expressed in the 
luminal and basolateral membranes of the proximal tubules, in epithelial cells of the 
thin descending limb of Henle's loop and in endothelial cells of the descending vasa 
recta
1, 2
. In addition, AQP-2 channels reabsorb the remaining 20% of the tubular 
ﬂuid in the collecting duct. Vasopressin, besides its known properties to stimulate 
water reabsorption, translocates AQP-2 from the intracellular vesicles to the apical 
plasma membrane in renal tubular cells and stimulates AQP-2 gene transcription
3
. 
The renin–angiotensin system is a major hormonal regulator of sodium homeostasis 
and mediates most of its effects via Ang II
4
. Ang II signals are mediated by 
stimulation of two receptor subtypes, named Ang II type 1 (AT1) and Ang II type 2 
(AT2). AT1 receptors are ubiquitously expressed in the kidney, mediate 
vasoconstriction of the afferent and efferent arterioles and medullary 
microvasculature and modulate the glomerular ﬁltration rate, the tubuloglomerular 
feedback mechanism, and cell growth. In addition, Ang II modulates also the 
activity of diverse ion transporters in the kidney, such as Na+/H+ interchanger, 
NKCC2 co-transporter, NCC co-transporter and ENaCs
5
. Altogether, these actions 
of Ang II contribute in a synergistic manner to increase the capability of the kidneys 
to conserve sodium and maintain blood pressure within normal levels. AT2 
receptors are localized in glomerular epithelial cells, proximal tubules, collecting 
ducts and in renal vasculature. They are considered as functional antagonists of AT1 
receptors, and are associated with vasodilatation, apoptosis, antiproliferation and the 
increase of natriuresis, by stimulating the NO/cGMP/protein kinase G pathway
6
. It 
has been recently demonstrated that Ang II also regulates the activity of the main 
AQPs in the kidney. Wintour et al. reported that the in vivo infusion of Ang II 
increased AQP-1 gene expression in the sheep kidney
7
. Moreover, it has been 
demonstrated that Ang II may regulate AQP-2 targeting to the plasma membrane in 
the inner medullar collecting duct cells, through AT1 receptor activation
8
, and that 
the peptide also potentiates vasopressin effects on AQP-2
9
 as well. In addition, 
Bouley et al.
10
 have shown a biphasic effect of exogenous Ang II administration, 
since 10
−8
 M to 10
−9
 M of Ang II upregulated and a higher concentration of Ang II 
(10
−7
 M) downregulated AQP-1 mRNA expression in proximal tubule cells. 
Furthermore, it was also documented that an autonomous renin–angiotensin system 
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is present in renal proximal tubules, being Ang II locally produced and secreted, 
reaching a concentration that is 100-fold higher in the lumen than in plasma
11
. The 
facts that renin and its mRNA expression were localized in the principal cells of the 
collecting ducts
12
, that angiotensin converting enzyme (ACE) was found in distal 
nephron segments and that angiotensinogen was found in the urine
13
, indicates that 
the distal part of the nephron is also a place of synthesis of intrarenal Ang II. In this 
way, locally formed Ang II in the kidney, in pathological conditions, may contribute 




Up to date, there are no reports analyzing the effects of a chronic overload of salt on 
AQP expression in the kidney. Rats fed a high-sodium diet constitute an 
experimental model, characterized by low plasma renin activity and circulating Ang 
II levels but with increased Ang II intrarenal levels
17
, which is useful to analyze that 
relationship. Based on these antecedents, we hypothesized that the increase of renal 
Ang II observed in rats subjected to sodium overload could downregulate AQP 
expression through a pro-inﬂammatory and proﬁbrotic effect, decreasing urinary 
sodium concentration. Then, the aim of the present study was to examine the 
immunoexpression of AQP-1 and AQP-2 in rats subjected to a high-salt diet, with or 
without simultaneous Ang II-AT1 receptor blockade.  
 
 
2. Materials and methods 
 
2.1. Animal protocol 
Male Sprague Dawley rats of 200–230 g body weight were used. Animals were 
housed in steel cages in a controlled temperature room at 23± 2 °C, exposed to a 
daily 12-hour light–dark cycle (lights on at 07:00 a.m. and off at 07:00 p.m.), and 
fed for 3 weeks with the diets described below, with free access to tap water. 
Experiments were conducted in accordance with the institutional guidelines for the 
care and use of research animals of the University of Buenos Aires, Argentina. 
Animals were randomly divided into four groups (n=6 each group): a) NS (control): 
animals fed a normosodic diet (0.4 g% NaCl); b) HS: animals fed a high-sodium diet 





; SigmaAldrich Inc., St. Louis, Missouri, USA) administered together 
with the drinking water; d) HS-L: animals fed a high-sodium diet plus losartan. At 
the end of the third week, the systolic blood pressure (SBP) was measured by the tail 
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cuff method and recorded in a Grass Polygraph 79D, before the sacriﬁce of the 
animals by decapitation. The kidneys were quickly removed and processed for 
histological studies which include the measurement of intrarenal levels of Ang II, 
TGF-β1, α-smooth muscle actin (α-SMA) and endothelial nitric oxide synthase 
(eNOS) by immunohistochemistry and AQP-1 and AQP-2 by both 
immunohistochemistry and Western blot analysis. 
To evaluate the renal function, additional four groups were performed. The last day 
of the third week, the animals were intraperitoneally anesthetized with urethane (1.2 
g.kg
−1
). A PE-90 tube (3 cm long) was inserted into the trachea to maintain an open 
airway and the left femoral vein was catheterized with a Silastic cannula (0.12 mm 
i.d.) for continuous infusion. The bladder was cannulated for urine collection using a 
PE-75 cannula. The femoral vein was infused with 0.15 M NaCl isotonic saline 
solution (ISS) at a rate of 0.04 mL.min
−1
 (Syringe Infusion Pump, Sage™, Orion) 
for 60 min, to achieve a steady diuresis and allow urine collection (equilibration 
period). Then, the ISS infusion continued for another 60 min at the same rate 
(experimental period). A blood sample was collected after 30 min of the 
experimental period and a urine sample was collected during 60 min of the 
experimental period, for measurement of urine volume, urinary and plasma sodium 
and creatinine. 
 
2.2. Urine and blood measurements 
Urinary and plasma sodium and creatinine were measured by standard methods 
using an autoanalyzer. Creatinine clearance was assessed to evaluate the 
glomerularﬁltration rate (GFR). GFR and sodium fractional excretion (FENa) were 
calculated according to a standard formula. Urinary ﬂow (UV) is expressed as 




, urinary sodium 
concentration (UNa) as mEq.L
−1
, GFR as mL.min
−1
 and FENa as percentage. 
 
2.3. Kidney processing for histological studies 
At the end of the experimental period, both kidneys were rapidly excised, 
decapsuled, longitudinally cut, ﬁxed in formol-buffer (pH 7.2) and then included in 
parafﬁn and cut into 3-μm sections. For immunohistochemistry, sections were 
deparafﬁned and rehydrated, and endogenous peroxidase activity was blocked by 
treatment with 0.5% H2O2 in methanol for 20 min. Local expression of AQP-1, 
AQP-2, Ang II, TGF-β1, α-SMA and eNOS was detected using the following 
speciﬁc antibodies: rabbit anti-AQP-1 (Santa Cruz Biotechnology, Inc., USA; 1:50 
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dilution), rabbit anti-AQP-2 (Santa Cruz Biotechnology, Inc.; 1:200 dilution), 
human antiAng II (Península, CA; 1:500 dilution), rabbit anti-TGF-β1 (Santa Cruz 
Biotechnology, Inc.; 1:200 dilution), rabbit anti-α-SMA (Santa Cruz Biotechnology, 
Inc.; dilution of 1:200), and rabbit anti-eNOS (Santa Cruz Biotechnology, Inc.; 
1:200 dilution). Immunostaining was carried out by means of a commercially 
modiﬁed avidin–biotin–peroxidise complex technique (Vectastain ABC kit, 
Universal Elite, Vector Laboratories, CA, USA) and counterstained with 
hematoxylin. Histological sections were observed in a Nikon E400 light microscope 
(Nikon Instrument Group, Melville, New York, USA). All measurements were 
carried out using an image analysis software (Image-Pro Plus ver. 4.5 for Windows, 
Media Cybernetics, LP, Silver Spring, MD, USA). The results are expressed as 
percentage of the stained area. 
 
2.4. Kidney processing for western blot analysis of aquaporins 
Kidneys were excised and the renal cortex and medulla were immediately dissected. 
Tissue samples were homogenized on ice with a Tissue Tearor (Biospec Products 
Inc.) in a buffer mixture (50 mmol.L
−1
 Tris, 0.1 mmol.L
−1
 EDTA, 0.1 mmol.L
−1
 
EGTA, 1% Triton, 1 mmol.L
−1
 PMSF, 1 μmol.L−1 pepstatin, 2 μmol.L−1 leupeptin, 
1x protease inhibitor cocktail (Roche Diagnostics)). Protein concentration was 
determined by Lowry technique in the Triton-soluble supernatant. Samples of cortex 
and inner medulla containing similar amounts of protein (100 μg protein/lane) were 
separated by electrophoresis in 7.5% SDS polyacrylamide gels (Bio-Rad, Munich, 
Germany), transferred to a nitrocellulose membrane (Bio-Rad), and then incubated 
with rabbit polyclonal anti-AQP-1 (Santa Cruz Biotechnology, 1:250 dilution), or 
rabbit polyclonal anti-AQP-2 (Santa Cruz Biotechnology,1:250 dilution). A 
secondary immunoreaction with a goat anti-rabbit antibody conjugated with 
horseradish peroxidase (1:5000 dilution) was then carried out. The samples were 
revealed by chemiluminescence using ECL reagent for 2–4 min (Amersham 
Pharmacia Biotech). The density of the respective bands was quantiﬁed by 
densitometric scanning of Western blots using a Hewlett–Packard scanner and a 
Totallab analyzer software (Biodynamics Corp., Seattle, WA). Protein amounts were 
calculated by densitometry. Protein levels are expressed as the ratio between AQP-1 
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2.5. Statistical analysis 
Results of urine and blood measurements and SBP are expressed as mean ± SEM 
(standard error of the mean). Immunostainings are expressed as the percentage of the 
positively stained area ± SEM. The Gaussian distribution was evaluated by the 
Kolmogorov and Smirnov method. The groups were compared using ANOVA 





3.1. Systolic arterial pressure and renal function 
 
The SBP increased in the HS group with respect to the NS group (mm Hg, NS: 128± 
2, HS: 148±2, p<0.01; ΔSBP: 20± 2). Losartan reduced the SBP in the NS-L and 
HS-L groups, but with a difference in tensional levels that is very similar to that 
observed between the NS and HS groups (NS-L: 107±2, HS-L: 122±4, p<0.05; 
ΔSBP: 15±2). 
Table 1 shows the parameters of renal function. UV increased in the HS group as 
compared with the NS group. Losartan did not alter UV in the NS-L group, but 
increased UV further in the HS-L group. UVNa exhibited a very similar behaviour to 
UV: it was higher in the HS group than in the NS group. Losartan did not modify 
UVNa in the NS-L group, but increased it further in the HS-L group. UNa increased in 
the HS group as compared with the NS group; whereas losartan increased UNa in 
both the NS-L and the HS-L groups, maintaining a signiﬁcant difference between 
the NS-L and HS-L groups. GFR was unaltered in the HS group with respect to the 
NS group. Losartan diminished GFR in the NS-L group, but did not alter it in the 
HS-L group. FENa increased in HS with respect to NS; whereas losartan increased 
FENa in both the NS-L and the HS-L groups, but with a difference between their 







Della Penna S. L. et al. 
 
~ 40 ~ 
 
 UV UVNa UNa GFR FENa 
NS 10.1±2.2 0.4±0.3 19.6±5.2 1.5±0.4 0.06±0.05 
HS 16.1±2.1* 2.9±1.6* 164.7±16.7* 1.3±0.3 0.51±0.24* 
NS-L 8.6±2.1 0.5±0.1 59.3±9.1† 0.4±0.1† 0.25±0.09† 
HS-L 27±1.4*† 8.5±0.5*† 315.0±23.5*† 1.5±0.5* 1.3±0.01* 
 
Table 1. Renal Function Parameters. Abbreviations: UV: Urinary flow (µL.min-1.kg-1); UVNa: urinary 
sodium excretion (µEq.min-1.kg-1); UNa: urinary sodium concentration (mEq.L
-1), GFR: Glomerular 
Filtration Rate (mL.min-1); FENa: Sodium Fractional Excretion (%). NS: normosodic diet; HS: high-
sodium diet; NS-L: normosodic diet plus losartan; HS-L: high-sodium diet plus losartan. Values are 
expressed as mean ± SEM. *p<0.05 vs. the respective normosodic control (NS and NS-L); † p<0.01 vs. 
the respective control without losartan (NS and HS). 
 
 
3.2. Expression of aquaporins in renal sections 
 
 Figure 1 shows AQP-1 and AQP-2 abundance determined by Western blot. AQP-1 
expression was slightly but signiﬁcantly diminished in the HS group with respect to 
the NS group. Losartan administration increased AQP-1 in both the NS-L and HS-L 
groups. AQP-2 was significantly decreased in the HS group compared with NS rats 




Figure 1. Western blot of AQP-1 and AQP-2. Representative Western blot analysis of AQP-1 abundance 
in renal cortex and AQP-2 abundance in renal medulla. Abbreviations: NS: normosodic diet; HS: high-
sodium diet; NS-L: normosodic diet plus losartan; HS-L: high-sodium diet plus losartan. Values [means ± 
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SEM (n=5)] represent the mean of densitometric units (DU) after background subtraction. All 
experiments were performed in triplicate. Each blot was normalized to ß-actin expression band in the 
same gel. * p<0.01 vs. the respective normosodic control (NS and NS-L); † p<0.01 vs. the respective 
control without losartan (NS and HS). 
 
 
Figure 2 shows the immunostaining of AQP-1 in renal tissue. AQP-1 
immunoexpression was decreased in proximal tubules of HS animals, and increased 







Figure 2. AQP-1 immunoexpression in renal tissues. Panel A. Histograms illustrate the values of AQP-1 
expression in renal tissue. Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic 
diet plus losartan; HS-L: high-sodium diet plus losartan. Values are expressed as percentage (%) of 
positive stained area  SEM; n=5; *p <0.01 vs NS group; †p< 0.01 vs the respective control without 
losartan. Panel B. Representative image of positive staining corresponding to AQP-1 expression in renal 
cortex (400x). 
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Figure 3 shows the immunostaining of AQP-2 in renal tissue. AQP-2 
immunoexpression decreased in the cortical and medullar collecting ducts of the HS 








Figure 3. AQP-2 immunoexpression in renal tissues. Panel A. Histograms illustrate the values of AQP-2 
expression in renal tissue. Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic 
diet plus losartan; HS-L: high-sodium diet plus losartan. Values are expressed as percentage (%) of 
positive stained area  SEM; n=5; *p <0.01 vs. NS group. Panel B. Representative image of positive 
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3.3. Immunohistochemical staining of Ang II and proﬁbrotic 
markers in renal sections 
 
Table 2 and Figures 4 to 7 show the immunostaining of Ang II, TGF-β1, α-SMA and 
eNOS in renal tissues, respectively. Immunoexpression of Ang II (Table 2 and Fig. 
4) and TGF-β1 (Table 2 and Fig. 5) increased in renal tubular cells of the HS group, 
while that of α-SMA (Table 2 and Fig. 6) increased in the interstitium of the renal 
cortex and medulla. Losartan (HS-L group) prevented the increase in Ang II, TGF-
β1 and α-SMA expression elicited by the sodium load, in renal cortex and medulla. 
On the other hand, losartan treatment did not alter Ang II and TGF-β1 staining in the 
NS-L group, although it slightly increased α-SMA staining in renal cortex and 




Figure 4. Ang II immunoexpression. Representative image of positive staining corresponding to Ang II 
expression (400x). Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic diet 
plus losartan; HS-L: high-sodium diet plus losartan. 
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Figure 5. TGF-β1 immunoexpression. Representative image of positive staining corresponding to TGF-β1 
expression (400x). Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic diet 




Figure 6. α-SMA immunoexpression. Representative image of positive staining corresponding to α-SMA 
expression (400x). Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic diet 
plus losartan; HS-L: high-sodium diet plus losartan. 
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Conversely, the intrarenal expression of eNOS (Table 2 and Fig. 7) was markedly 
decreased in tubular cells of the renal cortex and the medulla in the HS group with 
respect to NS rats. Losartan, which showed no effects in NS rats, prevented the 
decrease in eNOS staining in the HS-L group, showing a similar stain to that 
observed in the NS group. 
 
 








NS 16.6±1.8 23.4±2.1 26.9±0.6 4.2±0.8 
HS 44.7±0.8* 11.2±2.2* 48.7±1.1* 33.2±1.3* 
NS-L 20.9±0,9 20.7±3.3 29.1±1.1 16.8±2.4* 









NS 15.5±1,6 24.3±1,2 19.3±0.5 10.5±0.9 
HS 35.7±1.1* 10.4±2.3* 36.8±0.8* 127.4±1.9* 
NS-L 13.8±0.8 18.3±3.0 16.5±0.8 22.9±2.7* 
HS-L 17.1±1.1† 24.9±1.3† 17.3±0.7† 19.7±1.4*† 
 
Table 2. Expression of angiotensin II (Ang II), endothelial nitric oxide synthase (eNOS), transforming 
growth factor-β1 (TGF-β1) and alpha-smooth muscle actin (α-SMA) in renal cortex and medulla. 
Abbreviations: %: percentage of stained area; Nºmf: number of miofibroblasts per area; NS: normosodic 
diet; HS: high-sodium diet; NS-L: normosodic diet plus losartan; HS-L: high-sodium diet plus losartan. 
*p< 0.01 vs NS; †p< 0.01 vs respective control without losartan. 
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Figure 7. eNOS immunoexpression. Representative image of positive staining corresponding to α-SMA 
expression (400x). Abbreviations: NS: normosodic diet; HS: high-sodium diet; NS-L: normosodic diet 





The present study constitutes the ﬁrst report demonstrating that an excess in dietary 
salt downregulates AQP-1 and AQP-2 levels in proximal tubules and collecting 
ducts respectively, and that this downregulation is prevented by Ang II-AT1 
blockade by losartan. In addition, losartan increased AQP-1 expression in proximal 
tubules independently of sodium load, promoting the concentration of sodium in the 
urine. Furthermore, we showed that an excess of salt in the diet increases renal Ang 
II expression and develops a proﬁbrogenic response in the kidney, as evidenced by 
Ang II, TGF-β1 and α-SMA overexpression in renal tissues. All these alterations 
were prevented by the administration of the AT1 receptor antagonist, losartan. 
In the present study, we observed that Ang II immunoexpression increased in the 
renal cortex and medulla. This increase could be a result from a greater uptake of 
circulating Ang II by stimulation of AT1 receptor and/or from de novo generation of 
intrarenal Ang II, derived from local intrarenal angiotensinogen, produced and 
secreted by proximal tubular cells
4
. Data in literature are contradictory. Clinical and 
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experimental studies have demonstrated that the excessive salt intake increases 
oxidative stress, AT1 receptor expression as well as the renal Ang II levels
18–21
, 
whereas AT2 receptors are down-regulated
22
. However, Fox et al. reported that, in 
normal conditions, an increase in salt intake inhibits both, circulating Ang II and the 
tissue renin–Ang II system23. In addition, Lara et al. described that Sprague–Dawley 
rats subjected to a high salt diet for 2 weeks did not show changes in urinary 
angiotensinogen excretion although they exhibited enhanced deposition of collagen 
and increased NADPH oxidase activity in the kidneys
24
. However, it must be 
pointed out that, the oxidative stress is able to induce conformational molecular 
changes in the angiotensinogen molecule which facilitates a more rapid generation 
of Ang I, when it is exposed to renin
25
. In this order, we have previously 
demonstrated an increase of NADPH oxidase activity and a proﬁbrogenic response 
in the kidneys of normal rats fed a high salt diet, being all these changes prevented 
by the administration of tempol, a superoxide dismutase mimetic
26
. 
Since a dietary salt supplement increased blood pressure, we cannot exclude that the 
lower expression of AQPs found in rats fed a high-sodium diet, could be a 
consequence of hypertension. However, Mc Donough et al. reported that acute 
variations in tensional levels may cause rapid and reversible changes of sodium 
pump activity, as well as a relocation of the apical sodium transporters
27
. Therefore, 
we cannot exclude that chronic changes in blood pressure could be implicated in the 
downregulation of AQP expression in rats fed a high-salt diet. In order to investigate 
the effects of renal Ang II, through AT1 receptor stimulation, on AQP regulation in 
rats fed a high-salt diet, we analyzed the response caused by losartan. In the HS 
group, renal Ang II levels were increased and AQP levels were decreased, being 
these effects reversed by losartan administration. These results could be related to 
the inhibition of intrarenal rather than circulating Ang II, considering that in our 
experimental model, circulating Ang II would be decreased by the inhibition of 
renin secretion by sodium overload. In this order, it has been recently recognized 
that local renal Ang II is a powerful pro-inﬂammatory cytokine and growth factor, 
implicated in the pathogenesis of progressive renal diseases and the development of 
tubular–interstitial ﬁbrosis through AT1 receptor binding28, whereas stimulation of 
AT2 receptor reduces inﬂammation and ﬁbrosis in the ischemic kidney through 
nitric oxide and cGMP production
29
. It is generally admitted as a functional negative 
crosstalk between AT1 and AT2 receptors in several pathophysiological conditions 
including hypertension
30
. In addition, AT2 receptor activation may directly 
antagonize AT1 receptor mediated actions by forming heterodimers with AT1 
receptors
31
. Therefore, further studies are needed to elucidate the role of AT1 and 
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AT2 receptors in losartan effects on renal AQP expression. In addition, it has been 
also suggested that the chronic interstitial ﬁbrosis caused by Ang II could be the 
cause of AQP downregulation and that this fact would be clinically associated with 
the inability of the kidney to concentrate the urine in different pathological 
conditions. In this order, Cao et al.
15
 have demonstrated that during acute lung 
injury, Ang II levels are negatively correlated with AQP-1 mRNA in lung tissues. 
Similarly, Jensen et al. showed that the treatment with the AT1-receptor inhibitor 
candersartan prevented the decrease in AQP-2 expression in response to the bilateral 
ureteral obstruction and attenuates the post-obstructive polyuria as well as the renal 
sodium loss
16
. Moreover, Hasler et al. showed that the activation of NF-kB 
transcriptional factor by pro-inﬂammatory factors such as Ang II reduces AQP-2 
gene transcription
32
. In the present study, we observed that in the HS group, Ang II 
and TGF-β1 immunostaining increased in tubular cells of the renal cortex and 
medulla, and α-SMA staining increased in the renal interstitium, whereas eNOS was 
decreased in the renal cortex and medulla. Therefore, since losartan caused a marked 
decrease of the expression of proﬁbrogenic markers, and prevented changes in 
eNOS expression, it is possible to suggest that the enhancement of intrarenal Ang II 
expression in the HS group may be responsible for the downregulation of AQPs in 
the kidney, as a consequence of a pro-inﬂammatory or a pro-ﬁbrogenic action. 
Moreover, the protective action of losartan could not only be due to AT1 blockade, 
but also to Ang II stimulation on the available AT2 receptors and the response 
through eNOS–nitric oxide–cGMP signalling. The activation of the AT2 signalling 
pathway could prevent the pro-inﬂammatory response and up-regulate AQPs in 
renal tissues. In addition to preventing AQP-1 downregulation, losartan upregulated 
AQP-1 expression in the proximal tubule from both NS-L and HS-L groups, 
suggesting that this effect was independent of the sodium overload. Further studies 
are required to elucidate the signiﬁcance of these observations. 
In the present study, a high-salt intake caused a meaningful increase in UVNa and 
FENa, without changing the GFR. The simultaneous administration of losartan 
increased even more UVNa and FENa, but did not alter the GFR. Conversely, in the 
control group fed with normosodic diet, losartan caused a decrease in SBP and GFR, 
but did not modify sodium excretion, thus increasing the FENa. The control of 
sodium excretion and blood pressure by Ang II is exerted through multiple intrarenal 
as well as extrarenal mechanisms. The most important intrarenal effects of Ang II 
include efferent arteriolar constriction through AT1 receptor stimulation, as well as 
direct effects on sodium transport. The constrictor effect on efferent arterioles is also 
important in preventing reductions of GFR in circumstances associated with 
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impaired renal perfusion. Therefore, the fall in blood pressure and the direct effect 
on efferent arterioles produced by losartan in normal rats could cause reductions in 
the GFR, as we observed in the present work. Our studies revealed that losartan 
exerted a natriuretic effect at the tubular level, independently of its hypotensive 
effect and of GFR changes. Moreover, Ang II over-expression in rats fed a high-salt 
diet was accompanied by a marked decrease in eNOS expression in the renal cortex 
and medulla, being this decrease normalized by losartan treatment. It is well 
documented that renal AT1 receptors, via activation of renal sodium transporters, 
produce anti-natriuretic effects
27
, whereas AT2 receptors activate the nitric 
oxide/cGMP pathway leading to an increase in urinary sodium excretion
33, 34
, thus 
inﬂuencing renal sodium/ﬂuid homeostasis. Therefore, the natriuretic action of 
losartan could not only be due to AT1 blockade, but also to Ang II stimulation on 
the available AT2 receptors. Finally, we observed that losartan increased urinary 
sodium concentration. In this order, it has been described that AQP-2 expression in 
the kidney is related to changes in nitric oxide synthase activity
35
. Additionally, it 
has been shown that the activation of a cGMP-dependent pathway results in AQP-2 
insertion to the cell membrane, a fact that can be mediated by different cGMP 
pathway activators, such as the atrial natriuretic peptide, L-arginine and nitric 
oxide
36
. Therefore, we can suggest that the decrease of eNOS expression, elicited by 
increased intrarenal Ang II levels, could be responsible for AQP-2 down-regulation 
in the renal tubules of rats subjected to HS diet, and that losartan administration 
could exert an antidiuretic effect through Ang II–AT2–nitric oxide–cGMP 
signalling. 
As it is illustrated in Figure 8, a high salt diet may contribute to increase Ang II 
expression in renal tubular cells. In addition, intracellular Ang II, via AT1 receptor 
binding may stimulate cytokine production causing inﬂammation, ﬁbrosis and 
downregulating of AQP expression. The AT1 blocker losartan, prevented intrarenal 
Ang II overexpression and the ﬁbrogenic response, and increased AQP 
immunoexpression. In contrast, the signalling cascade AT2–eNOS–NO could be 
suppressed by a high salt diet. These effects were prevented by losartan 
administration, suggesting that intrarenal Ang II also has a deleterious proﬁbrogenic 
effect and decreases urinary concentration ability. The fact that losartan also 
normalized eNOS expression, suggests that its antiﬁbrotic, natriuretic and 
antidiuretic effects could be partly attributed to unmasked AT2 receptor stimulation 
by Ang II. 
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Figure 8. Schematic ﬁgure summarizing our ﬁndings. White arrows indicate inhibition, black arrows 
indicate stimulation. A high salt diet may contribute to increase Ang II expression in renal tubular cells. 
Intrarenal Ang II, via AT1 receptor binding may stimulate cytokine production causing inﬂammation and 
ﬁbrosis, NADPH oxide activation, AQP downregulation and sodium retention, enhancing urine 
concentration. On the other hand, the signalling cascade AT2–eNOS–NO which normally 
counterbalances AT1 receptor stimulatory actions could be suppressed by a high salt diet, reinforcing the 
effects of AT1 stimulation. These effects were prevented by AT1 receptor blockade by losartan 
administration, suggesting that intrarenal Ang II also has a deleterious proﬁbrogenic effect and decreases 
urinary concentration ability in the kidney. The fact that losartan also normalized eNOS expression, 
suggests that its antiﬁbrotic, natriuretic and antidiuretic effects could be partly attributed to unmasked 
AT2 receptor stimulation by Ang II. 
 
 
In summary, our ﬁndings support the idea that renal Ang II is closely involved in 
AQP downregulation when an excess of sodium is included in the diet. In addition, 
AT1 receptor blockade by losartan administration during a dietary salt 
supplementation could exert beneﬁcial effects, enhancing the ability of the kidney to 
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The aim of this study was to assess whether endogenous Ang II and oxidative stress 
produced by acute hypertonic sodium overload may regulate the expression of 
aquaporin-1 (AQP-1) and aquaporin-2 (AQP-2) in the kidney. 
Groups of anesthetized male Sprague Dawley rats were infused with isotonic saline 
solution (Control) or with hypertonic saline solution (Na group, 1M NaCl), either 
alone or with losartan (10mg.kg
-1




) during two hours. 
Renal function parameters were measured. Groups of unanesthetized animals were 
injected intraperitoneally with hypertonic saline solution, with or without free access 
to water intake, Na+W and Na-W respectively. The expression of AQP-1, AQP-2, 
Ang II, eNOS, and NF-kB were evaluated in the kidney by Western blot and 
immunohistochemistry. 
Na group showed increased natriuresis and diuresis, and Ang II and NF-kB 
expression, but decreased eNOS expression. Losartan or tempol enhanced further 
the diuresis, and AQP-2 and eNOS expression, as well as decreased Ang II and NF-
kB expression. In unanesthetized rats, Na+W group presented increased diuresis, 
natriuresis and AQP-2 expression (112±25 vs 64±16; *p<0.05). Water deprivation 
increased plasma sodium and diuresis but decreased AQP-2 (46±22 vs 112±25; 
§p<0.05) and eNOS expression in the kidney. 
This study is a novel demonstration that renal endogenous Ang II-oxidative stress, 








Under normal conditions, plasma sodium levels are regulated within a physiological 
range despite the large variations in daily sodium and water intake. On the other 
hand, in states of hypernatremia, such as after acute sodium overload, the brain and 
the kidney contribute both in concert to restore plasma sodium homeostasis
1
. Brain 
and kidney responses include changes in water intake and renal excretion. In the 
kidney, aquaporin-1 (AQP-1) channels are responsible for the 80-90% of the fluid 
reabsorption of the glomerular filtrate
2
, and their main expression appear in the 
luminal and basolateral membranes of the proximal tubules, in the epithelial cells of 
the thin descending limb of Henle’s loop, and in the endothelial cells of descending 
vasa recta
3-6
. Aquaporin-2 (AQP-2) channels reabsorb most of the 10-20% 
remaining fluid and are mainly expressed in the principal cells of the collecting 
ducts
7, 8
. The vasopressin hormone (AVP), which is released from the pituitary gland 
into the bloodstream in cases of hypernatremia, enhances collecting duct water 
permeability due to AQP-2 accumulation at the cell surface and increase AQP-2 
protein abundance
9
. However, it has been shown that AQP-2 expression levels 
decreased shortly (>3 h) following hypertonic challenge implying another regulation 
mechanism AVP-non dependent
10
. In this order, the hyperosmolality regulates, AVP 
independently, the expression, targeting, stability and degradation of AQP-2 in the 
medullary collecting duct
11
. In this order, it has been demosntrated that the addition 
of hypertonic NaCl upregulated AQP-1 and AQP-2 expression in cultured renal 
epithelial cells, by activating the transcription factor associated with hypertonicity 
(TonEBP)
12-14
. However, studies carried out in vitro using cultured principal cells of 
collecting duct have shown that the activation of NF-kB, a main transcription factor 
related to renal inflammation, decreased AQP-2 mRNA and protein levels, as a 
result of the binding of NF-kB complexes, consisting of p50 and/or p52, to specific 
kB elements of the AQP-2 promoter
15, 16
. In this regard, a wide range of stimuli 
closely linked to kidney inflammation, including the increase of renal angiotensin II 
and the oxidative stress, activates NF-kB and simultaneously reduces the NO-cGMP 
signaling
17, 18
. In previous studies, we have observed that renal NF-kB and 
angiotensin II (Ang II), as well as the oxidative stress, were also increased in rats 
with hypernatremia provoked by an acute sodium overload
19
. Based on these 
antecedents, it was hypothesized that a hypernatremia produced by sodium overload 
could early suppress, rather than increase renal AQP-2 expression through the 
activation Ang II-oxidative stress pathway. Thus, the aim of this study was, first, to 
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investigate in vivo, AQP-1 and AQP-2 protein expression levels in renal tissues of 
hypernatremic rats induced by acute hypertonic sodium overload, and secondly, to 





2.1. Animal Preparation 
 
Male Sprague-Dawley rats (10-12 weeks old; 270-350 g body weight) were housed 
at controlled temperature (232C) and exposed to a daily 12-hour light-dark cycle 
(lights on from 07:00 a.m. to 07:00 p.m.), with free access to tap water and standard 
rat chow (Cooperación SRL, Argentina). Experiments were conducted in accordance 
with the institutional guidelines for the care and use of research animals of 
Universidad de Buenos Aires and protocols were approved by Universidad de 
Buenos Aires (UBACYT B113) and the National Scientific and Technical Research 
Council (CONICET, PIP 1337/09). 
 
2.2. Experimental Protocols 
 
2.2.1. Anesthetized rats 
Animals were anesthetized with urethane (1.2 g.kg
-1
, intra-peritoneal: i.p.) and the 
anesthesia plane was kept on a surgical level by repeatedly testing the absence of 
corneal reﬂex every 15 minutes throughout the surgical procedure. A tracheotomy 
was then performed and a PE-90 tube (3 cm long) was inserted into the trachea to 
maintain an open airway. The left femoral vein was catheterized with a Silastic 
cannula (0.12 mm i.d.) for continuous infusion. The right carotid artery was also 
catheterized with a T4 tube for blood sampling and arterial pressure recording using 
a Statham GOULD P23ID transducer coupled to a Grass Polygraph 79D. The 
bladder was cannulated with a PE-75 cannula for urine collection. During a 45-
minute stabilization period, the animals were infused with isotonic saline solution 
(0.15M NaCl) at a rate of 0.04 mL.min
-1
 (Syringe Infusion Pump, SageTM, Orion) 
for diuresis to reach a steady state and allow urine collection (basal records). 
Infusion continued at the same rate for 120 minutes (experimental period). Urine 
was collected every 30 minutes for sodium measurement and urine flow rate, and a 
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blood sample was collected at the end of the experimental period. Mean arterial 
pressure (MAP) was recorded at the end of the experimental period. 
 
The animals were randomized into six experimental groups: 
1) C group (n=5): Infused with isotonic saline solution for 120 minutes 
(experimental period).  
2) C-Los group (n=5): Injected with losartan (10mg. mL
-1
 in iv bolus, at a dose of 10 
mg.kg
-1
) at the beginning of the experimental period. Thereafter, animals were 
infused with isotonic saline solution for 120 minutes. 





) during the 120 minutes of the experimental period. 
4) Na group (n=5): Infused with of hypertonic saline solution (NaCl 1.0M) for 120 
minutes.  
5) Na-Los group (n=5): Injected with losartan (10 mg.mL
-1
 in iv bolus, at a dose of 
10 mg.kg
-1
) at the beginning of the experimental period. Thereafter, animals were 
infused with hypertonic saline solution (NaCl 1.0M) for 120 minutes. 





) during the 120 minutes of the experimental period. 
 
2.2.2.Unanesthetized Rats 
In order to confirm that the results observed in Na group were caused by the 
hypertonicity of the plasma and not by the sodium overload per se, another set of 
experiments was carried out in unanesthetized rats subjected to an intraperitoneal 
(i.p.) injection of hypertonic saline solution and without access to water intake. The 
control group consisted in rats subjected to a hypertonic saline solution, but their 
plasma isotonicity was maintained by allowing free access to drinking water. 
Unanesthetized animals were housed in metabolic cages during 48hs before the 
experiments with ad-libitum water intake. At the day of the experiment, the 
following groups of animals were slowly injected with saline solution (2mL.100g
-1
 
of body weight, i.p.): control group: C group (0.15 mol.L
-1
 NaCl) and experimental 
group: Na group (0.8 mol.L
-1
 NaCl). The animals were immediately returned to the 
metabolic cages for the urine collection and to record water intake for 90 min, with 
(+W) or without (-W) free access to drinking water. Then, they were anesthetized 
with urethane (1.2 g.kg
-1
, i.p.) and 1ml of blood samples were obtained from the 




 were measured by 
standard methods by means of an auto-analyzer. In order to determine AQP-1, AQP-
2, Ang II, NF-kB and eNOS protein expression, the kidneys were isolated, rapidly 
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excised, decapsulated, longitudinally cut and harvested for immunohistochemistry 
and Western blot as described below. 
 
2.3. Urine and Blood Measurements 
Urine flow rate (UV), urine and plasma sodium and plasma potassium (respectively 
UNa, PLNa, PLK), were measured by standard methods using an autoanalyzer. Urinary 
osmolality was determined by freezing-point depression. FENa were calculated 
according to standard formula. Urine flow is expressed as ml/min, urinary and 
plasmatic UNa, PLNa, PLK as mEq.L
-1
, Urinary osmolarity (UOsm) as mOsmol.Kg
-1
, 
FENa as the percentage (%) of filtrated sodium. UV is expressed as μL.min
-1
, UNa, 




2.4. Preparation of Renal Homogenates for Western blot 
The right kidney from all groups was extracted and the renal cortex and medulla 
were immediately dissected and separated. Tissue samples were homogenized on ice 





 EDTA, 0.1 mmol.L
-1
 EGTA, 1% Triton, 1 mmol.L
-1





 leupeptin, 1x protease inhibitor cocktail (Roche Diagnostics). 





2.5. Western blot Analysis for AQP-1, AQP-2 and eNOS 
Pooled samples of cortex and medulla from five animals of each group and 
containing similar amounts of protein (100 µg protein/lane) were separated by 
electrophoresis in 7.5% SDS-polyacrylamide gels (Bio-Rad) and then transferred to 
a nitrocellulose membrane (Bio-Rad) and incubated with rabbit polyclonal anti-
AQP-1 (Santa Cruz Biotechnology, Inc. 1:250 dilution), rabbit polyclonal-anti-
AQP-2 (Santa Cruz Biotechnology, Inc.; 1:200 dilution), or rabbit polyclonal anti-
eNOS (Santa Cruz Biotechnology, Inc.; 1:200). The polyclonal AQP-1 antibody 
recognized the 29 and 38 kDa forms corresponding to non-glycosylated and 
glycosylated AQP-1, respectively. A secondary immunoreaction followed with a 
goat anti-rabbit IgG (H+L) conjugated with horseradish peroxidase (dilution of 
1:5000). The samples were revealed by chemiluminescence using ECL reagent 
(Amersham Pharmacia Biotech) for 2-4 min. The density of the respective bands 
was quantified by densitometric scanning of Western blots using a Hewlett-Packard 
scanner and Totallab analyzer software (Biodynamics Corp.). To avoid inaccuracies 
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in protein loading, beta-actin was measured as internal standard (anti-beta actin, 
clone EP1123Y, rabbit monoclonal antibody) for each blot and protein levels were 
calculated and expressed as the ratio between the optical densities of the bands 
corresponding to AQP-1, AQP-2 or eNOS and β-actin. 
 
2.6. Kidney Processing for Immunohistochemistry 
In order to determine the effect of sodium overload on AQP-1, AQP-2, Ang II, 
eNOS and NF-kB immunostaining, left kidneys were isolated, rapidly excised, 
decapsulated, incised in the midline longitudinal plane to divide them into two 
similar halves, and harvested for immunohistochemical studies. Tissues were fixed 
in 10% phosphate-buffered formaldehyde (pH 7.20) and embedded in paraffin. 
Paraffin-embedded tissue sections of 3-µm were deparaffined and dehydrated. 
Endogenous peroxide activity was blocked by treatment with 0.5% H2O2 in 
methanol for 30 minutes. Immunohistochemical assays were conducted as reported 
previously
18
. Immunostaining was detected using the following specific antibodies: 
rabbit polyclonal anti-AQP-1 (Santa Cruz Biotechnology, Inc. 1:200 dilution), 
polyclonal rabbit anti-AQP-2 (Santa Cruz Biotechnology, Inc.; 1:200 dilution), 
monoclonal human anti-Ang II (Peninsula, 1:500 dilution), polyclonal rabbit anti-
eNOS (C-20, Santa Cruz Biotechnology Inc., 1:200 dilution), and rabbit anti-NF-κB 
p65 (Santa Cruz Biotechnology Inc., 1:200 dilution). Immunostaining was 
performed using a commercial modified avidin-biotin-peroxidase complex 
technique (Vectastain ABC kit, Universal Elite, Vector Laboratories). 
Immunostaining was expressed as a percentage (%) of positive stained area  
standard error media (SEM). 
 
2.7. Quantitative Imaging and Morphological Analysis  
Histological sections of five animals were studied in each group. All tissue samples 
were evaluated blindly and separately by two researchers. All measurements were 
carried out on 20 fields per tissue section, using image analyzer Image-Pro Plus, 
version 4.5 for Windows (Media Cybernetics, LP, Silver Spring). Data were 
averaged and the results of positive staining for AQP-1, AQP-2, Ang II, eNOS and 
NF-kB were expressed as a percentage of positive stained area in renal tubules  
SEM. Identification of the different tubule segments was based on main cell 
characteristics observed in the histological photos. 
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2.8. Statistical Analysis 
All results are expressed as mean ± SEM. Gaussian distribution was evaluated by 
the Kolmogorov and Smirnov method and comparisons between groups were made 






3.1. Studies in Anesthetized rats 
 
3.1.2. Mean Arterial Pressure (MAP) 
As reported previously
19
, MAP did not increase after 2 hours of acute sodium 
overload (Na group) compared to basal levels. Moreover, no differences in MAP 
were observed when losartan or tempol were administered to sodium overloaded 



















C 92 ± 3 141 ± 1 3.6 ± 0.1 0.28 ± 0.08 1764 ± 49 
C-Los 65 ± 3* 139 ± 1 3.5 ± 0.2 0.36 ± 0.09 1630 ± 35 
C-Temp 87 ± 1 140 ± 1 3.6 ± 0.1 0.45 ± 0.09 1835 ± 23 
Na 88 ± 3 156 ± 1* 3.7 ± 0.2 8.38 ± 0.75* 721 ± 29* 
Na-Los 84 ± 4 156 ± 1* 3.5 ± 0.2 11.60 ± 1.25*§ 1012 ± 15*§ 
Na-Temp 94 ± 4 154 ± 1* 3.6 ± 0.1 13.74 ± 1.37*§ 1070 ± 22*§ 
 
Table 1. Mean arterial pressure, electrolytes and urinary osmolality in anesthetized rats. All values are 
mean ± SEM (n= 5-6 per group), * p< 0.05 vs C group, §p<0.05 vs. Na group. Abbreviations: MAP: 
mean arterial pressure, PLNa: sodium plasmatic concentration, PLK: potassium plasmatic concentration, 
FENa: fractional excretion sodium, UOsm: urinary osmolality, C: control group infused with isotonic saline 
solution; C-Los: control group infused with isotonic saline solution plus losartan; C-Temp: control group 
infused with isotonic saline solution plus tempol; Na: infused with sodium overload; Na-Los: infused 
with sodium overload plus losartan; Na-Temp: infused with sodium overload plus tempol. 
Chapter 2 
 
~ 65 ~ 
 
3.1.3. Urine and Blood Measurements 
Table 1 shows biochemical results for each group. As expected, the animals 
subjected to an acute sodium overload showed higher levels of PLNa respect to the 
control group. This increase was not modified by the co-administration of losartan 
or tempol with the sodium overload. Plasmatic potassium concentration was not 
statistically modified. The group with acute sodium overload showed higher levels 
of FENa and lower levels of UOsm compared to the control group infused with 
isotonic solution. The co-administration of losartan or tempol with sodium overload 
increased further FENa and increased UOsm as compared to the Na group. The 
administration of losartan or tempol with isotonic saline solution did not shown 
significant changes in both parameters. 
Figure 1 shows results of UV (panel A) and UNa (panel B). As reported previously
19
, 
the group with acute sodium overload showed higher levels of UV and UNa 
compared to the control group infused with isotonic solution. The co-administration 
of losartan or tempol with sodium overload increased further UV but did not modify 
UNa as compared to the Na group. The administration of losartan or tempol with 









Della Penna S. L. et al. 
 






Figure 1. Urinary flow (UV, µL.min-1.kg-1) (panel A) and Urinary sodium concentration (UNa, mEq.L
-1) 
(panel B). C: Control group infused with isotonic saline solution, Na: sodium overload, Los: isotonic 
saline solution plus losartan, Temp: isotonic saline solution plus tempol, Na-Los: sodium overload plus 
losartan, Na-Temp: sodium overload plus tempol. Values are expressed as mean ± SEM; n=5-8. *p<0.05 
vs. C group, §p<0.05 vs. Na group, at the time of infusion. 
 
 
3.1.4. Immunohistochemistry and Western Blot Analysis of AQPs 
Expression in Renal Tissue 
Figure 2 shows AQPs immunostaining in renal tubules. As indicated in panel A, 
AQP-1 staining in the control group was not statistically modified either by the 
sodium overload or by losartan or tempol administration. As shown in panel B, 
AQP-2 staining was similar in Na and control groups. Nonetheless, losartan or 
tempol co-administration with the sodium overload increased AQP-2 

















Figure 2, Panel A. Histograms illustrate the values of AQP-1 expression (top) in proximal tubules of renal 
cortex. Values are expressed as a percentage (%) of positive stained area  SEM; n=5; §p<0.01 vs. Na 
group. Representative immunohistochemical images of negative staining control, positive staining of 
AQP-1 in renal cortex (bottom) of control group infused with isotonic saline solution (C) and 
experimental groups infused with sodium overload (Na), sodium overload plus losartan (Na-Los), and 
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Figure 2. Panel B. Histograms illustrate the values of AQP-2 expression (top) in medullar collecting duct. 
Values are expressed as a percentage (%) of positive stained area  SEM; n=5; §p<0.01 vs. Na group. 
Representative immunohistochemical images of negative staining control, positive staining of AQP-2 in 
renal medulla (bottom) of control group infused with isotonic saline solution (C) and experimental groups 
infused with sodium overload (Na), sodium overload plus losartan (Na-Los), and sodium overload plus 
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Figure 3 shows the Western blot analysis of both AQPs, carried out in homogenates 
of renal tissues. The sodium overload did not modify AQP-1 protein levels in renal 
cortex (panel A). Additionally, losartan and tempol did not modify AQP-1 staining 
area, compared with control and sodium overload groups. The sodium overload did 
not modify AQP-2 protein levels in renal medulla (panel B). However, both losartan 
and tempol enhanced AQP-2 protein expression in sodium overloaded rats, without 
changes in control rats. Thus, AQPs expressions measured by western blot and by 
inmmunohistochemistry showed a similar fashion. 
 
 
Panel A                                                       Panel B 
 
 
Figure 3. Representative Western blot analysis of AQP-1 in renal cortex (panel A) and AQP-2 in renal 
medulla (panel B) of control group infused with isotonic saline solution (C) and experimental groups 
infused with sodium overload (Na), sodium overload plus losartan (Na-Los), and sodium overload plus 
tempol (Na-Temp). Histograms illustrate the values of protein expression of AQP-1 and AQP-2 for every 
group. Each blot was normalized to the expression of -actin from the same gel. Data are mean  SEM, 
expressed as relative optical densities; n=5. *p<0.05 vs. C group; §p<0.05 vs. Na group. 
 
 
Table 2 shows Ang II, NF-kB and eNOS immunostaining in renal tubules. Ang II 
and NF-kB immunostaining in collecting ducts increased in the Na group, compared 
with the C group, where losartan and tempol treatments prevented this increase. In 
addition, eNOS immunostaining in renal medulla in the Na group was significantly 
lower than in the C group, being the decrease prevented by losartan and tempol 
administration. As an illustration of the observed changes, figure 4 shows 
immunostaining images of NF-kB nuclear factor. 
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 Ang II (%) eNOS (%) NF-kB(%) 
C 13.9 ± 0.6 6.18 ± 0.20 6.4 ± 0.5 
Na 27.8 ± 0.4* 2.87 ± 0.13* 10.8 ± 0.9* 
Na-Los 12.1 ± 0.5 6.18 ± 0.2 7.0 ± 0.1 
Na-Temp 8.9 ± 0.7 7.49 ± 0.49 2.6 ± 0.2* 
 
Table 2. Ang II, eNOS and NF-kB immunostaining in renal medulla of anesthetized rats. Abbreviations: 
C: control group infused with isotonic saline solution; Na: infused with sodium overload; Na-Los: infused 
with sodium overload plus losartan; Na-Temp: infused with sodium overload plus tempol. All values are 





Figure 4. Representative immunohistochemical images of positive staining of NF-kB in renal medulla of 
control group infused with isotonic saline solution (C) and experimental groups infused with sodium 
overload (Na), sodium overload plus losartan (Na-Los), and sodium overload plus tempol (Na-Temp). 
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3.2. Studies in Unanesthetized Rats. 
Table 3 shows the results of diuresis, urinary and plasmatic electrolytes and water 
intake. Water deprivation (C-W) did not alter PLNa in i.p. isotonic saline injected 
animals compared to those who had free access to drinking water (C+W). On the 
other hand, the hypertonic saline solution did not modify PLNa in (+W) rats as it was 
expected, but it was increased in water deprived animals (–W). Plasmatic potassium 
values remained unchanged in all studied groups. Both groups i.p injected with 
sodium overload (+W and –W) had higher levels of UV and UNa as compared with 
their respective control group (+W or –W), injected with isotonic solution. 
Additionally, the urine flow rate increased further after the hypertonic saline 
injection in (–W) rats respect to (+W) rats. The water intake in Na+W group was 




























C+W 139.0 ± 0.6 4.1 ± 0.2 32.2 ± 10.1 36.6 ± 11.1 0.81±0.13 
Na+W 141.4 ± 0.4 4.2 ± 0.1 186.0 ± 14.5* 273.2 ± 8.2* 4.03±0.26* 
C-W 139.6 ± 0.5 4.0 ± 0.2 37.2 ± 12.2 37.7 ± 10.6 ----- 
Na-W 145.8 ± 0.7*§ 4.3 ± 0.1 263.3 ± 12.1*§ 282.7 ± 5.6* ----- 
 
Table 3. Electrolytes, diuresis and water intake in unanesthetized rats. Abbreviations: PLNa: sodium 
plasmatic concentration, PLK: potasium plasmatic concentration, UV: urinary volume, UNa: urinary 
sodium concentration, WI: water intake, C: Control, Na: Infused with sodium overload, with (+W) or 
without (-W) access to drinking water. All values are mean ±SEM (n= 5-6 per group), *p< 0.05 vs. 
respective control group; §p<0.05 vs. respective group with access to drinking water. 
 
 
Figure 5 shows that AQP-2 staining increased in Na+W group as compared with 
isotonic infused rats with free access to water (C+W group) in renal cortex (panel A) 
and medulla (panel B). On the other hand, water deprivation decreased AQP-2 
staining in sodium overloaded rats (Na-W group) compared with hypertonic infused 
rats with free access to water (Na+W group). 
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Figure 5. Panel A. Histograms illustrate the values of AQP-2 expression in renal cortex (top) of 
unanesthetized rats intraperitoneally injected with saline solution in two concentrations: C group (control, 
0.15 mol.L-1 NaCl) and experimental group: Na group (0.8 mol.L-1 NaCl), with (+W) or without (-W) 
access to drinking water. Values are expressed as a percentage (%) of positive stained area  SEM; n=5; 
*p<0.01 vs. C group, §p<0.01 vs. Na group. Representative images of positive staining of AQP-2 in renal 











Figure 5. Panel B. Histograms illustrate the values of AQP-2 expression in renal medulla (top) of 
unanesthetized rats intraperitoneally injected with saline solution in two concentrations: C group (control, 
0.15 mol.L-1 NaCl) and experimental group: Na group (0.8 mol.L-1 NaCl), with (+W) or without (-W) 
access to drinking water. Values are expressed as a percentage (%) of positive stained area  SEM; n=5; 
*p<0.01 vs. C group, §p<0.01 vs. Na group. Representative images of positive staining of AQP-2 in renal 
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Figure 6 illustrates renal protein expression of AQP-2 (panel A) in renal medulla 
and eNOS expression (panel B) in cortex and medulla from unanesthetized rats as 
measured by Western-blot. AQP-2 expression increased in Na+W group respect to 
C+W group. In addition, AQP-2 and eNOS protein levels in renal medulla of the 
Na-W group were significantly lower than those in Na+W group. Moreover, eNOS 








Figure 6. Representative Western blot analysis of AQP-2 (panel A) and eNOS (panel B) in renal cortex 
and medulla of unanesthetized rats injected intraperitoneally with saline solution at two concentrations: C 
group (control, 0.15 mol.L-1 NaCl) and experimental group: Na group (0.8 mol.L-1 NaCl), with (+W) or 
without (-W) access to drinking water. Histograms illustrate the values of protein expression of AQP-2 
and eNOS for every group. Each blot was normalized to the expression of -actin from the same gel. AU: 










The present results indicate that increased endogenous Ang II and oxidative stress in 
response to hypernatremia produced by acute sodium overload could early prevent 
AQP-2 over-expression in collecting duct. The sodium-overloaded animals had 
increased diuresis, UNa and FENa, decreased urinary osmolality, together with 
increased Ang II and NF-kB expression, decreased eNOS and unchanged AQP-1 
and AQP-2 expression. In previous reports, we demonstrated that these animals also 
had increased glomerular filtration rate and sodium tubular reabsorption, favouring 
greater flow and sodium transport, which produces oxidative stress
19
. The 
administration of losartan or tempol to these animals increased further the diuresis 
and FENa, without changes in UNa and restored partially the urinary osmolality. This 
was accompanied by a significantly higher expression of AQP-2, and eNOS, and 
decreased Ang II and NF-kB expression. The increased AQP-2 expression is 
reflected in changes of urinary osmolality but not of UNa. Urinary osmolality 
diminishes in the hypertonic group, as a result of the osmotic diuresis produced by 
the sodium overload but partially increased in groups Na-Los and Na-Temp. 
Whereas, the maximum capacity of concentrating sodium is already achieved in Na 
groups, and thus losartan and tempol cannot increase the value of UNa over such 
group, as we have already described in a previous work
19
. Considering that 
plasmatic hypertonicity independently of AVP increase AQP-1 and AQP-2 
expression in the kidney through TonEBP, it would be expected that the rats with 
hypernatremia produced by an acute sodium overload had increased the expression 
of these aquaporins. However, we observed that the expression of both aquaporins 
did not change in the kidney of rats with sodium overload compared with the control 
group, but when sodium overloaded rats were treated with losartan or tempol, in 
both circumstances, the AT1 receptor blockade or the inhibition of the oxidative 
stress, produced an increase in AQP-2 expression in renal tubular cells. 
In order to confirm that the results observed in Na group were caused by the 
hypernatremia and not by the sodium overload per se, we designed another 
experimental model of hypernatremia, carried out in unanesthetized rats subjected to 
the i.p. administration of a hypertonic saline solution and with no access to drinking 
water. Water deprivation did not modify any parameter in controls subjected to 
isotonic saline solution intraperitoneally injected. The i.p. administration of 
hypertonic saline solution to animals with free access to drinking water did not 
change plasma sodium and potassium levels and renal eNOS expression but 
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increased the diuresis, natriuresis and renal AQP-2 expression. On the other hand, 
water deprivation in these animals, increased plasma sodium levels, increased the 
diuresis but did not show enhancement of AQP-2 and eNOS expression in renal 
medulla tissues. These results support the hypothesis that, whereas AQP-1 was not 
modified, AQP-2 expression could be initially inhibited rather than activated by 
hypernatremia. In summary, in both models of hypernatremia produced by sodium 
overload, in which should increase AQP-2 expression, we observed decreased or no 
changes, suggesting another regulatory mechanism. Therefore, we speculate that the 
increase of AQP-2 expression in the kidney tubules induced by hypertonicity may be 
masked by the over-expression of Ang II and the development of oxidative stress 
and this may be the reason why its expression increased after the treatment with 
losartan and tempol. 
It is known that NF-kB downregulates AQP-2 expression by binding to its promoter, 
which contains two highly conserved kB elements
21
. On the other hand, it has been 
reported that the intrarenal Ang II, through nuclear AT1 receptor binding, stimulates 
renal tubular functions through a redox-sensitive pathway and that it inhibits eNOS 
expression through the increase of superoxide production
16
. Our group has 
previously reported the presence of an imbalance between Ang II and eNOS 
expression in sodium overloaded rats
22
. This imbalance was now confirmed, as 
shown in the Results section, and may favor the increase of superoxide anion 
production and lower nitric oxide availability, two circumstances that are able to 
activate the NF-kB transcription factor
23, 24
. Thus, the imbalance between increased 
Ang II and decreased eNOS expressions, would contribute to enhance NF-kB 
activation, and therefore to the inhibition of AQP-2 expression. In order to 
investigate the participation of Ang II-NF-kB signal on AQPs expression, we 
studied the intrarenal expression of Ang II, eNOS and NF-kB in rats with 
hypernatremia and the effects of the inhibition of Ang II by the AT1 receptor 
blocker losartan or the oxidative stress by the administration of tempol. The results 
showed that the rats with hypernatremia by the sodium overload had an increase in 
NF-kB expression in renal tubules and the above commented imbalance between 
intrarenal expressions of Ang II and eNOS. In addition, the administration of 
losartan as well as tempol prevented the increase of NF-kB and Ang II expression, 
restored that of eNOS to control levels, and increased AQP-2 expression, with no 
changes in AQP-1 in renal cortex. Consequently, our results could indicate that the 
Ang II- oxidative stress- NF-kB pathway may be a repressor mechanism to diminish 
AQP-2 expression in rats with hypernatremia. This possibility is also supported by 
previous findings in vitro using renal tubule cells obtained from rat kidney slices. 
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They showed that NF-kB activation, stimulated by a hypertonic medium, decreased 
AQP-2 mRNA and protein levels as a result of the binding of NF-kB complexes to 
specific kB elements of the AQP-2 promoter
21
. Therefore, one explanation of the 
present results would be that NF-kB could decrease AQP-2 gene transcription, while 
the blockage of AT1 receptors by losartan and the inhibition of oxidative stress by 
tempol could prevent NF-kB activation and cause an acute increase of AQP-2 
expression. 
Alternatively, inhibited eNOS expression by sodium overload, could also decrease 
AQP-2 levels by another mechanism, in this case, NF-kB non-dependent. A recent 
report showed that the hypertonicity-induced activation of the NFATc factor may 
also increase AQP-2 transcription
15
. Furthermore, it has been demonstrated that NO 
can enhance the nuclear import of NFATc and decrease its export via PKG, thus 
enhancing NFATc nuclear accumulation and transcriptional activity, supporting a 
novel mechanism by which NO could regulate AQP-2 expression via NFATc
24
. In 
agreement with this finding, the present data also show that sodium overload 
lowered eNOS expression, while losartan and tempol administration caused a 
marked increase. Furthermore, the unanesthetized rats subjected to i.p. sodium 
overload and deprived of water drinking had lower AQP-2 expression in renal 
medulla and simultaneously, lowered eNOS expression. Therefore, although the 
mechanism for the up-regulation of AQP-2 expression in rats with renal Ang II 
blockade and oxidative stress inhibition remains unclear, it is possible suggest that 
the NO system may be involved in this process. 
On the other hand, the results show that the urinary excretion in the present work 
increased in the sodium overloaded group, and losartan and tempol administration 
increased further the urine flow rate despite the rise of renal AQP-2 expression. 
Moreover, in the unanesthetized rats subjected to i.p. sodium overload and deprived 
of water intake, AQP-2 expression decreased, but urine flow rate increased. The 
reason for this different behavior is unknown. It must be mentioned that when a NO 
donor as sodium nitroprusside interacts with the Cys 189 of AQP-1 water channel, it 
suppresses water permeability of renal cell membranes
25
. Thus, a possible 
explanation to support our results, is that NO could act as an inhibitor of the water 
transport through AQP-1 channels. Then, the enhanced eNOS expression observed 
after losartan and tempol administration would facilitate the improvement of NO 
availability. Enhanced NO, in turn, may show opposed effects on the diuresis by 
different pathways: 1) NO may inhibit AQP-1 water channel functions and increase 
water excretion; 2) NO may increase AQP-2 expression and inhibit tubular water 
reabsorption, being this effect masked by AQP-1 inhibition. 
Della Penna S. L. et al. 
 
~ 78 ~ 
 
In conclusion, AQP-2 levels in renal tubular cells are acutely regulated in rats 
subjected to sodium overload. The inflammatory response including imbalance 
between Ang II and eNOS expression levels in renal medulla may be one of the 
repressor mechanisms on AQP expression, through NF-kB pathway. The higher 
levels of eNOS and lower Ang II expression observed after losartan or tempol 
administration may result in increased NO availability, which could regulate AQP-2 
expression, through NF-kB pathway. Accordingly, a better understanding of the 
interaction between NO and AQPs in the kidney would clarify the mechanisms 
involved in water balance disorders. Since NF-kB plays an anti-apoptotic role, it is 
therefore reasonable to consider that the appropriate down-regulation of AQP-2 
expression may be crucial for the survival of cells expressing this AQP isoform 
following acute hypertonic stress. 
The present study constitutes a novel demonstration that the hypernatremia induced 
in vivo by an acute sodium overload in rats, may display an early inhibitory effect 





This study was supported by grants from the National Scientific and Technical 
Research Council (CONICET, PIP 1337) and Universidad de Buenos Aires, 
Argentina (UBACYT B113 and 20020100100688). 
Chapter 2 
 




1. Sinke AP, Deen PM. The 
physiological implication of novel 
proteins in systemic osmoregulation. 
FASEB J. 2011; 25(10):3279-89. 
2. Nielsen S, Kwon TH, Frokier J, 
Agre P. Regulation and 
dysregulation of aquaporins in water 
balance disorders. J Internal 
Medicine. 2007; 261: 53-64. 
3. Schnermann J, Chou CL, Ma T, 
Traynor T, Knepper MA, Verkman 
AS. Defective proximal tubular fluid 
reabsorption in transgenic 
aquaporin-1 null mice. Proc Natl 
Acad Sci USA. 1998; 95: 9660–64. 
4. King LS, Nielsen S, Agre P. 
Aquaporin-1 water channel protein 
in lung: ontogeny, steroid-induced 
expression, and distribution in rat. J 
Clin Invest. 1996; 97: 2183–91. 
5. Pallone TL, Edwards A, Ma T, 
Silldorff EP, Verkman AS. 
Requirement of aquaporin-1 for 
NaCl-driven water transport across 
descending vasa recta. J Clin Invest. 
2000; 105: 215–22. 
6. Sabolic I, Valenti G, Verbavatz JM, 
Van Hoek AN, Verkman AS, 
Ausiello DA, et al. Localization of 
the CHIP28 water channel in rat 
kidney. Am J Physiol Cell Physiol. 
1992; 263: C1225–33. 
7. Takata K, Matsuzaki T, Tajika Y, 
Ablimit A, Hasegawa T. 
Localization and trafficking of 
aquaporin 2 in the kidney. 
Histochem Cell Bio. 2008; 
130(2):197-209. 
8. Hasler U, Leroy V, Martin PY, 
Féraille E. Aquaporin-2 abundance 
in the renal collecting duct: new 
insights from cultured cell models. 
Am J Physiol Renal Physiol. 2009; 
297(1):F10-8. 
9. Hasler U, Nielsen S, Féraille E, 
Martin PY. Posttranscriptional 
control of aquaporin-2 abundance by 
vasopressin in renal collecting duct 
principal cells. Am J Physiol Renal 
Physiol. 2006; 290(1):F177-87. 
10. Hasler U, Vinciguerra M, 
Vandewalle A, Martin PY, Féraille 
E. Dual effects of  hypertonicity on 
aquaporin-2 expression in cultured 
renal collecting duct principal cells. 
J Am Soc Nephrol. 2005; 
16(6):1571-82. 
11. Li C, Wang W, Summer SN, 
Cadnapaphornchai MA, Falk S, 
Umenishi F, Schrier RW. 
Hyperosmolality in vivo upregulates 
aquaporin 2 water channel and Na-
K-2Cl co-transporter in Brattleboro 
rats. J Am Soc Nephro. 2006; 
17(6):1657-64. 
12. Umenishi F, Narikiyo T, Schrier 
RW. Effect on stability, degradation, 
expression, and targeting of 
aquaporin-2 water channel by 
hyperosmolality in renal epithelial 
Della Penna S. L. et al. 
 
~ 80 ~ 
 
cells. Biochem Biophys Res 
Commun. 2005; 338(3):1593-9. 
13. Lanaspa MA, Andres-Hernando A, 
Li N, Rivard CJ, Cicerchi C, Roncal-
Jimenez C, et. Al. The expression of 
aquaporin-1 in the medulla of the 
kidney is dependent on the 
transcription factor associated with 
hypertonicity, TonEBP. J Biol 
Chem. 2010; 285(41):31694-703. 
14. Conner MT, Conner AC, Brown JE, 
Bill RM. Membrane trafficking of 
aquaporin 1 is mediated by protein 
kinase C via microtubules and 
regulated by tonicity. Biochemistry. 
2010; 49(5):821-23. 
15. Hasler U. An example of functional 
interaction between 
NFAT5/TonEBP and nuclear factor-
κB by hypertonic stress: aquaporin-2 
transcription. Cell Cycle. 2011; 
10(3):364-5. 
16. Sanz AB, Sanchez-Niño MD, Ramos 
AM, Moreno JA, Santamaria B, 
Ruiz-Ortega M, Egido J, Ortiz A. 
NF-kappaB in renal inflammation. J 
Am Soc Nephro. 2010; 21(8):1254-
62. 
17. Pendergrass KD, Gwathmey TM, 
Michalek RD, Grayson JM, 
Chappell MC. The angiotensin II-
AT1 receptor stimulates reactive 
oxygen species within the cell 
nucleus. Biochem Biophys Res 
Commun. 2009; 384(2):149-54. 
18. Massey KJ, Hong NJ, Garvin JL. 
Angiotensin II stimulates superoxide 
production in the thick ascending 
limb by activating NOX4. Am J 
Physiol Cell Physiol. 2012; 
303(7):C781-9. 
19. Rosón MI, Cavallero S, Della Penna 
S, Cao G, Gorzalczany S, Pandolfo 
M, et. al. Acute sodium overload 
produces renal tubulointerstitial 
inflammation in normal rats. Kidney 
Int. 2006; 70 (8):1439-46. 
20. Lowry OH, Rosebrough NJ, Farr 
AL, Randall RJ. Protein 
measurement with the Folin phenol 
reagent. J Biol Chem. 1951; 193: 
265–75. 
21. Hasler U, Leroy V, Jeon US, Bouley 
R, Dimitrov M, Kim JA, et. al. NF-
κB Modulates Aquaporin-2 
Transcription in Renal Collecting 
Duct Principal Cells. J Biol Chem. 
2008; 283(42): 28095–28105. 
22. Rosón MI, Della Penna SL, Cao G, 
Gorzalczany S, Pandolfo M, Toblli 
JE, et. al. Different protective 
actions of losartan and tempol on the 
renal inflammatory response to acute 
sodium overload. J Cell Physiol. 
2010; 224(1):41-8. 
23. Vellaichamy E, Sommana NK, 
Pandey KN. Reduced cGMP 
signaling activates NF-kappaB in 
hypertrophied hearts of mice lacking 
natriuretic peptide receptor-A. 
Biochem Biophys Res Commun. 
2005; 327(1):106-11. 
24. Albertoni Borghese MF, Bettini LM, 
Nitta CH, de Frutos S, Majowicz M, 
Gonzalez Bosc LV. Aquaporin-2 
promoter is synergistically regulated 
Chapter 2 
 
~ 81 ~ 
 
by nitric oxide and nuclear factor of 
activated T cells. Nephron Extra. 
2011; 1(1):124-38. 
25. Lahajnar G, Pecar S, Sepe A. Na-
nitroprusside and HgCl2 modify the 




Della Penna S. L. et al. 
 
~ 82 ~ 
 
 
 Part II 
 







Different Protective Actions of Losartan and 
Tempol on the Renal Inflammatory Response to 


















María I. Rosón, Silvana L. Della Penna, Gabriel Cao, Susana Gorzalczany, Marcela 
Pandolfo, Jorge E. Toblli, Belisario E. Fernandez. 
 
Journal of Cellular Physiology 
 
J Cell Physiol. 2010;224(1):41-8 
Della Penna S. L. et al. 
 




The aim of this work was to study the role of local intrarenal angiotensin II (Ang II) 
and the oxidative stress in the up-regulation of pro-inflammatory cytokines 
expression observed in rats submitted to an acute sodium overload. 
Sprague–Dawley rats were infused for 2 h with isotonic saline solution (Control 
group) and with hypertonic saline solution alone (Na group), plus the AT1 receptor 
antagonist losartan (10 mg.kg
-1
 in bolus) (Na–Los group), or plus the superoxide 




) (Na–Temp group). 
Mean arterial pressure, glomerular filtration rate, and fractional sodium excretion 
(FENa) were measured. We evaluated by immunohistochemistry, the expression of 
Ang II, nuclear factor kappa-B (NF-B), hypoxia inducible factor-1alpha (HIF-1), 
transforming growth factor-beta1 (TGF-1), smooth muscle actin (-SMA), 
endothelial nitric oxide synthase (eNOS), and RANTES. Ang II, NF-B, TGF-1 
and RANTES early inflammatory markers were over-expressed in Na group, 
accompanied by enhanced HIF-1 immunostaining, lower eNOS expression, and 
unmodified -SMA. Losartan and tempol increased FENa in sodium overload 
group. Although losartan reduced Ang II and NF-B staining and increased eNOS 
expression, it did not restore HIF-1 expression and did not prevent inflammation. 
Conversely, tempol increased eNOS and natriuresis, restored HIF-1expression, 
and prevented inflammation. Early inflammatory markers observed in rats with 
acute sodium overload is associated with the imbalance between HIF-1 and eNOS 
expression. While both losartan and tempol increased natriuresis and eNOS 
expression, only tempol was effective in restoring HIF-1 expression and down-
regulating TGF-1 and RANTES expression. 
The protective role of tempol, but not of losartan, in the inflammatory response may 
be associated with its greater antioxidant effects. 
Chapter 3 
 




In normal physiological conditions, the antioxidative function of nitric oxide (NO) 
and superoxide dismutase (SOD) activity in the tissues, counterbalances superoxide 
anion (·O2
-
) oxidative effects, maintaining its production at a minimum level. 
However, this balance is altered when tissular NO production by the endothelial 
nitric oxide synthase (eNOS) or the adequate removal of NO by ·O2
-
 is impaired, 
allowing ·O2
-




 activates transcription 
nuclear factor NF-B, which in turn modulates the induction of genes involved in 
renal inflammatory and fibrogenic responses through release of cytokines and 
accumulation of inflammatory cells in the kidney
2
. Several studies have 
demonstrated that a disbalance between NO and ·O2
-
 in the kidney determines the 
initial condition of oxidative stress, which alters renal hemodynamia and the 
excretory function, leading to the development of sodium retention, hypertension, 
and renal injury
1
. It is well known that a high salt intake leads to the development of 
hypertension in Dahl salt-sensitive rats, which is associated with an increase in 
oxidative stress and a decrease in the antioxidant capacity
3, 4
. NO deficiency is also 
known to impair kidney function, contributing to the development of salt-sensitive 
hypertension
5, 6
. Moreover, an antioxidant treatment increases NO bioavailability, 
contributing to reduce renal damage in salt-sensitive rats
7
. 
It is known that ·O2
-
 might increase PKC- activity in thick ascending limb and 







which in turn stimulate tubular sodium reabsorption
8
. Furthermore, studies carried 
out in vitro in macula densa have shown that the transport of luminal NaCl to the 
inside of tubular cells induces the depolarization of the tubular cell membrane, 










 are able by themselves to increase ·O2
-
 production. This 
cascade of events leads to the development of a vicious circle in which a small 
increase in sodium transport begets an increase in ·O-2 production. 
Intrarenal angiotensin II (Ang II) is also linked to oxidative stress and the 
inflammation observed in salt-sensitive models
15
. Besides its actions on hydrosaline 
balance regulation, the attention has been recently focused on the possibility that 
intrarenally formed Ang II behaves like a true cytokine, modulating the induction of 
genes involved in renal inflammatory and fibrogenic responses
16
. In this way, Ang II 
increases ·O2
-
 production through the activation of NADPH oxidase, which is a 
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major source of ·O2
-
 in the kidney
17
. Ang II activates transforming growth factor-
beta1 (TGF-1) expression, stimulates collagen and fibronectin synthesis, and 
participates in renal failure development, controlling the deposition and remodelling 
of extracellular matrix
18
. Then, the increase in intrarenal Ang II production or 
sodium tubular transport as well as the mechanic effect mediated by the increase in 
the tubular flow or the stretch can generate oxidative stress and tissular 
inflammation in the kidney. 
Studies carried out in vivo in our laboratory have shown that an acute sodium 
overload up-regulated intrarenal Ang II and the expression of diverse pro-
inflammatory and pro-fibrogenic markers in renal tissues
19-21
. However, up to date it 
remains unclear which are the pathophysiological mechanisms involved in the early 
expression of inflammatory markers after an acute sodium overload. 
Based on these antecedents, the aim of our study was to evaluate the role of tubular 
Ang II signalling through the AT1 receptor (AT1R) and the participation of the 
oxidative stress and NO in the development of renal pro-inflammatory response 
observed in rats submitted to an acute hypertonic sodium overload. The AT1R 
antagonist losartan or the SOD mimetic tempol was administered to sodium 






2.1. Animal Preparation 
Male Sprague–Dawley rats (10–12 weeks old; 270–350 g body weight) were used. 
Animals were housed at controlled temperature (23±28ºC) and exposed to a daily 
12-h light–dark cycle (lights on from 07:00 a.m. to 07:00 p.m.) with free access to 
tap water and standard rat chow (Isidro Casanova, Buenos Aires, Argentina). 
Experiments were conducted in accordance with the Institutional University of 
Buenos Aires guidelines for the care and use of research animals. 
The rats were intraperitoneally anesthetized with urethane (1,2 g.kg
-1
). After then, a 
tracheotomy was performed and a PE-90 tube (3-cm long) was inserted into the 
trachea to maintain an open airway. The left femoral vein was catheterized with a 
Silastic cannula (0.12 mm i.d.) for continuous infusion. The right carotid artery was 
also catheterized with a T4 tube for blood sampling and continuous mean arterial 
pressure (MAP) measurement, by means of a Statham GOULD P23ID transducer 
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coupled to a Grass Polygraph 79D. The bladder was cannulated for urine collection 
using a PE-75 cannula. A45-min infusion with isotonic saline solution, 0.15M NaCl 
(ISS) allowed reaching a steady diuresis and permitted urine collection in all groups. 
Then, all the animals were infused for 120 min, at the same rate of 0.04 mL.min
-1
 
(Syringe Infusion Pump, SageTM, Orion, Mass, USA). The following groups were 
studied: C (control): infused with SSI (NaCl 0.15 M), and three experimental groups 
subjected to an acute sodium overload: Na: infused with hypertonic saline solution 
(NaCl 1.0 M); Los: infused with NaCl 0.15M + losartan (Merck, Buenos Aires, 
Argentina) (10 mg.kg
-1
 in bolus); Temp: infused with NaCl 0.15M + tempol (Sigma-




); Na–Los: infused with 
NaCl 1.0M + losartan (10 mg.kg
-1
 in bolus) and Na–Temp: infused with NaCl 1.0M 




). Two blood samples were collected at 60 and 120 min 
and urine was collected along 30 min periods (from 0 to 120 min) for sodium, 
potassium, and creatinine measurements. MAP was continuously monitored during 
all the procedures. 
 
2.2. Urine and blood measurements 
Urinary and plasmatic sodium, potassium, and creatinine were measured by standard 
methods using an autoanalyzer. Creatinine clearance was assessed in order to 
evaluate the glomerular filtration rate (GFR). GFR and sodium fractional excretion 
(FENa) were calculated according to a standard formula. Urinary flow (UV) is 
expressed as ml.min
-1
; plasmatic sodium and potassium as mEq.L
-1
, sodium as 
mmol.min
-1
, GFR as mL.min
-1
, and FENa as percentage. 
 
2.3. Kidney processing for histological examination 
At the end of the infusion period, the left kidney was perfused with ISS through the 
abdominal aorta until the blood was washed out and the parenchyma showed a pale 
appearance. The kidney was rapidly excised, decapsulated, longitudinally cut, and 
harvested for immunohistochemical studies. 
Tissues were fixed in phosphate-buffered 10% formaldehyde (pH 7.2) and 
embedded in paraffin. For immunohistochemistry, sections were deparaffined and 
rehydrated, and endogenous peroxidise activity was blocked by treatment with 0.5% 
H2O2 in methanol for 20 min. Samples were sectioned to 3mm thickness, stained 
with Masson’s trichromic, and were examined by light microscopy for tubular injury 
and interstitial fibrosis. Immunostaining of Ang II, hypoxia inducible factor-1alpha 
(HIF-1), NF-kB, TGF-1, endothelial nitric oxide synthase (eNOS), smooth 
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muscle actin (-SMA), and RANTES were detected using the following specific 
monoclonal antibodies: human anti-Ang II (Peninsula, CA; dilution of 1:500), rabbit 
anti-HIF-1 (Novus Biologicals, Inc., Littleton, CO; dilution: 1:1,000), rabbit anti-
NF-B p65 (Santa Cruz Biotechnology, Inc, California, USA), rabbit anti-TGF-1 
(Santa Cruz Biotechnology, Inc, California, USA), rabbit anti-eNOS (Santa Cruz 
Biotechnology, Inc, California, USA), mouse anti--SMA (Santa Cruz 
Biotechnology, Inc, California, USA), and goat anti-RANTES (Santa Cruz 
Biotechnology, Inc, California, USA; dilution: 1:200), respectively. Immunostaining 
was carried out by means of a commercial modified avidin–biotin–peroxidase 
complex technique (Vectastain ABC kit, Universal Elite, Vector Laboratories, 
Burlingame, California, USA) and counterstained with hematoxylin. 
Histological sections were observed in a Nikon E400 light microscope (Nikon 
Instrument Group, Melville, NY). All measurements were carried out using image 
analysis software (Image-Pro Plus ver. 4.5 for Windows, Media Cybernetics, LP, 
Silver Spring, MD). The identification of different nephron segments was based on 
main cell characteristics, which were observed in the histological pictures
22
. 
Immunoreactivities for Ang II, HIF-1, NF-B, TGF-1, RANTES, -SMA, and 
eNOS are expressed as percentage of positive stained area ± SEM. 
 
2.4. Statistical analysis 
Results from urine and blood measurements and MAP levels are expressed as mean 
± SEM. Gaussian distribution was evaluated by the Kolmogorov and Smirnov 
method, and comparisons among groups were carried out using ANOVA followed 



















3.1 Mean arterial pressure and plasma measurements 
As we have previously reported
11
, the acute 2-h salt overload (Na group) did not 
increase MAP (mmHg) compared with basal levels (basal 95±2 vs. after salt 
overload 91±2). When losartan was infused alone (Los group), it decreased MAP 
values compared with its own basal levels (basal: 96±4 vs. after Los: 63±4, p<0.01). 
In addition, when losartan was simultaneously administered with sodium overload 
(Na–Los group), no change was observed compared with its own basal period levels 
(basal: 94±4 vs. after Na–Los: 84±6), but it decreased MAP with respect to C group 
after 120 min of ISS infusion (C: 98±4 vs. after Na–Los: 84±6, p<0.05). On the 
other hand, tempol administration did not reduce MAP levels, neither when it was 
administered alone (basal: 92±2 vs. after tempol 87±2), nor when it was co-
administered with sodium overload (Na–Temp, basal: 96±5 vs. after tempol 96±3). 
As we have previously reported
19
, plasmatic Na concentration (mEq.L
-1
) increased 
after sodium overload, compared with the control group (C: 137.6±0.4, Na: 
154.0±1.4, p<0.01). Neither losartan nor tempol administration elicited significant 
changes in plasmatic Na concentrations in Na overloaded rats (Na–Los: 153.2±1.6; 
Na–Temp: 154.1±1.0). Plasmatic potassium levels (mEq.L-1) were altered neither by 
sodium overload nor by losartan or tempol, when compared to control animals (C: 
2.8±0.1, Na: 3.0±0.1, Na–Los: 3.0±0.1, and Na–Temp: 2.8±0.1). 
 
3.2. Urinary measurements 
Figure 1 shows urine flow, urinary sodium excretion, and urinary sodium and 
potassium concentrations. We have previously reported that an acute sodium 
overload increased urine flow and sodium excretion
19
. Losartan administration 
caused an increase in urine flow in acute sodium overloaded rats in a greater 
proportion than that of urinary sodium excretion, when compared with Na group; 
thus, urine sodium concentration diminished. In contrast, tempol administration 
increased both urinary sodium excretion and urinary flow in a similar proportion. 
Therefore, tempol did not decrease urinary sodium concentration as losartan did. 
Neither losartan nor tempol administration modified urinary potassium excretion, 
which was increased by the acute sodium overload. 
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Figure 1. Renal Function. Urinary flow (UV, µL.min-1.kg-1) (top left); potassium urinary excretion (UVK, 
µmol.min-1.kg-1) (top right); sodium urinary excretion (UVNa, µmol.min
-1.kg-1) (bottom left) and sodium 
urinary concentration (UNa, mEq.L
-1) (bottom right). Abbreviations: C: control group infused with 
isotonic saline solution (dash line and open circle), Na: sodium overload (full line and open circle), Na-
Los: sodium overload plus losartan (closed triangle), and Na-Temp: sodium overload plus tempol (closed 
square). Values are expressed as mean ± SEM; n=5-8; *p<0.05 vs. Na group. 
 
 
3.2.1. Glomerular filtration rate and fractional sodium excretion 
We have shown
19
 that an acute sodium overload increased the GFR, inducing 
glomerular hyperfiltration. Losartan prevented that increase in Na group after the 
first 60 min infusion period. On the other hand, tempol did not modify the GFR in 
the Na group at any time (Fig. 2, top). As shown in Figure 2 (bottom), the acute 
sodium overload increased FENa. When losartan or tempol were co-administered, a 
further increase in FENa was observed. 
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Figure 2. Glomerular Filtration Rate (GFR) and Sodium Fractional Excretion (FENa). GFR (µL.min
-1, top) 
and FENa (%, bottom) along 60min (left) and 120min (right). Abbreviations: C: control group infused 
with isotonic saline solution, Na: sodium overload, Na-Los: sodium overload plus losartan, and Na-Temp: 
sodium overload plus tempol. Values are expressed as mean ±SEM; n=5-8. *p<0.05 and **p<0.01 vs. C 
group; §p<0.05 vs. Na group. 
 
 
3.3. Immunohistochemical expression in renal sections 
The analysis of renal sections obtained from rats subjected to sodium overload 
revealed increased Ang II, HIF-1, NF-B (Fig. 3), and TGF-1 (Fig. 4) staining, 
which was mainly localized in proximal convolute tubules (PCT) and cortical 
collecting ducts (CCDs) (Fig. 5) and medullar collecting ducts (MCDs) (Fig. 6), 
with respect to control group. RANTES expression only increased in CCD (Fig. 5) 
and MCD (Fig. 6). Acute sodium overload reduced eNOS expression, compared to 
control group, in renal cortex (C: 5.49±0.24%, Na: 4.30±0.18%; p<0.05) and 
medulla (C: 4.08±0.21%, Na: 2.87±0.13%; p<0.05). Neither the staining with 
Trichromic-Maisson, nor the -SMA immunoexpression revealed histopathological 
signs of fibrosis in Na group (data not shown). 
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Figure 3. Panel A. Immunohistochemical expression of Ang II, HIF-1 and NK-B in proximal 
convoluted tubules (PCT). Abbreviations: C: control group infused with isotonic saline solution, Na: 
sodium overload, Na-Los: sodium overload plus losartan (closed triangle), and Na-Temp: sodium 
overload plus tempol. Values are expressed as mean ± SEM; n=5-8. *p<0.05 and **p<0.01 vs. C group; 
§p<0.05 vs. Na group. Representative images of positive staining (original magnification 400x) of Ang II 
(Panel B), HIF-1 (Panel C), and NF-B (Panel D) in renal cortex. 
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3.3.1. Effects of losartan and tempol on renal proximal tubules 
The renal staining of none of the inflammatory markers studied in rats infused with 
ISS was modified by losartan or tempol administration, in any of the areas examined 
(data not shown). Increased Ang II, HIF-1, and NF-B staining in Na overloaded 
rats was reduced in proximal tubules when losartan was administered (Fig. 3) but 
losartan failed to restore HIF-1 and to decrease TGF-1 staining (Fig. 4). On the 
other hand, tempol caused a further inhibition of Ang II, HIF-1, and NF-B 
expression (Fig. 3) and restored TGF-1 staining in Na overloaded rats, reaching 
similar levels to those observed in C group (Fig. 4). RANTES staining was neither 
modified by sodium overload nor by losartan or tempol co-administration (Fig. 4). 
In addition, losartan increased eNOS expression in renal cortex, compared with Na 
group (7.09±0.35% vs. 4.30±0.18%; p<0.001) and medulla (6.18±0.20% vs. 
2.87±0.13%; p<0.001). Moreover, the increase in eNOS expression elicited by 
tempol was higher than that stimulated by losartan in renal cortex (10.44±0.59% vs. 

























Figure 4. Panel A. Immunohistochemical expression of TGF-1 and RANTES in proximal convoluted 
tubules (PCT). Abbreviations: C: control group infused with isotonic saline solution, Na: sodium 
overload, Na-Los: sodium overload plus losartan (closed triangle), and Na-Temp: sodium overload plus 
tempol. Values are expressed as mean ± SEM; n=5-8; *p<0.05 and **p<0.01 vs. C group; §p<0.05 vs. Na 
group. Representative images of positive staining (original magnification 400x) of TGF-1 (Panel B), and 
RANTES (Panel C) in renal cortex. 
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3.3.2. Effects of losartan and tempol on cortical collecting ducts 
Losartan reduced Ang II, HIF-1, and NF-B staining in CCDs of sodium 
overloaded rats, but it did not attenuate TGF-1 and RANTES staining. Whereas 
tempol reduced Ang II, HIF-1, NF-B, and TGF-1 staining in CCDs of sodium 





Figure 5. Immunohistochemical expression of Ang II, HIF-1, NK-B, TGF-1 and RANTES in cortical 
collecting ducts (CCD). Abbreviations: C: control group infused with isotonic saline solution, Na: sodium 
overload, Na-Los: sodium overload plus losartan (closed triangle), and Na-Temp: sodium overload plus 




3.3.3. Effects of losartan and tempol on medullar collecting ducts 
Losartan and tempol markedly reduced Ang II, HIF-1, and NF-B expression in 
MCDs in acute sodium overloaded rats. While losartan did not attenuate TGF-1 
and RANTES staining, already overstained in these rats, tempol diminished the 









Figure 6. Immunohistochemical expression of Ang II, HIF-1, NK-B, TGF-1 and RANTES in 
medullar collecting ducts (MCD). Abbreviations: C: control group infused with isotonic saline solution, 
Na: sodium overload, Na-Los: sodium overload plus losartan (closed triangle), and Na-Temp: sodium 






In the present study, we demonstrate that the early expression of inflammatory 
markers observed in the kidney of rats submitted to sodium overload was associated 
with the simultaneous decrease in eNOS expression and increase in HIF-1 
expression, which suggests greater oxidative stress. Both losartan and tempol had a 
natriuretic effect and inhibited Ang II up-regulation. However, only tempol showed 
an anti-inflammatory effect accompanied by an antioxidant action, since it increased 
eNOS expression and lowered HIF-1 expression to control level. On the contrary, 
AT1 receptor inhibitor losartan, though it increased eNOS expression, did not 
restore HIF-1expression and did not prevent the over-expression of inflammatory 
markers in renal tubules. These results demonstrate an anti-inflammatory effect of 
tempol associated with an antioxidant action, independently of renal Ang II 
expression. 
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In earlier studies from our laboratory we have observed that rats submitted to 
sodium overload showed hyperfiltration, an increased Na tubular reabsorption, 
accompanied by enhanced renal Ang II and HIF-1 expression and inflammatory 
markers in renal tubules
19
. In the present study, besides we observed lower eNOS 
expression. These considerations suggest that the oxidative stress produced by an 
imbalance between the production of NO and ·O2
-
 in the kidney could play a role in 
the pathogenesis of the inflammation. It is well known that several factors, like the 
hyperfiltration as well as the peripheral sympathetic nervous system or the oxidative 
stress, regulate angiotensinogen expression and consequently, Ang II production in 
proximal tubules
23, 24
. Furthermore, Ang II induces, through AT1 receptor 
stimulation, angiotensinogen gene expression, and in consequence, Ang II 
expression is enhanced by a positive feedback mechanism
25, 26
. It is also known that 
renal tubular Ang II regulates NADPH oxidase-dependent ·O-2 production, and 
consequently the HIF-1 stabilization27. On the other hand, Ang II regulates tubular 
sodium transport, stimulates Na
+–K+–ATPase activity and ATP consumption, 
decreases ATP concentration, leading to a diminished eNOS expression
28
. In order 
to evaluate the participation of intrarenal Ang II in the inflammatory response, we 
studied losartan effects, as a specific antagonist of AT1 receptors. Losartan 
normalized Ang II and NF-B expression in Na group reaching similar levels to 
controls animals, but it failed to restore GFR and HIF-1 immunoexpression, which 
was partially decreased. Moreover, losartan did not modify RANTES and TGF-1 
expression, although it simultaneously enhanced eNOS expression. In addition, 
losartan exerted a natriuretic effect without changing the MAP. While losartan 
inhibited partially the hyperfiltration, it normalized the Ang II expression to control 
levels. We assume that another cause independent from the hyperfiltration could be 
involved in Ang II expression, that is, sympathic nervous activity or oxidative stress 
produced by a mechanical effect
12, 23
. However, Ang II, besides its known binding to 
AT1 or AT2 plasma membrane receptors, it may be internalized and translocated to 
the nucleus, where it would directly interact with the receptor located near the 
nuclear membrane
26
. In this way, specific AT1 receptors have been shown at the 
nuclear membrane, where they induce the transcription of renin and angiotensinogen 
mRNA modulating their synthesis
25
. Then, we cannot exclude that losartan 
modulates the signalling pathway of Ang II independently of hyperfiltration. These 
facts could explain why, while GRF inhibition was a partial effect, on the other 
hand, losartan normalized Ang II expression to control levels. Independent of the 
cause that produces upregulation of Ang II expression, losartan enhanced eNOS 
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expression but could neither restore HIF-1 expression nor prevent the 
inflammatory response. Our results suggest that another pathway, independent of the 
up-regulation of renal Ang II, may be responsible of HIF-1 increase in sodium 
overloaded rats. Besides, since losartan increased natriuresis and FENa, we suggest 
that increased renal Ang II is more involved in Na tubular transport. 
On the other hand, tempol, a SOD mimetic, which scavenges ·O2
-
 production and 
enhances NO bioavailability
29
, normalized Ang II, NF-B, and TGF-1 
immunoexpression in PCT and CCD and RANTES in MCD to control levels, and 
augmented natriuresis without affecting MAP or hyperfiltration. These effects were 
simultaneously accompanied by HIF-1 normalization and eNOS expression, 
suggesting inhibition of oxidative stress. The oxidative stress produced by the 
increase of GFR or the tubular stretch may be the signalling for angiotensinogen–
renin–Ang II cascade activation. Tempol inhibited Ang II staining restoring the 
levels observed in Na group and simultaneously maintained the hyperfiltration 
observed salt overloaded animals. These results suggest that hyperfiltration would 
not be the cause of Ang II upregulation. However, we cannot exclude that the 
hyperfiltration is the cause of oxidative stress which may activate the 
angiotensinogen–Ang II cascade. Another possibility to justify tempol effects on 
renal Ang II would be based on its action over the renal sympathetic system. Renal 
sympathetic system stimulates Ang II production
23
, and tempol by inhibiting this 
system, could be reducing Ang II synthesis
30
. 
The natriuretic action of tempol agrees with the literature. It has been shown that 
tempol produces natriuresis regulating Na
+–K+–ATPase, Na+/H+ interchanger, Na+–
K
+–2Cl- co-transporter and ENaC activities and increasing medullar renal blood 
flow
29, 31
. Furthermore, tempol prevents dopamine D1 receptors down-regulation in 
proximal tubules of rats submitted to oxidative stress, leading to a reduction in 
sodium reabsorption by proximal tubules
32
. In addition, tempol administration to 
salt-sensitive rats fed a high salt diet prevented the enhancement of intrarenal 
angiotensinogen expression, decreasing in this way anti-natriuretic Ang II actions
33
. 
However, considering that both tempol and losartan inhibited sodium transport and 
increased natriuresis, but only tempol decreased the over-expression of 
inflammatory markers, while losartan lacked these effects, we suggest that the 
beneficial effect of tempol was more related to its antioxidant role, than to its 
natriuretic effects. 
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Our results are in agreement with previous reports, which have shown that the acute 
response to tempol administration in anesthetized rats was an antioxidant effect, 
besides its diuretic and natriuretic actions
31
. 
Then, it is possible that another source of ·O2
-
, independent of Ang II–AT1 receptor 
signalling, may be responsible for the inflammatory marker over-expression in 
sodium overloaded rats, which were not modified by losartan. As known, some 
mechanical factors as hyperfiltration, tubular epithelial stretch and/or the epithelial 
sodium transport can be able to generate oxidative stress, inducing in turn cytokines 
and chemokines over-expression
11, 12
. It has been demonstrated that TGF-1 was up-





regulation as well as lower NO availability, may contribute, at least in part, to 
stimulate TGF- production. We have observed that tempol, but not losartan, 
prevented the increase in TGF-1 expression in rats submitted to sodium overload. 
Therefore, it is probable that TGF- over-expression in sodium overloaded group 
was a consequence of the oxidative stress independently of Ang II. 
RANTES over-expression was observed in CD but not in PCT. Renal interstitial 
hypertonicity is one of the main causes of oxidative stress by production of reactive 
oxygen species of mitochondrial origin
36, 37
 and inflammation. Then, a higher 
interstitial hypertonicity in CD than in PCT may be related to different RANTES 
staining in those nephron segments. In addition, tempol favours renal blood flow and 
inhibits sodium transport, increasing this way natriuresis and diminishing medullar 
interstitial tonicity. Then, we suggest that the different response to tempol in PTC 
and MCD regarding RANTES staining may be related to tempol actions tending to 
diminish medullar tonicity and reduce the oxidative stress. Moreover, RANTES 
over-expression observed in CD of sodium overloaded rats was unchanged by 
losartan, but it was diminished by tempol only in renal medulla. High extracellular 
sodium concentration constitutes a challenge to the normal cell function and 
stimulates the inflammatory response in intestinal, bronchial, and renal epithelial 
cells
38
. A hyperosmotic stress results in activation of osmosensitive NF-B, MAPK 
signalling pathways and expression of IL-8 and RANTES
39
. In addition to NF-B, 
the gene expression of a variety of other transcription factors (AP-1, CREB) has 
been shown to be affected by salt-induced stress. Present results do not rule out the 




In conclusion, Ang II and the oxidative stress are involved in the activation of 
transcriptional factors in rats submitted to acute sodium overload. However, only 
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tempol was effective in down-regulating early inflammatory markers TGF-1 and 
RANTES expression. These effects can be associated with an enhanced eNOS and 
simultaneously decreased HIF-1 expression. Further studies are required to 
characterize and delineate these interactions at the level of the production of ·O2
-
 and 
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Studies carried out in vitro have recently shown that salt loading induces an 
increasing mechanical stretch and a flow-induced superoxide production in the thick 
ascending limb of Henle’s loop. In this regard, we hypothesized that the oxidative 
stress induced by salt overload could stimulate inflammatory and fibrogenic 
signalling pathways in normal rats. 
Sprague Dawley rats were fed with an 8% NaCl high- (HS) or 0.4% NaCl normal-
salt (NS) diet for 3 weeks, with or without Tempol (T) administration (1 mM, 
administered in drinking water). Mean arterial pressure (MAP), glomerular filtration 
rate (GFR) and urinary sodium excretion (UVNa) were measured. NAD(P)H oxidase 
p47phox, angiotensin II (Ang II), transforming growth factor-beta1 (TGF-β1), 
alpha-smooth muscle actin (α-SMA) and nuclear factor-kappa B (NF-B) 
expression were evaluated in renal tissues by immunohistochemistry. 
A high NaCl diet produced a slight but significant increase in MAP and enhanced 
UVNa and oxidative stress. Administration of a high NaCl diet induced the over-
expression of TGF-β1, α-SMA and NF-кB in cortex and medulla, while Ang II 
increased in proximal convoluted tubules, and decreased in cortical collecting ducts. 
Tempol administration prevented these changes and simultaneously normalized 
MAP accompanied by an enhancement in GFR and UVNa. 
The results showed that a high NaCl diet is able to produce a renal profibrotic 
response also in normal rats, which could be associated with oxidative stress rather 
than intrarenal Ang II expression. 
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It is well known that a high NaCl intake enhances superoxide production, lipid 
peroxidation and oxidative stress in salt sensitive rat kidneys
1, 2
. In addition, it has 
been shown that the superoxide anion exerts direct renal vasoconstrictor and anti-
natriuretic effects in vivo
3
 and increases sodium transport in vitro
4
, suggesting that 
the superoxide anion plays an important pathophysiological role in the kidney, 
contributing to the development of hypertension. An increase in intrarenal 
angiotensin II (Ang II) expression in salt-sensitive rats can induce renal injury 
development, despite the suppression of the systemic renin-angiotensin system and 
even before a rise in arterial pressure takes place
5-7
. It is well known that Ang II may 
increase the production of reactive oxygen species through reduced nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase activity
8
. Superoxide anion 
activates transcription nuclear factor-kappa B (NF-B), which modulates the 
induction of genes involved in the inflammatory and fibrogenic response through the 
release of cytokines and accumulation of inflammatory cells in the kidney
9
. 
Inflammation is a crucial event, previous to the subsequent development of fibrosis, 
which is the final contributing factor to kidney failure. In this order, it has been 
demonstrated that the Ang II-activated transforming growth factor-beta1 (TGF-β1) 
expression stimulates collagen and fibronectin synthesis and participates in renal 
failure development, controlling the extracellular matrix deposition and 
remodelling
10, 11
. The peritubular accumulation of myofibroblasts that express alpha-
smooth muscle actin (α-SMA) and contribute to abnormal extracellular matrix 
production constitutes an early event in the fibrotic process. 
However, there is no strong evidence whether high salt intake in normal rats can 
promote renal damage. In this regard, a recent study has provided further evidence 
that the current dietary intake of salt in Western societies is an important factor for 
the genesis of essential hypertension and may even partly cause blood pressure–
independent target organ damage, including the kidney
12
. The issue of whether the 
reduction of dietary salt intake should be recommended, even to normotensive 
individuals, is currently debated in the political field, and there are examples to 
show that salt intake reduction can be a successful recommendation in the general 
population. Considering that assertion, we investigated for the first time whether a 
high-salt diet administered to normal rats is able to induce the early expression of 
tubulointerstitial pro-fibrogenic and pro-inflammatory markers. Additionally, we 
studied the participation of oxidative stress and tubular Ang II in the genesis of those 
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markers’ expression. With that purpose, Sprague Dawley rats were fed a high-salt 
diet for 3 weeks in the presence or absence of Tempol administration to observe 
oxidative stress blockade effects on high sodium overload–derived inflammation 
and fibrosis. Blood pressure changes, renal excretory function, oxidative stress 
through NADPH oxidase p47phox, as well as expression of intrarenal pro-





2.1. Animal protocol 
Male Sprague Dawley rats, 5-6 weeks old (180-200g body weight), were used in the 
experiments. The animals were housed in steel cages in a controlled temperature 
animal room at 23±2ºC, exposed to a daily 12-hour light-dark cycle (light on from 
07:00 am to 07:00 pm), fed for 3 weeks with the diets described below and given tap 
water ad libitum. Experiments were conducted in accordance with the institutional 
University of Buenos Aires guidelines for the care and use of research animals. The 
experiments were performed in animals randomly divided into 4 groups (n=6, each 
group): (a) NS (control): animals fed a normal diet (0.4% NaCl); (b) HS: fed a high 
NaCl diet (8% NaCl); (c) NS-T: fed a normal diet (0.4% NaCl), plus Tempol 
(Sigma-Aldrich Inc, St. Louis, MO, USA) administered in drinking water (1 mM); 
and (d) HS-T: fed a high NaCl diet (8% NaCl), plus Tempol administered in 
drinking water (1 mM). After a 3-week diet, the rats were intraperitoneally 
anesthetized with urethane (1.2 g.kg
-1
). A PE-90 tubing (3-cm long) was inserted 
into the trachea to maintain an open airway. The left femoral vein was catheterized 
with a Silastic cannula (0.12 mm i.d.) for continuous infusion. The right carotid 
artery was also catheterized with a T4 tube for blood sampling and for continuous 
mean arterial pressure (MAP) recording; by means of a Statham GOULD P23ID 
transducer coupled to a Grass Polygraph 79D during all the procedures. The bladder 
was cannulated for urine collection using a PE-75 cannula. A femoral vein infusion 
with isotonic saline solution (ISS, 0.15 M NaCl) was performed at a 0.04 mL.min
-1
 
rate (Syringe Infusion Pump, Sage, Orion) for 60 minutes, to allow the reaching of a 
steady diuresis and permitting urine collection in all groups. Then, ISS infusion 
continued for another 60 minutes at the same rate as an experimental period. Blood 
samples were collected at 30 minutes, and urine samples were collected during the 
60-minute ISS infusion, for sodium, potassium and creatinine measurement. 
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2.2. Urine and blood measurements 
Urinary and plasma sodium, potassium and creatinine were measured by standard 
methods using an autoanalyzer. Creatinine clearance was assessed to evaluate 
glomerular filtration rate (GFR). GFR and sodium fractional excretion (FENa) were 
calculated according to a standard formula. Urinary flow (UV) is expressed in 
μL.min-1, plasmatic and urinary sodium (PLNa, UNa) and potassium (PLK, UK) 
concentration in mEq.L
-1
, sodium and potassium urinary excretion (UVNa, UVK ) in 
μmol.min-1, GFR as ml/min and FENa as a percentage (%). 
 
2.3. Kidney processing for histological examination 
At the end of the infusion period, the left kidney was perfused with ISS through the 
abdominal aorta until the blood was washed out and the parenchyma showed a pale 
appearance. The kidney was rapidly excised, decapsuled, longitudinally cut and 
harvested for immunohistochemical studies. Tissues were fixed in phosphate-
buffered 10% formaldehyde (pH 7.2) and embedded in paraffin. Samples were 
sectioned to 3-μm thickness and stained with Masson’s trichrome. Examined by 
light microscopy, the samples did not reveal histopathological signs for tubular 
injury or interstitial fibrosis in the HS group (data not shown). 
For immunohistochemistry, renal sections were deparaffined and rehydrated, and 
endogenous peroxidase activity was blocked by treatment with 0.5% H2O2 in 
methanol for 20 minutes. Local Ang II, TGF-β1, α-SMA and NF-κB were detected 
using the following specific monoclonal antibodies: human anti-Ang II (dilution of 
1:500; Peninsula, CA, USA), rabbit anti-TGF-β1 (dilution: 1:200; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), rabbit anti-α-SMA (dilution: 1:200; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit anti-NF-κB p65 (dilution: 
1:300; Santa Cruz Biotechnology, Santa Cruz, CA, USA), respectively. 
Immunostaining was carried out by means of a commercial modified avidin-biotin-
peroxidase complex technique (Vectastain ABC kit, Universal Elite; Vector 
Laboratories, CA, USA) and counterstained with hematoxylin. Histological sections 
were observed under a Nikon E400 light microscope (Nikon, Melville, NY, USA). 
All measurements were carried out with image analysis software (Image-Pro Plus, 
ver. 4.5 for Windows; Media Cybernetics, LP, Silver Spring, MD, USA). 
Immunoreactivities for Ang II, TGF-β1 and RANTES are expressed as percentage 
of positive stained area ± SEM in proximal convoluted tubules (PCT), distal 
convoluted tubules (DCT), thick ascending limb (THAL) of Henle’s loop, cortical 
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collecting duct (CCD) and medullar collecting duct (MCD). The identification of 
different nephron segments was based on main cell characteristics, which were 
observed in the histological pictures
13
. For immunofluorescence staining slices were 
incubated with monoclonal antibodies for NAD(P)H oxidase-p47phox (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) and were next incubated with conjugated 
secondary antibodies. Tubular cells were documented by cell staining of 
hematoxylin, and nuclear integrity was confirmed using 4’,6’-diamidino-2-
phenylindole hydrochloride (DAPI) staining. For analysis, slides were viewed using 
a fluorescence microscope (Eclipse 600, Nikon, Melville, NY, USA), and images 
were digitally captured by a digital camera. 
 
2.4. Statistical analysis 
Results from urine, blood measurements and MAP are expressed as means ± SEM. 
Gaussian distribution was evaluated by the Kolmogorov-Smirnov method, and 
comparisons between groups were made using ANOVA followed by the Newman-





3.1. Body weight and MAP 
Body weight and MAP values are shown in Table 1. There were no significant 
differences in body weight between the experimental and control groups. MAP 
increased in HS-fed animals compared with NS-fed rats. Tempol administration 
reduced MAP in the HS-T group, reaching very similar levels to those of the NS 
group. In addition, Tempol did not modify MAP levels in NS-fed animals. 
 
3.2. Plasma electrolytes, GFR and excretory function 
Table 1 shows HS diet and Tempol effects on glomerular hemodynamics and renal 
excretory function in the NS and HS groups. PLNa was not significantly modified in 
any experimental group. HS diet raised UNa and FENa% compared with the NS 
group. On the other hand, PLK, UK and GFR were not altered by an HS diet. Tempol 
administration increased PLK and UNa in both NS-T and HS-T groups, and also 
raised GFR in HS-T animals. Figure 1 shows diuresis (UV), UVNa and UVK values. 
UV did not differ between NS and HS groups, but Tempol increased it in the HS-T 
group. UVNa exhibited a very similar pattern to UNa: HS diet led to a marked 
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increase in UVNa, which was further increased in HS-T. In addition, UVK was not 
different between NS and HS, but Tempol markedly increased potassium excretion 
in HS-T animals, compared with the other groups. 
 
 NS HS NS-T HS-T 
BW (g) 330±9 320±6 314±13 320±7 
MAP (mmHg) 96±2 107±3 * 100±2 95±3 
PLNa (mEq.L
-1
) 141±1 140±3 142±1 143±2 
PLK (mEq.L
-1
) 3.1±0.1 2.9±0.2 3,5±0.1 # 3.6±0.1# 
UNa (mEq.L
-1
) 15.7±2.7 198.0±17.6* 54.5±20.8# 332.0±38.5*# 
UK (mEq.L
-1
) 122.8±17.4 111.0±11.1 180.5±29.8 79.1±13.0* 
GFR (mL.min
-1
) 1.62±0.12 1.48±0.09 1.22±0.24 3.09±0.69*# 
FENa (%) 0.1±0.1 0.5±0.1* 0.1±0.1 1.2±0.4* 
     
Table 1. BW: body weight; MAP: mean arterial pressure; PLNa: plasmatic sodium; PLK: plasmatic 
potassium; UNa: urinary sodium concentration; UK: urinary potassium concentration; GFR: glomerular 
filtration rate; FENa: fractional excretion; NS: normosodic diet group, HS: hypersodic diet group, NS-T: 
normosodic diet plus tempol group; HS-T: hypersodic diet plus tempol group. Values are expressed as 




Figure 1. Renal Function. Abbreviations: Diuresis: urinary flow, UV (µL.min-1) (left); Natriuresis: urinary 
sodium excretion, UVNa (µmol.min
-1) (middle); and Kaliuresis: urinary potassium excretion, UVK 
(µmol.min-1) (right); NS: normal salt diet, HS: high salt diet, NS-T: normal salt diet plus Tempol, HS-T: 
high salt diet plus Tempol. Values are expressed as mean ± SEM; n=5-8; *p<0.05 vs. NS; #p<0.05 vs. 
respective control without tempol. 
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3.3. Intrarenal NADPH oxidase p47phox 
NF-κB staining was increased in Na group (Figure 2), in each tubular segment 
except in THAL (%, PCT, NS: 4.2±0.3, HS: 11.9±0.8*; DCT, NS: 3.7±0.3, HS: 
5.9±0.2*; CCD, NS: 2.7±0.4, HS: 5.1±0.5*; MCD, NS: 3.3±0.3, HS: 6.5±0.6*, 
p<0.001; THAL, NS: 2.3±0.3, HS: 2.0±0.2, *p< 0.001 vs NS). Tempol prevented 
increased staining in all tubular segments from HS group without changes in NS 
group (%, PCT, NS-T: 3.9±0.3, HS-T: 3.7±0.2; DCT, NS-T: 3.2±0.3, HS-T: 
3.3±0.4; CCD, NS-T: 2.0±0.4, HS-T: 2.4±0.4; MCD, NS-T: 3.7±0.3, HS-T: 3.4±0.4; 
THAL, NS-T:2.6±0.4, HS-T:2.0±0.3). 
 
 
Figure 2. Immunofluorescence images of NADPH oxidase p47phox. Arrows point strong expression of 
the p47phox, cytosolic component in cortical tubular cells in HS group. Abbreviations: NS, normal salt 
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3.4. Intrarenal Ang II expression 
Figure 3 shows Ang II immunoexpression in renal tissues. Immunohistochemical 
analysis of renal sections obtained from rats subjected to high salt intake revealed 
positive staining for Ang II in all tubular sections examined, although Ang II 
staining was very low in THAL (data not shown). HS diet increased Ang II 
expression in PCT but decreased it in CCD compared with those in the NS group, 
without altering it in the rest of the examined tubular segments. It is worth noting 
that immunohistochemical staining in PCT showed greater staining of Ang II in the 
nucleus than in the cytoplasm. Tempol administration in NS rats only reduced Ang 
II staining in MCD, without changing its staining in other tubules. In addition, 
Tempol administration in HS diet-fed rats, substantially decreased Ang II staining in 
PCT, DCT and MCD and increased Ang II levels in CCD, restoring the staining 
observed in the NS group. No changes elicited by Tempol were observed in THAL 
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Figure 3. Panel A. Intrarenal Angiotensin II Immunostaining (Ang II). Abbreviations: PT: proximal 
tubule; DCT: distal convolute tubule; CCD: cortical collecting duct; MCD: medullar collecting duct. NS: 
normosodic diet group, HS: hypersodic diet group, NS-T: normosodic diet plus tempol group; HS-T: 
hypersodic diet plus tempol group. Quantitative representation of positive staining/µ2; expressed as mean 
percentage ± SEM; *p<0.05 vs. respective control NS, #p<0.05 vs. respective control without tempol. 
Panel B. Intrarenal Angiotensin II Immunostaining. Representative images of positive staining (Original 
magnification x 400). 
 
 
3.5. Intrarenal TGF-β1 expression 
TGF-β1 inmmunoexpression was markedly increased in THAL, CCD and MCD 
kidney segments of the HS group. TGF-β1 expression was normalized in the HS-T 
group, reaching a similar staining to that in the NS group. No changes in TGF-β1 
staining were observed in renal tubular segments obtained from rats fed with normal 



















Figure 4. Panel A. Intrarenal Transforming Growth Factor-β1 immunostaining (TGF-β1). Abbreviations: 
THAL: thick Henle ascending loop; CCD: cortical collecting duct; MCD: medullar collecting duct; NS: 
normosodic diet group, HS: hypersodic diet group, NS-T: normosodic diet plus tempol group; HS-T: 
hypersodic diet plus tempol group. Quantitative representation of positive staining/µ2; expressed as 
percentage ± SEM. Values are expressed as mean ± SEM.* p<0.05 vs. respective control NS, #p vs. 
respective control without tempol. Figure 4. Panel B. Representative images of positive staining (Original 
magnification x 400) in renal medulla. 
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3.6. Intrarenal α-SMA expression 
α-SMA immunolabelling was markedly increased in interstitium from renal cortex 
(% staining: NS: 3.09±0.12; HS: 18.11±0.61*; NS-T: 4.03±0.17 and HS-T: 
4.98±0.16, *p<0.001 vs NS) and medulla (% staining: NS: 5.37±0.13; HS: 
24.98±0.68*; NS-T: 5.91±0.16 and HS-T: 7.19±0.17, *p<0.001 vs NS) obtained 
from rats subjected to HS diet, showing α-SMA peritubular interstitial localization. 
Tempol normalized α-SMA expression in the HS-T treated group. 
 
3.7. Intrarenal NF-κB expression 
NF-κB staining was increased in the HS group, in each tubular segment except in 
THAL (%, PCT: NS: 4.2% ± 0.3%, HS: 11.9% ± 0.8% [**p<0.001 vs. NS]; DCT: 
NS: 3.7% ± 0.3%, HS: 5.9% ± 0.2% [**p<0.001 vs. NS]; CCD: NS: 2.7% ± 0.4%, 
HS: 5.1% ± 0.5% [**p<0.001 vs. NS]; MCD: NS: 3.3% ± 0.3%, HS: 6.5% ± 0.6% 
[**p<0.001 vs. NS]; THAL: NS: 2.3% ± 0.3%, HS: 2.0% ± 0.2% [**p<0.001 vs. 
NS]). Tempol prevented increased staining in all tubular segment from the HS group 
without changes in the NS group (%, PCT: NS-T: 3.9% ± 0.3%, HS-T: 3.7% ± 
0.2%; DCT: NS-T: 3.2% ± 0.3%, HS-T: 3.3% ± 0.4%; CCD: NS-T: 2.0% ± 0.4%, 
HS-T: 2.4% ± 0.4%; MCD: NS-T: 3.7% ± 0.3%, HS-T: 3.4% ± 0.4%; THAL: NS-T: 






In the present study, we analyzed the profibrogenic and proinflammatory response in 
kidneys of normal rats subjected to high salt intake, in the presence and absence of 
the superoxide anion scavenger, Tempol. We observed that the HS group exhibited a 
slight increase in MAP, and an enhancement of oxidative stress, profibrotic markers 
such as NF-κB in cortical and medullar tubules, expression of TGF-β1 in the distal 
nephron and α-SMA in the interstitium of renal cortex and medulla. In addition, Ang 
II staining increased in PCT, while it decreased in CCD. Tempol administration 
prevented all of these changes observed in the HS group, a fact that was 
accompanied by a potent natriuretic and diuretic effect. Since the profibrogenic 
response bears no association with Ang II localization, the present results suggest 
that a high-salt diet administered to normal rats was able to induce an early 
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profibrogenic response, independently of any Ang II inflammatory signalling, but 
associated to the oxidative stress. 
In our experiments, a chronic salt overload (8% NaCl diet during 3 weeks) raised the 
UVNa, and produced a slight but significant increment in MAP. In addition, we 
observed that Tempol administration normalized MAP elevated levels observed in 
the HS group, and it also enhanced GFR, FENa and UVNa. These results are in 
agreement with previous studies, where treatment with Tempol improved renal 
hemodynamics and electrolyte excretory function in salt-sensitive hypertension 
models, while it abolished salt-sensitive hypertension as well as systemic, vascular 
and renal oxidative stress
14, 15
. Superoxide anion is a free radical known to stimulate 





















, processes which 
are prevented by Tempol. Moreover, Tempol can raise the blood flow to the renal 
medulla more than to the renal cortex in different experimental models, contributing 
to increased natriuresis and the reduction of MAP levels
17
. It is well known that 
Tempol moderates the tubuloglomerular feedback response, thus reducing macula 
dense stimulation and afferent arteriole vasoconstrictor responses, consequently 
inducing renal vasodilation and a fall in MAP levels. Therefore, our findings 
confirmed that the glomerular hyperfiltration and the natriuretic effect elicited by 
Tempol could contribute to preventing enhanced blood pressure. 
The present results showed an increased Ang II immunoexpression in PCT, but 
simultaneously decreased Ang II expression in CCD in rats fed with high NaCl diet. 
It is well known that the PCT synthesizes and secretes Ang II into the lumen
18
. In 
addition, we have indicated that Ang II levels are higher in the nucleus than in the 
cytoplasm of tubular cells in the HS group. These findings are in agreement with Li 
et al, who showed that Ang II may directly stimulate nuclear AT1R to induce 
transcriptional responses, which may be associated with stimulation of tubular 
epithelial sodium transport, cell growth and proinflammatory cytokine expression
19
. 
However, our experiments did not show increments in TGF-β1 levels in PCTs of 
kidneys from rats fed with a high NaCl diet. Therefore, we suggest that the elevated 
levels of Ang II observed in PCT of animals fed with a high NaCl diet could 
regulate sodium transport rather than activate proinflammatory cytokines. Moreover, 
in high NaCl diet–nourished rats, an unexpected Ang II effect on PCT increasing 
sodium transport has recently been shown
20
. In this way, Ang II could stabilize 
nephron functions, avoiding a sodium overload to distal segments rather than 
contributing to salt homeostasis. It is known that a high-sodium diet produces 
oxidative stress, which up-regulates AT1R in the PCT, enhancing Ang II levels by 
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internalization from the luminal fluid. In addition, it has been described that 
oxidative stress leads to dopamine D1 receptor dysfunction in PCT. Tempol, which 
reduces the oxidative stress, restores AT1 and D1 receptor functions
21
. Furthermore, 
the fact that Tempol may reduce AT1R up-regulation, supports the hypotheses that 
this inhibition would permit a lesser protective effect of Ang II on distal nephrons. 
This may cause distal sodium overload, which in turn may increase the 
tubuloglomerular feedback thus decreasing the GFR. Nevertheless, Tempol might 
reduce sodium signaling in the macula densa as well as afferent arteriole responses, 
which would contribute to moderate the tubuloglomerular feedback response and to 
increase the GFR, as we have observed in our experiments. On the other hand, 
decreased Ang II levels, as we found in the CCD, could be well correlated with the 
increase in UVNa and in the FENa that we observed in the HS-fed group. It has been 
reported that Ang II stimulates H
+
 secretion to the lumen in CCD tubules
22
. In turn, 
proton secretion forces pendrin-mediated Cl
−





exchanger and generates a more favourable electrochemical gradient for sodium 
reabsorption, mediated by the epithelial sodium channel (ENaC)
22
. Regarding 
Tempol effects in the HS-fed group, our results showed that the increased Ang II 
expression in PCT and decreased expression in CCD was normalized by Tempol 
treatment. Tempol also diminished Ang II expression in the DCT of the HS-fed 





 cotransporter (NCC) mediates the electroneutral NaCl reabsorption in the 
DCTs. In this regard, Ang II stimulates the acute trafficking of NCC to the apical 
membrane
23
. Some evidence has emerged that the NCC may participate in 
natriuresis and diuresis modulation. In this way, a fall in tubular Ang II levels can 
induce the retraction of NCC from the apical plasma membrane, with the NCC 
internalized in the cell. Therefore, Tempol could facilitate sodium excretion, by 
inhibiting Ang II expression in the DCT. Altogether, our findings support the idea 
that the changes observed in Ang II expression along the tubular segments of the 
nephron may represent an adaptive mechanism to sodium overload. 
After 3 weeks of high salt load we found an enhanced tubulointerstitial TGF-β1 
expression in distal nephrons and α-SMA immunolabeling in renal cortex and 
medulla. Both over-expressions were prevented by Tempol treatment. It has been 
demonstrated that TGF-β1 is up-regulated by Ang II and oxidative stress, and 
inhibited by nitric oxide. Recently published data have shown that, despite the 
positive-feedback loop between TGF-β1 and nitric oxide under physiological 
conditions, the inhibitory effect of nitric oxide on TGF-β1 production was reduced 
after salt intake in Dahl salt-sensitive rats
24, 25
. The authors showed that 
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administration of the antioxidant kallistatin restored nitric oxide levels and 
prevented salt-induced TGF-β1 overexpression. Since we have not observed any 
correlation between Ang II and TGF-β1 immunolabeling, the profibrogenic response 
(showed by α-actin and TGF-β1 enhanced staining) observed in our experiments 
could be related to the balance of oxidative stress and nitric oxide, rather than to 
renal Ang II expression. 
Our results confirmed that Tempol, a superoxide anion scavenger, exerts a beneficial 
action in high-salt diet–fed rats since it ameliorated the high arterial pressure, an 
effect that may be associated with its antioxidant and natriuretic and diuretic effects. 
During salt loading, intrarenal Ang II levels showed an opposite behaviour 
according to the different nephron segments studied. Surprisingly, Ang II levels 
increased in PCT, but decreased in CCD, while TGF-β1 expression was enhanced in 
distal nephrons, and α-SMA staining increased in renal cortex and medulla. The 
chronic administration of Tempol prevented these changes and decreased Ang II 
levels in DCT. These results provide evidence that intrarenal Ang II expression is 
not correlated with proinflammatory and profibrogenic marker expression in the 
kidney of HS diet–fed animals. Moreover, the changes in TGF-β1 expression, 
observed in the HS diet–fed group, would not result from Ang II-initiated 
inflammation signalling
26
. While in salt-sensitive rats fed with a high-salt diet, the 
development of hypertension and renal disease are associated with intrarenal Ang II 
expression, our results suggest that in normal rats, the early fibrogenic response of 
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In the kidney, a high salt intake favours oxidative stress and hypoxia, and causes the 
development of fibrosis. Both atrial natriuretic peptide (ANP) and hypoxia inducible 
factor-1 alpha (HIF-1α) exert cytoprotective effects. We tested the hypothesis that 
renal expression of ANP and HIF-1α is involved in a mechanism responding to the 
oxidative stress produced in the kidneys of rats chronically fed a high sodium diet. 
Sprague-Dawley rats were fed a normal-salt (0.4% NaCl) (NS) or a high-salt (8% 
NaCl) (HS) diet for 3 weeks, with or without the administration of tempol (T), an 
inhibitor of oxidative stress, in the drinking water. We measured the mean arterial 
pressure (MAP), glomerular filtration rate (GFR), and urinary sodium excretion 
(UVNa). We evaluated the expression of ANP, HIF-1α, and transforming growth 
factor-beta1 (TGF-ß1) in renal tissues by immunohistochemistry. The animals fed 
high salt diet showed increased MAP and UVNa levels, and enhanced renal 
immunostaining of ANP, HIF-1α, and TGF-ß1. The administration of tempol 
together with the sodium overload increased the natriuresis further, prevented the 
elevation of blood pressure, and the increased immunostaining of ANP, TGF-ß1, 
and HIF-1α expression compared to their control. 
These findings suggest that HIF-1α and ANP, synthesized by the kidney, are 
involved in an adaptive mechanism in response to a sodium overload to prevent or 
attenuate the deleterious effects of the oxidative stress and the hypoxia on the 
development of fibrosis. 
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Reactive oxygen species (ROS) have been demonstrated to play an important 
pathophysiological role in the kidney
1-4
. ROS can activate the mitochondrial 
uncoupling protein 2 (UCP-2), leading to inefficient renal O2 usage and contributing 
to renal hypoxia
5
. Changes in cellular oxygen concentrations induce tightly 
regulated response pathways that attempt to restore oxygen supply to cells and 
modulate cell function in hypoxic conditions. Most of these responses occur through 
the induction of the transcription factor hypoxia-inducible factor-1alpha (HIF-1) 
which coordinates the expression of diverse adaptive genes against the hypoxic 
injury
6, 7
. HIF-1 transcriptionally upregulates the expression of metabolic proteins 
(GLUT-1), adhesion proteins (integrins), soluble growth factors (TGF-β1 and 
VEGF), and extracellular matrix components (type I collagen and fibronectin), 
which enhance the repair process. For these reasons, HIF-1 is viewed as a positive 
regulator of organ repair and tissue fibrosis
8, 9
. 
In the kidney, a predominant enzyme involved in oxidative stress development is 
NADPH-oxidase, which is up-regulated by increased sodium tubular transport, 
luminal flow or cytokines release
10, 11
. In turn, the superoxide anion increases tubular 
NaCl transport, further enhancing oxidative stress
12
. It is well known that a high salt 
intake increases the oxidative stress in the kidneys of normal and salt-sensitive rats
1-
4
. In this regard, we have reported that a high salt diet in Sprague-Dawley rats is able 
to increase the oxidative stress. We also showed that the administration of tempol 
(4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl), which is a permeate superoxide 
dismutase mimetic commonly used to inhibit the oxidative stress, prevented those 
changes and produced a potent natriuretic and diuretic effect. Thus, we concluded 
that the increase of the oxidative stress induced by sodium overload could account 
for anti-natriureris
1
. It has also been described that in models of experimental salt-
sensitive hypertension, tempol improved the renal hemodynamic response and 




A growing number of mammalian genes have been identified to play a key role in 
the cellular adaptive response to counter-regulate renal hypoxia and the consequent 
process of fibrosis, among which is atrial natriuretic peptide (ANP). ANP is a 
member of a natriuretic peptide family which, besides its role in the regulation of 
volume homeostasis, has been noted to exert protective effects in several cell types 




 and on the adaptation to hypoxia
16
. 
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Based on these data, we hypothesized that endogenous renal ANP and HIF-1α could 
constitute endogenous adaptive mechanisms in response to the oxidative stress 
produced in the kidney of rats chronically fed with a high sodium diet. Therefore, in 
the current study we determined the effect of a high-salt diet on the regulation of 
renal expression of HIF-1α, ANP, and TGF-β1 in Sprague-Dawley rats. In addition, 
we evaluated whether tempol administration, by inhibiting oxidative stress, prevents 
the increase of these molecules. Understanding these endogenous mechanisms can 





2.1. Animal protocol and experimental measurements 
Experiments were conducted in accordance to the care and use of research animals 
of international guiding principles and local regulations concerning the care and use 
of laboratory animals for biomedical research (ANMAT, 6344/96; Institute of 
Laboratory Animal Resources, 1996)
17, as well as the “International Ethical Guiding 
Principles for Biomedical Research on Animals” established by the CIOMS 
(Council for International Organizations of Medical Sciences)
18
. These protocols 
were approved by Universidad de Buenos Aires (UBACYT B113) and the National 
Scientific and Technical Research Council (CONICET, PIP 1337/09).  
Male Sprague Dawley rats, 5-6 weeks old (180-200g body weight), were used in the 
experiments. The animals were housed in steel cages in a controlled temperature 
animal room at 23±2ºC, exposed to a daily 12-hour light-dark cycle (light on from 
07:00 a.m. to 07:00 p.m.), fed the diets described below for three weeks, and were 
given free access to tap water. The experiments were performed in rats randomly 
divided into four groups (n=6 for each group): a) NS (control): fed a normal salt diet 
(0.4 g% NaCl); b) HS: fed a high salt diet (8 g% NaCl); c) NS-T: fed a normal salt 
diet (0.4 g% NaCl) plus 1 mM tempol (Sigma-Aldrich Inc, St. Louis, Missouri, 
USA), administered in the drinking water; d) HS-T: fed a high salt diet (8 g% NaCl) 
plus 1 mM tempol administered in the drinking water. After 3 weeks, the rats were 
anaesthetized intraperitoneally with urethane (1.2 g.kg
-1
) and a PE-90 tube (3 cm 
long) was inserted into the trachea to maintain an open airway. The left femoral vein 
was catheterized with a Silastic cannula (0.12 mm i.d.) for continuous infusion. The 
right carotid artery was catheterized with a T4 tube for blood sampling and for 
continuous mean arterial  pressure recording (MAP) by means of a Statham GOULD 
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P23ID transducer coupled to a Grass Polygraph 79D during all the procedures. The 
bladder was cannulated for urine collection using a PE-75 cannula. A femoral vein 
infusion with isotonic saline solution (ISS, 0.15M NaCl) was performed at a rate of 
0.04 mL.min
-1
 (Syringe Infusion Pump, SageTM, Orion) for 60 minutes to allow for 
a steady diuresis and to permit urine collection in all groups. Then, ISS infusion 
continued for another 60 min at the same rate during the experimental period. From 
each animal, a blood sample was collected at 30 minutes and a urine sample was 
collected from 0 to 60 minutes for sodium, potassium and creatinine measurements. 
At the end of the experimental period, other blood samples were obtained from the 
abdominal cava vein, immediately placed into plastic tubes containing 15% EDTA, 
and kept on ice for ANP dosage. The kidney was rapidly excised, decapsulated, 
longitudinally cut and harvested for immunohistochemical studies. 
 
2.2. ANP radioimmunoassay  
The plasma ANP extraction procedure was followed as described by Cavallero et al. 
[19]. The radioimmunoassay (RIA) was performed using an ANP-rat RIA 




2.3. Urine and blood measurements  
Urinary and plasma sodium and creatinine were measured by standard methods 
using an autoanalyzer. Creatinine clearance was assessed in order to evaluate the 
glomerular filtration rate (GFR). GFR and sodium fractional excretion (FENa) were 
calculated according to a standard formula. Urinary flow (UV) is expressed as 
μL.min-1; plasmatic sodium (PLNa) concentration as mEq.L
-1
, sodium urinary 
excretion (UVNa) as μmol.min
-1
, GFR as mL.min
-1
 and FENa as percentage. 
 
2.4. Kidney processing for histological examination  
Renal tissues were fixed in phosphate-buffered 10% formaldehyde (pH 7.20) and 
embedded in paraffin. For immunohistochemistry, sections were deparaffinated and 
rehydrated, and endogenous peroxidase activity was blocked by treatment with 0.5% 
H2O2 in methanol for 20 minutes. Local ANP, HIF-1α and TGF-β1 were detected 
using the following specific antibodies: rabbit anti-ANP (Phoenix Pharmaceutical; 
dilution 1:500), rabbit anti-HIF-1 (Novus Biologicals, Inc., Littleton, CO; dilution 
1:1000), and rabbit anti TGF-β1 (Santa Cruz Biotechnology; dilution 1:200). 
Immunostaining was performed with a commercial modified avidin-biotin-
peroxidase complex technique (Vectastain ABC kit, Universal Elite, Vector 
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Laboratories, CA) and with counterstaining with haematoxylin. Histological sections 
were observed in a Nikon E400 light microscope (Nikon Instrument Group, 
Melville, New York, USA). All measurements were carried out using image analysis 
software (Image-Pro Plus ver. 4.5 for Windows, Media Cybernetics, LP. Silver 
Spring, MD, USA). Immunoreactivities for ANP, HIF-1α and TGF-β1 are expressed 
as percentage of positive stained area ± standard error of the mean (SEM) in 
proximal convoluted tubules (PT), distal tubules (DT), thick ascending limb of the 
loop of Henle (THAL), cortical collecting ducts (CCD), and medullary collecting 
ducts (MCD). 
 
2.5. Statistical analysis  
Results from urine and blood measurements and MAP are expressed as mean ± 
SEM. Gaussian distribution was evaluated by the Kolmogorov and Smirnov method 
and the comparison among groups was carried out using ANOVA followed by the 






3.1. Body Weight and Mean Arterial Pressure  
There were no significant differences in body weight between control and 
experimental groups (grams; NS: 330±9; HS: 320±6; NS-T: 314±13; HS-T: 320±7). 
The MAP was increased in the HS-fed group compared to the NS-fed group 
(mmHg; NS: 94±3 vs HS: 107±3*). Tempol administration did not modify MAP 
levels in NS animals, but normalized MAP in the HS-T group, reaching MAP levels 
very similar to those observed in NS rats (mmHg; NS-T: 97±2 vs HS-T: 95±3†). 
*p< 0.05 vs. respective NS group, †p< 0.05 vs. respective group without tempol. 
 
3.2. Plasma Sodium and Urinary Sodium Excretion (Table 1) 
High salt diet and tempol administration did not alter plasma sodium in any 
experimental group. The administration of a high salt diet did not alter the GFR, 
which was increased by tempol in HS-T group with respect to the HS group. Tempol 
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The administration of a high salt diet led to a greater UVNa, which was further 
increased in HS-T group with respect to the NS-T and HS groups. Moreover, tempol 
increased UVNa in NS-fed rats. The administration of a high salt diet raised FENa in 
HS group with respect to the NS group. Tempol administration increased the FENa 
further in the HS-T group as compared with NS-T and to the HS group. FENa was 







) 142±1 145±2 143±1 143±2 
GFR (mL.min
-1





) 0.23±0.1 3.50±0.64* 2.00±0.92† 13.0±1.5*† 
FENa (%) 0.04±0.02 0.53±0.08* 0.12±0.06 1.20±0.20*† 
 
Table 1. Renal Function Parameters. Abbreviations: NS: normal salt diet group, HS: high salt diet group, 
NS-T: normal salt diet plus tempol group, HS-T: high salt diet plus tempol group, PLNa: Plasmatic sodium 
concentration, GFR: glomerular filtration rate, UVNa: Urinary sodium excretion, FENa: fractional sodium 
excretion. All values are mean ±SEM (n= 5-6 per group), *p< 0.05 vs. respective NS group, †p< 0.05 vs. 
respective group without tempol. 
 
 
3.3. Plasmatic ANP 
Plasma ANP concentration (pg.mL
-1
) did not differ significantly between the NS 
(325.75 ± 66.69) and HS (260.00±7.38) groups, as measured by RIA. 
 
3.4. Intrarenal ANP Expression 
Figure 1 shows quantified levels of ANP immunoexpression in renal tissues. 
Representative images of ANP positive staining are shown in Figure 2 panel A 
(renal cortex) and B (renal medulla). The analysis of renal sections obtained from 
the HS group revealed increased positive staining for ANP in glomeruli, THAL, and 
CCD with respect to the NS group. Tempol prevented the elevation of ANP staining 
in HS-T group in glomeruli, THAL, and CCD, and decreased ANP staining in PT 
and MCD of both NS-T and HS-T groups. 
 
Della Penna S. L. et al. 
 




Figure 1. Quantitative representation of positive intrarenal atrial natriuretic peptide (ANP). Abbreviations: 
NS: normal salt diet group, HS: high salt diet group, NS-T: normal salt diet plus tempol group, HS-T: 
high salt diet plus tempol group. PT: proximal tubule, CCD: cortical collecting duct, THAL: thick 
ascending limb of the loop of Henle and MCD: medullar collecting duct. Values are expressed as 













Figure 2. Panel A: Representative images of positive staining of atrial natriuretic peptide (ANP) in renal 
cortex. Panel B: Representative images of positive staining of ANP in renal medulla. Original 
magnification 400x. Abbreviations: NS: normal salt diet group, HS: high salt diet group, NS-T: normal 
salt diet plus tempol group, HS-T: high salt diet plus tempol group. G: glomerulus, CCD: cortical 
collecting duct, MCD: medullar collecting duct. 
 
 
3.5. Intrarenal HIF-1α Expression 
Figure 3 shows quantified levels of HIF-1α immunoexpression in renal tissues. 
Representative images of HIF-1α positive staining are shown in figure 4 panel A 
(renal cortex) and B (renal medulla). Immunostaining analysis of renal sections 
obtained from HS group revealed that HIF-1α staining was increased in all examined 
tubular segments (PT, DT, CCD, THAL, and MCD) with respect to the NS group. 
The administration of tempol did not alter HIF-1α staining in the NS-T group, 
except in THAL where it was augmented. Whereas in HS-T group, HIF-1α staining 
decreased in all tubular segments except in THAL compared with HS group. 
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Figure 3. Quantitative representation of positive intrarenal hypoxia-inducible factor-1 (HIF-1α). Values 
are expressed as percentage ± SEM. *p<0.05 vs respective NS control; #p<0.05 vs. respective control 
without tempol. Abbreviations: NS: normal salt diet group, HS: high salt diet group, NS-T: normal salt 
diet plus tempol group, HS-T: high salt diet plus tempol group. PT: proximal tubule, DT: distal tubule, 












Figure 4. Panel A: Representative images of positive staining of hypoxia inducible factor-1 (HIF-1α) in 
renal cortex. Panel B: Representative images of positive staining of HIF-1α in renal medulla. Original 
magnification 400x. Abbreviations: NS: normal salt diet group, HS: high salt diet group, NS-T: normal 
salt diet plus tempol group, HS-T: high salt diet plus tempol group. PCT: proximal convoluted tubule, 
DT: distal tubule, CCD: cortical collecting duct, MCD: medullar collecting duct. 
 
 
3.6. Intrarenal TGF-β1 Expression 
Figure 5 shows quantified levels of TGF-β1 immunoexpression in renal tissues. 
Representative images of TGF-β1 positive staining are shown in figure 6 in panel A 
(renal cortex) and B (renal medulla). Immunostaining analysis of renal sections 
revealed increased positive staining for TGF-β1 in glomeruli, THAL, CCD, and the 
MCD in HS group, with respect to the NS group. Tempol did not show additional 
effects in the NS-T group as compared with its control, and prevented the increase 
of TGF-β1 staining in HS-T group. 
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Figure 5. Quantitative representation of positive intrarenal transforming growth factor (TGF-β1). Values 
are expressed as percentage ± SEM. *p<0.05 vs respective control NS; #p<0.05 vs. respective control 
without tempol. Abbreviations: NS: normal salt diet group, HS: high salt diet group, NS-T: normal salt 
diet plus tempol group, HS-T: high salt diet plus tempol group. PT: proximal tubule, CCD: cortical 














Figure 6. Panel A: Representative images of positive staining of TGF-β1 in renal cortex. Panel B: 
Representative images of positive staining of TGF-β1 in renal medulla. Original magnification 400x. 
Abbreviations: NS: normal salt diet group, HS: high salt diet group, NS-T: normal salt diet plus tempol 






Our results showed that a high salt diet in normal rats resulted in a greater ANP 
expression in glomeruli, THAL and CCD, where the pro-fibrotic marker TGF-β1 
was also increased. In addition, enhanced HIF-1α expression was observed, not only 
in the renal medulla as it has been previously described
21
, but also in renal cortex. 
We found that tempol administration, a superoxide dismutase mimetic, favoured 
urinary sodium excretion, prevented the increase of ANP and TGF-β1 expression, 
and normalized HIF-1α expression, the latter except in THAL. These results suggest 
that increased ANP and HIF-1α expression in renal cortex and medulla could be 
involved in an adaptive response to the oxidative stress resulting from a high salt 
diet. 
As we have previously reported, a chronic salt overload (8% NaCl diet during 3 
weeks) does not alter body weight or plasma sodium, but causes higher MAP levels 
as well as urinary sodium excretion
1
. Even though the animals used in this study 
have their blood pressure taken under anesthesia, we have recently reported the same 
effect of a high salt diet on the MAP in conscious animals
22
, allowing us to conclude 
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that the anesthesia does not affect the blood pressure when the different diet groups 
are compared. On the other hand, the administration of tempol normalized MAP 
levels observed in the HS group, and it also increased further urinary sodium 
excretion. These results are in agreement with previous studies, where treatment 
with tempol improved renal hemodynamic and electrolyte excretory function in salt-
sensitive hypertension models
1, 23
. The effects of tempol, promoting natriuresis and 
preventing endogenous increase of ANP, could suggest that by inhibiting oxidative 
stress, tubular sodium transport decreases and thus prevents the endogenous ANP 
expression as natriuretic hormone. However, we observed a clear raise in ANP 
expression also in glomeruli from rats fed a high salt diet, in which sodium transport 
does not occur. Therefore, in addition to a natriuretic effect, endogenous ANP could 
be exerting other effects in glomeruli and tubules. Furthermore, the increase of renal 
ANP levels coincided with TGF-β1 over-expression in glomeruli, THAL and CCD. 
In this regard, it is known that TGF-β1 up-regulates the transcription of the serum 
and glucocorticoid-dependent kinase hSGK1, involved in the regulation of two 
important factors for cell volume regulation, i.e. the renal epithelial Na+ channel 









increase of cell volume stimulates protein synthesis and inhibits protein degradation, 
contributing to enhance the net formation and deposition of matrix proteins. In 
addition, TGF-β1 transduces intracellular signals through type 1 (TGF-βR1) and 
type 2 (TGF-βR2) receptors, via the nuclear translocation of Smad3 proteins, thus 
contributing to a fibrotic response
25
. It has been demonstrated that the activation of 
ANP/cGMP/PKG signaling phosphorilates Smad3 and disrupts TGF-β1-induced 
nuclear translocation of pSmad3 and later downstream events, including 
myofibroblast transformation and the proliferation and expression of extracellular 
matrix molecules
26, 27
. Moreover, we have previously demonstrated that an increase 
in TGF-β1 expression produced by an acute saline overload was prevented and 
reversed by the administration of low and non-hypotensive doses of ANP
28
. Taking 
this into account, the present results suggest that the raise of ANP expression in rats 
fed a high salt diet could constitute a counter-regulatory mechanism against anti-
natriuretic and/or pro-fibrotic TGF-β1 actions. 
Meanwhile, the plasmatic concentration of ANP was not affected by dietary salt, 
suggesting that these animals did not change cardiac ANP secretion
19
. Several 
reports provide evidence that plasmatic ANP increases after a chronic salt loading 
given by drinking 1–18% NaCl solutions29, 30 or by a rat chow with high salt 
content
31
. However, the literature also shows conflicting results reporting that ANP 
mRNA expression and circulating levels of ANP remained unaltered after the 
Chapter 5 
 
~ 141 ~ 
 
ingestion of high sodium diets
32
. The present results show that renal ANP expression 
levels are independent of circulating ANP levels and are subjected to a different 
regulation. These findings are in accordance with Sun et al, who have previously 
demonstrated that a dietary salt supplementation may selectively increase ANP 
levels in the kidney by down-regulating its clearance receptor (NPR-C)
33
. 
Our study also shows that a high salt intake increased HIF-1α expression not only in 
the renal medulla, as it has been described before
20
, but also in renal cortex. 
Considering that a high salt intake increases oxidative stress, renal tubular transport 
and hypoxia, it may constitute one of the possible factors involved in the up-
regulation of HIF-1α expression in renal tissues6, 34. Additionally, it has been 
reported that a high salt intake inhibits PHD-2 expression, the predominant isoform 
in renal medulla of prolyl-hydroxylase enzyme, which promotes the degradation of 
HIF-1α, increasing its expression level35. In this way, recent studies have shown that 
HIF-1α may regulate the encoding genes of some enzymes in the THAL, as those of 
nitric oxide synthase (NOS), cyclooxygenase-2 (COX-2) and hemeoxygenase-1 
(HO-1), which are highly expressed in renal medulla
36, 37
. However, the tempol 
administration, which prevents oxidative stress and enhanced urinary sodium 
excretion, normalized HIF-1α expression in the HS group, except in THAL from 
both groups fed a normal or a high salt diet. These data suggest that tempol could 
prevent the hypoxia produced by the oxidative stress as it has been described
5, 22
, but 
not the hypoxia produced by greater sodium transport in THAL, where the 
enhancement of sodium reabsorption in this tubular segment may be compensating 
the inhibition of sodium transport in PT, elicited by tempol. 
In summary, the present findings suggest that HIF-1α and ANP could represent a 
main adaptive mechanism in normal rats, in response to a salt overload, counter-
regulating the hypoxia and fibrosis produced by oxidative stress, and playing a 
crucial role in the maintenance of sodium balance. The administration of tempol, as 
a scavenger of superoxide anion, prevents over-expression of HIF-1α and ANP. The 
disruption of this salt adaptive pathway in salt-sensitive rats could be the cause of 
sodium retention, oxidative stress, inflammation and fibrosis in these animals. The 
pharmacological potentiation of endogenous ANP may be a therapeutic approach for 
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Small increases of plasma sodium are thought to affect vascular tone. Recent data 
suggest that endothelial alterations may play a major role in this phenomenon. The 
objective of the present study was to investigate the possible endothelial loss of 
ecto-apyrase (CD39) and the angiotensin II type 1 receptor (AT1R) expression that 
may occur as a result of minor increase of salt content of the culture mediums in 
vitro and the potential involvement of reactive oxygen species in the mechanism of 
damage. 
The expression of CD39 and AT1R was tested by flow cytometry, western blot and 
immunostaining of cytospins in vitro after co-culturing with peripheral blood 
mononuclear cells (PBMC) using medium supplemented with low concentrations of 
salt. In addition, production of reactive oxygen species (ROS) was measured in 
PBMC of these cultures. 
Endothelial cells showed reduced CD39 expression after increase of 1.0%- 3.0% of 
salt (p<0.01) and reduced AT1R expression after increase of 0.5%-2.0% salt into the 
medium (p<0.01) as compared with standard medium. Significant raise of ROS 
production by PBMC occurred after enhancement of salt up to 1.0% (p<0.05). 
Down regulation of endothelial CD39 and AT1R can be achieved by relatively low 
amounts of salt in vitro. Concomitant increase of ROS in PBMC after addition of 
salt suggests that the mechanism of this type of endothelial injury in vitro is 








High dietary salt intake is associated with hypertension, cardiovascular and renal 
risk. Recently, it has been suggested that plasma sodium plays an important role in 
the control of blood pressure, as a small increase in plasma sodium was observed in 
subjects with hypertension
1, 2
. Although little is known about the complete 
mechanism by which salt may increase blood pressure, evidence is accumulating 
that vascular endothelium could participate in a sodium-mediated blood vessel 
function
3-5
. For instance, endothelial cell elasticity, determined by the sodium 




High salt may also decrease the production of a powerful vasodilator, nitric oxide 
(NO), and enhance the production of superoxide anion (·O2
-
), both which can lead to 
the formation of peroxynitrite. Besides its local effect on tissue, the latter oxidant 
may also result in reduced availability of NO
7
. 
CD 39 is an ecto-phosphatase lining the vascular endothelium and present on 
various other cell surfaces. This ecto-enzyme, also known as ecto-apyrase or Ecto-
Nucleoside Triphosphate Diphosphohydrolase 1 (ENTPD1), is able to hydrolyze 
extracellular ATP and ADP
8, 9
. Regulation of these nucleotides by CD39 reflects an 
essential control mechanism for local inflammation and intravascular 
microthrombus formation
10, 11
. CD39 is highly sensitive for reactive oxygen species 
(ROS)
12, 13
 leading to diminished expression of this ecto-enzyme in ischemic 
conditions as observed in vascular endothelium of subjects with preeclampsia
14, 15
, 
and in the glomerular microvasculature in chronic kidney graft rejection
16
. 
Another important molecule found on the endothelium is Angiotensin II type-1 
receptor (AT1R), which mediates most of the physiological and pathophysiological 
actions of Ang II. However, still little is understood about the importance of this 
receptor on endothelial cell signaling
17
. 
Recent evidence suggests that AT1R activation is critical in the pathogenesis of 
endothelial dysfunction by increasing the production of oxidants
18
. Preliminary data 
in our laboratory suggested that increased salt intake may affect expression of CD39 
and AT1R on monocytes and endothelial cells in vitro. The question emerged 
whether salt intake increments as low as approximately 1%, which is the rise of 
plasma sodium after high- versus low-salt diets in healthy volunteers
19
, affects CD39 
and AT1R expression on endothelial cells. We tested the hypothesis that endothelial 
loss of CD39 and AT1R expression occurs as a result of minor increase of salt 
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content of the culture medium. In addition, we investigated whether this putative 
affect is dependent on ROS production in the co-culture system used since high salt 







2.1. Cell culture 
A human endothelial cell culture line (ECV304) was used. Confluent cultures were 
carried out using 6-well tissue culture plates in Medium 199 containing 10% fetal 
calf serum (FCS), supplemented with 100 U.mL
-1
 penicillin, 100 g.mL
-1
 
streptomycin, and 2 mmol/L glutamine at 37ºC. 
 
2.2. Peripheral blood cells preparation 
Heparin blood samples from healthy volunteers were collected. Peripheral Blood 
Mononuclear Cells (PBMC) were isolated using Ficoll-Isopaque according to 
standard methods, washed in Hank's Balanced Salt Solution (HBSS) and 
resuspended in tissue culture medium (RPMI 1640). 
 
2.3. Cell Co-culture 
Endothelial cell cultures were washed and incubated for 12hs in RPMI 1640 serum 




 per well) using medium with different salt 
concentrations, as listed below: 
- 154.00 mmol.L
-1
 (physiological amount of NaCl): indicated as “Standard”, 
- 154.77 mmol.L
-1
 of NaCl: increase of 0.5%, 
- 155.54 mmol.L
-1
 of NaCl: increase of 1.0%, 
- 157.08 mmol.L
-1
 of NaCl: increase of 2.0%, 
- 158.62 mmol.L
-1
 of NaCl: increase of 3.0%. 
Endothelial cells were also cultured without PBMC in standard medium. 
After overnight incubation, the supernatants with PBMC were separated from the 
monolayer of endothelial cells and reserved for analysis (See “Reactive Oxygen 
Species production” section). The endothelial cell monolayer was washed with 
HBSS and carefully harvested from the 6-well plates using a disposable rubber cell 
scraper (Corning Inc). Cell viability, as estimated by dye exclusion (Tripan Blue), 
showed approximately 97% viable cells. Three sets of experiments were performed 
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in order to assess the expressions of CD39 and AT1R using flow cytometry, 
Western blot and immunohistochemistry. 
 
2.4. CD39 and AT1R expression 
 
2.4.1. Flow cytometry 
In order to evaluate the expression of CD39 and AT1R, the endothelial cells were 
subsequently washed (x2) in phosphate buffered saline supplemented with 1% 
bovine serum albumin (PBS/BSA) and incubated with 2µL monoclonal anti AT-1 
IgG (clone TONI, Abcam) or 2µL monoclonal anti-apyrase (anti CD39) on ice. 
After 60 min cells were washed (x2) in PBS/BSA buffer and incubated with goat-
anti-mouse IgG conjugated with fluorescein isothiocyanate (FITC) (DAKO) for 30 
min on ice. Control cells were incubated with 2µL of the second antibody only (i.e. 
goat-anti mouse-IgG FITC). After washing (x2) with PBS/BSA cells were fixed 
with 2% paraformaldehyde in PBS. The fluorescence was measured by flow 
cytometry using a fluorescence activated cells sorting (FACS) device (Calibur 
Beckton Dickinson, USA). According to standard methods, the data were processed 
using a standard software program (Winlist 6.0, Verify Software House, Topsham, 
ME). 
 
2.4.2. Western blot Analysis 
After washing the endothelial cell monolayer with PBS, 300L of cold RIPA buffer 
was added to each well (150mM sodium chloride, 1.0% NP-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate, 50mM Tris, pH 8.0) plus protease 
inhibitors (250mM EDTA, 20mg.mL
-1
 leupeptin, 1/100 phenylmetylsulphonyl 
fluoride). The cells were carefully harvested from the 6-well plates using a cell 
scraper and transferred to 1.5mL eppendorf tubes, and incubated on ice for 45min. 
Then each sample was centrifuged at maximum (20.000 RCF) speed for 5 minutes at 
4°C, and the supernatant was transferred to a new 1.5mL tube. Total protein was 
measured in Varioskan plate reader) (Thermo Electro Corporation) with pyrogallol 
red-molybdate complex method [22]. Loading buffer 2x was added in a proportion 
of 1:1 (sample:buffer) (2.5mL Tris/HCl pH 6.8, 4mL 10%SDS, 2ml glycerol, 1ml β-
mercapto-ethanol, 0.5mL water, beads of bromophenol blue). After homogenizing, 
the tubes were placed in a heatblock at 100ºC during 10min. Aliquots of 20 μL from 
each sample were separated by SDS-PAGE (Sodium Dodecyl Sulphate 
PolyAcrylamide Gel Electrophoresis) on 8% polyacrylamide gels using the BioRad 
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electrophoresis system. Proteins were electroblotted (BioRad blotting system) onto 
PVDF membranes (Immobilon, Millipore). Blots were blocked 1 hour in TBS 
(10mM Tris-HCl) containing 2% skim milk solution. Blots were then incubated 
overnight at 4°C with antibodies recognizing AT1 receptor (polyclonal anti-AGTR1, 
Sigma) and monoclonal mouse anti-CD39 in 5ml TBS containing 0.05% Tween 20 
(TBS-T 0.05%) supplemented with 1% skim milk. After washing with TBS-T, 
secondary probing was done with a 60 minutes incubation with peroxidase-labeled 
anti-rabbit IgG (Garpo; Dako) and rabbit anti-mouse IgG (Rampo; Dako) antibodies 
respectively (both at 1:1000) diluted in 5 mL of TBS-T plus 1% skim milk. Blots 
were washed and membrane-bound antibodies were visualized using Bio-Rad 
method as follows: Two tubes were prepared, one containing 20 ml of 0.1M Tris 
(pH 8.5) plus 12.5 µL of 30% H2O2, and the other containing 20 ml of 0.1M Tris 
(pH 8.5) plus 200 µL of 250 mM luminol and 88 µL of 90 mM p-coumaric acid. The 
tubes were then mixed and blots were incubated for 1 minute with this solution 
before developing. The density of the respective bands was quantified by 
densitometric scanning of the blots using a Chemidoc MP Imaging system and 
Image Lab analyzer software (BioRad). Then, the blots were washed with TBS-T, 
and the antibodies were incubated for 1 hour in stripping buffer (0.94g glycine, 50ul 
10% SDS, 500mL water, pH 2.0 with 1N HCl). After washing again with TBS-T, 
the same blots were incubated with beta-actin (1:2000, Santa Cruz Biotehcnology) 
for 1 hour, used as an internal standard. After washing with TBS-T, secondary 
probing was done with a 60 minutes incubation with peroxidase-labeled anti-rabbit 
IgG at a dilution of 1:1000 in 5 mL of TBS-T plus 1% skim milk, Garpo; Dako). 
Detected bands were quantified and normalized for the beta-actin signal on the same 
blot. Protein levels were expressed as a ratio between the mean intensity of CD39 or 
AT1R and β-actin bands to avoid inaccuracies in protein loading. 
 
2.4.3. Immunohistochemistry 
Cytospins were prepared from endothelial cells, and stained for either CD39 or 
AT1R expression according to standard procedures. Cytospin preparations were 
fixed with icecold acetone (100%; room temperature) for 10 minutes, air dried and 
subsequently stained for CD39 using monoclonal antiapyrase antibody at a dilution 
of 1:150 for 60 minutes, and peroxidase-conjugated goat antimouse IgM 
(GaM/IgM/po; Pierce), as a second step, at a dilution of 1/50 for 30 minutes; or for 
AT1R, using monoclonal anti AT-1 IgG (clone TONI, Abcam) at a dilution of 1:75 
for 60 minutes, peroxidaseconjugated rabbit antimouse IgG (Rampo; Dako) as a 
second step at a dilution of 1:50 for 30 minutes, followed by goat antirabbit IgG 
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conjugated with peroxidase (Garpo; Dako) as a third step at a dilution of 1:100 for 
30 minutes. Endogenous peroxidise activity was blocked by addition of 0.3% of 
H2O2 in PBS for 30 minutes, between the first and the second antibodies. The 
reaction product was visualized using 3-amino-9-ethyl-carbazol (AEC) according to 
standard methods. The sections were counterstained using hematoxylin. 
 
2.5. Reactive Oxygen Species (ROS) production 
In order to evaluate the production of ROS in PBMC, the PBMC containing 
supernatant previously separated from the co-cultures was washed (x2) and the cells 
were labelled with dihydrorhodamine 123 (DHR, Invitrogen) for 60 min in a water 
bath at 37ºC. Cells were then washed again (2x) and resuspended in PBS/BSA. 
Unlabelled cells were used as negative controls. ROS production as reflected by the 




Flow cytometry and immunohistochemistry statistical analysis were performed 
using Mann Whitney test. Western blot statistical analysis was performed using 






3.1. CD39 and AT1R expression 
 
3.1.1. Flow cytometry 
The expression of CD39 on endothelial cells after co-culture with PBMC is shown 
in figure 1A. As it can be observed, an increase from 0.5% to 3.0% of salt presents 
significant lower mean expression of CD39, as detected by flow cytometry. Figure 
1B, shows the mean expression of AT1R after co-culture with PBMC in standard 
versus high salt medium. Significantly decreased mean expression of AT1R after 
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        Panel A                                           Panel B 
    
 
Figure 1. Panel A. Expression of CD39 on endothelial cells as measured by flow cytometry. Figure 1B. 
Expression of AT1R on endothelial cells as measured by flow cytometry. Columns represent mean 
expression of CD39 and AT1R after co-culture with PBMC in standard medium (154.00 mmol.L-1 NaCl) 
or medium supplemented with salt (0.5-3.0% increase). Bars represent mean ± SEM; n= 6-10; *p<0.05, 
**p<0.01 vs standard medium. 
 
 
3.1.2. Western Blot 
Figure 2 shows protein expression of CD39 and AT1R on endothelial cells after 
treatment, as measured by Western blot. In figure 2A, total protein expression of 
CD39 on endothelial cells was significantly down-regulated in the presence of 2% 
and 3% of salt, as it is shown in panel A (*p<0.05). Figure 2B shows the total 
protein expression of AT1R, where a slight tendency towards down-regulation is 









Figure 2A. Protein expression of CD39 on endothelial cells as measured by Western blot. Columns 
represent mean expression of CD39 after co-culture with PBMC in standard medium (154.00 mmol.L-1 
NaCl) or medium supplemented with salt (0.5-3.0% increase). Bars represent Mean ± SEM; n= 5; 




   
Figure 2B. Protein expression of AT1R on endothelial cells as measured by Western blot. Columns 
represent mean expression of AT1R after co-culture with PBMC in standard medium (154.00 mmol.L-1 
NaCl) or medium supplemented with salt (0.5-3.0% increase). Bars represent Mean ± SEM; n= 6. 
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3.1.3. Immunohistochemistry 
Immunostaining in cytospins of endothelial cells following co-culturing with PBMC 
in high salt (from 0.5% to 3.0% increase) versus standard medium, presents 
decreased expression of CD39 and AT1R as showed in figures 3 and 4. In figure 3B, 
clear reduction of stainability for CD39 is shown in cells cultured in medium with 
increased salt content (1.0% NaCl) versus standard medium which shows more 
reaction product (Figure 3A). Figure 4B shows a decreased expression of AT1R 
after culture with high salt (1% NaCl) versus standard medium (Figure 4A). 
 
 




Figure 3A. Endothelial cells following co-culture with PBMC in standard medium after immunostaining 
for CD39. It can be seen that reaction product in cytoplasm as well as along cell membranes is present in 
most of the cells. Final magnification x 200. Figure 3B. Endothelial cells following co-culture with 
PBMC in medium supplemented with salt (1.0% increase) after immunostaining for CD39. It can be seen 
that a clear reduction of reaction product occurs as compared with standard medium (fig 3A). The 









Standard 1% NaCl 
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Panel A     Panel B 
 
 
Figure 4A. Endothelial cells following co-culture with PBMC in standard medium after immunostaining 
for AT1R. It can be seen that in most cells reaction product is present. Final magnification x 200. Figure 
4B. Endothelial cells following co-culture with PBMC in medium supplemented with salt (1.0% increase) 
after immunostaining for AT1R. It can be seen that a clear reduction of reaction product occurs as 
compared with standard medium (Fig 4A). The standard method 3-amino-9-ethyl-carbazol (AEC) was 
used. Final magnification x 200. 
 
 
3.2. Reactive Oxygen Species production 
In order to evaluate the production of ROS by PBMC after co-culturing with 
endothelial cells and various increments of salt into the medium, we analyzed the 
mean fluorescence intensity in these cells using flow cytometry. It can be seen in 
Figure 5 that, after salt is added to the culture medium, a mean increase of ROS in 
PBMC occurs, as compared to standard medium, in particular after increasing the 
salt content of the medium with 1% of NaCl. Although 0.5%, 2.0%, or 3.0% salt 
increase seems also to induce a mean increase of ROS production, these differences 
were not statistically significant as compared to standard medium. 
 
1% NaCl Standard 
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Figure 5. Staining for ROS in PMBC using flow cytometry, with dihydrorhodamine as a label. Columns 
represent mean staining for ROS in PBMC after co-culture with endothelial cells in either standard 
medium or medium supplemented with salt (0.5-3.0% increase). It can be seen that 1% increase of salt 
induces a significant increase of ROS generation as compared with standard medium. Bars represent 





The major observation of the present experiments is that minor increments of salt in 
the culture medium caused significant alterations along the endothelial cell surface 
i.e. loss of CD39 (fig. 3B) and AT1R (fig. 4B). 
In the present in vitro study, where we used a concentration range of salt increase 
(0.5%-3%), no dose response could be observed (figs. 1A and 2A) for CD39 
expression. The reason for this is obscure. Since it has been shown that CD39 is 
highly sensitive for oxidant stress
20, 23, 24
, it is likely that ROS production induced by 
enhanced salt in the culture system causes the down regulation of endothelial CD39. 
Indeed, 1% NaCl increase causes a significant rise of ROS as compared with 
standard medium (fig. 5). Again no dose-dependency could be shown. The reason 
for this remains to be established but may be related with kinetics of ROS 
production as detected by the DHR 123 label and the incubation time. It is 
conceivable that a part of the ROS induced by the 2% salt increment has already 
diffused out of the cells before measurement occurs following overnight incubation. 
It is clear, however, that 1% increase of salt in the medium is associated with 
significant ROS production and CD39 affection in the present co-culture, which 
makes it highly likely that this type of endothelial injury is due to oxidative stress 
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caused by salt. This is in line with recent studies which demonstrated that salt may 
induce ROS mediated damage to the vessel wall in vivo
20, 21
. 
A rise of salt (0.5%-2%) in the culture medium also reduces endothelial expression 
of AT1R (fig.1B). An increase of 3% of salt showed no statistically significant drop 
of AT1R expression. The mean AT1R loss between the ranges of 0.5% to 2.0% of 
salt increment shows a tendency to a dose-dependent response, as observed in both 
flow cytometry (fig. 1B) and western blot analysis (fig. 2B). Reduced expression of 
AT1R on endothelial cells after increasing the salt content of the medium up to 1.0% 
was also shown by immunostaining on cytospins (fig. 4B). Whether AT1R down 
regulation due to increased salt content of the medium is due to either a direct effect 
of sodium upon the cell membrane, or reduced AT1R production reflected by a 
reduced mRNA signal for this receptor, cannot be concluded from the present data. 
However, it is likely that loss of AT1R in this particular in vitro model is also a 
result of oxidant injury, as seems the case for diminished CD39 expression. This is 
in line with data from Nickering et al., who found ROS dependent down regulation 
of AT1R in vascular smooth muscle cells
25
. In addition, it was recently found that 
small increases of sodium resulted in another form of endothelial injury i.e. 
endothelial stiffness, although this endothelial alteration in vitro appeared dependent 
of aldosterone present in the culture medium
3
. The suggestion of these authors that 
small changes in plasma sodium concentration (possibly in cooperation with other 
unknown factors) can affect endothelial function supports also our present data. 
Thus, slightly increased salt concentrations affect an important endothelium 
protecting ecto enzyme i.e. CD39, which prevents local proinflammatory and 
proaggregatory reactions which can be induced by extracellular ATP and ADP
6
. 
Down regulation of endothelial CD39 in vivo greatly affects endothelial function as 
also observed in diseases with endothelial dysfunction like preeclampsia, 
characterized by hypertension and proteinuria
15, 26
. 
Loss of AT1R from endothelial cells may lead to vascular non-responsiveness to 
angiotensin II, resulting in vasodilatation. This mechanism has been suggested in 
healthy pregnancy (after week 10). In this condition, expansion of the vascular bed 
occurs concomitantly with loss of endothelial AT1R due to enhanced activity of 
plasma hemopexin
27
. However, as the interaction of AT1R with angiotensin II may 
also induce NO release through eNOS activation, it is conceivable that 
downregulation of endothelial AT1R by salt may promote increase of blood pressure 
as well
16
. It is clear that extrapolation of the present data to the in vivo situation is 
complicated by the fact that besides endothelium, the vessel wall also contains 
vascular smooth muscle cells carrying AT1R
28
. 
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In conclusion, we feel that loss of endothelial CD39 and AT1R due to small increase 
of sodium, mediated by ROS production may reflect significant endothelial injury 
which in vivo potentially may result in alterations in vascular tone. Although it has 
been suggested recently that small increases of plasma sodium may be associated 
with hypertension
1
, the potential contribution of loss of endothelial CD39 and AT1R 
to salt dependent hypertension, requires further investigations in vivo. 
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Salt in health and disease 
The body’s fluid balance is influenced by two primarily variables: water and 
sodium. Salt is an essential nutrient, since the body cannot produce it by itself. It is a 
requirement for good health
1
. Sodium is involved in muscle contraction, nerve 
impulses. Sodium is also the major extracellular electrolyte responsible for 
regulating water balance, pH, and osmotic pressure. Angiotensin and aldosterone 
adjust the system in the event of consumption of insufficient amounts of salt, which 
would threaten the body's nerves and muscles and interfere with the sodium-
potassium pump that adjusts intra- and extra-cellular pressures
2
. 
For several million years humans consumed a diet containing less than 1g of salt per 
day, which means that humans are genetically programmed to this amount of salt 
intake. However, with the development of agriculture and farming, salt was utilized 
to store food for prolonged periods of time, leading to an increase of salt intake. 
High sodium ingestion has been related to hypertension, stroke, coronary heart 
disease and renal fibrosis
3-5
. Although the deleterious effects of a high sodium intake 
are obvious, the underlying mechanisms are still not resolved, especially regarding 
their role in kidney damage. 
 
Models of sodium overload 
In order to evaluate the consequences of the excessive salt intake, we utilized several 
models of sodium overload. We first tested the in vivo effects of sodium excess in 
normal rats, in a chronic model using a high salt diet, and in an acute model by 
administering high salt both in anaesthetized and unanaesthetized animals. As an in 
vitro model, we used endothelial cells exposed to high salt. 
It is known that excess intake of salt increases water and more sodium retention
6
. To 
investigate the role of sodium excess in water retention, we studied the expression of 
the main water channels: aquaporin-1 (AQP-1) and aquaporin-2 (AQP-2) (Water 
Balance). High extracellular sodium concentration also constitutes a challenge to 
normal cell function. Renal acute inflammation initiated by sodium overload, 
suggests an active participation of sodium and hyper-osmolarity in the pathogenesis 
of the inflammatory process
7-11
. We analyzed the expression of inflammation 
markers in models of acute and chronic sodium overload (Inflammation Markers). 
We also evaluated the role of tubular Ang II-induced AT1 receptor (AT1R) 
activation by using the AT1R blocker losartan. Furthermore, we tested the 
participation of the oxidative stress and NO in the development of renal pro-
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In the high salt diet model (Chapter 1), we demonstrated that chronic administration 
of an excess of salt down-regulates AQP-1 and AQP-2 in proximal tubules and 
collecting ducts respectively. We observed that blockade of AT1R prevents the 
increase in Angiotensin II (Ang II) staining and the decrease of endothelial nitric 
oxide synthase (eNOS) staining. It also augments AQPs expression and promotes 
urinary sodium concentration. It has been suggested that Ang II plays a role in AQPs 
down-regulation, and that this is clinically associated with the inability of the kidney 
to concentrate the urine
13-15
. In addition, the activation of a cGMP-dependent 
pathway, mediated by different cGMP pathway activators, such as atrial natriuretic 
peptide (ANP), L-arginine and nitric oxide, results in AQP-2 insertion to the cell 
membrane
16-17
. Therefore, we hypothesize that the decrease of eNOS expression 
(and thus less nitric oxide) elicited by elevated intrarenal Ang II levels, could be 
responsible for AQP-2 down-regulation in the renal tubules of these animals, and 
that losartan administration could exert an antidiuretic effect through Ang II–AT2–
nitric oxide–cGMP signalling pathway. 
On the other hand, anaesthetized rats under acute sodium overload or unanesthetized 
rats subjected to the i.p. administration of a hypertonic saline solution without access 
to water, exhibited unchanged or decreased expression of these AQPs (Chapter 2). 
Therefore, our results demonstrate that sodium overload could be involved in an 
early down-regulation of AQP-2 expression in the collecting ducts. It is known that 
nuclear factor-kappaB (NF-B) modulates AQP-2 expression by binding to its 
promotor
18
. As we have shown in Chapters 1, 2 and 3, there is an imbalance between 
Ang II (increased) and eNOS (decreased) expression in sodium overloaded rats. 
These two conditions activate the NF-B transcription factor which was elevated in 
our experiments and in accordance to literature
19, 20
. In order to investigate the 
participation of Ang II-NF-B signal on AQPs expression, we studied the effects of 
the inhibition of Ang II by losartan or the oxidative stress by tempol (Chapter 2), as 
discussed in the section “Inflammation markers”. Our results indicate that the Ang 
II-oxidative stress-NF-B pathway could be a repressor mechanism to diminish 
AQP-2 expression in rats under high sodium
21
. Alternatively, a recent report showed 
that the hypertonicity-induced activation of the NFATc factor may also increase 
AQP-2 transcription. In this order, it has been demonstrated that NO can enhance 
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the nuclear import of NFATc and decrease its export via PKG by NO signalling
22
. In 
agreement with this finding, our data show that sodium overload lowered eNOS 
expression, probably lowering NO production, while losartan and tempol 
administration caused a marked increase in eNOS expression. 
 
Renal function and Mean Arterial Pressure 
Following the study of water channels in a high sodium condition, we evaluated 
arterial pressure and renal function. In the acute model of sodium overload in 
anaesthetized normal rats (Chapters 2 and 3), the animals showed no significant 
alterations in the mean arterial pressure (MAP) and exhibited hyperfiltration, 
increased diuresis, natriuresis, and preserved glomerular function and tubular 
morphology. Both, tempol and losartan did not increase blood pressure and 
glomerular filtration rate (GFR) but produced greater sodium fractional excretion, 
suggesting that they are predominantly involved in sodium tubular transport. 
A high salt diet in normal rats during three weeks produced a slight but significant 
increase in MAP and urinary sodium excretion (Chapters 1, 4 and 5). Our studies 
showed that losartan exerted a natriuretic effect at the tubular level, independently of 
its hypotensive effect and of GFR changes. It is well documented that renal AT1R, 
via activation of renal sodium transporters, produce antinatriuretic effects
23
, whereas 
AT2R activation results in rise of urinary sodium excretion through the nitric oxide-
cGMP pathway
24-25
 as commented in the previous section (Water Balance). Finally, 
tempol improved renal hemodynamic and electrolyte excretory function in this 
model of high salt diet. It normalized MAP levels observed in the high salt group, 
and showed a potent diuretic and natriuretic effect, as we could also see in the acute 
model. We conclude that in every case, losartan and tempol could regulate blood 
pressure by improving sodium excretion. 
 
Inflammation markers 
In Chapters 2 and 3, we showed an early renal expression of inflammatory markers, 
such as Ang II, NF-B, transforming growth factor-beta1 (TGF-1), alpha-smooth 
muscle actine (-SMA) and RANTES, in rats submitted to acute sodium overload. 
This was associated with the simultaneous decrease in eNOS expression and 
increase in hypoxia inducible factor-1alpha (HIF-1) expression, suggesting greater 
oxidative stress and hypoxia, respectively. We tested the effect of tempol and 
losartan on the expression of the aforementioned markers. Tempol showed an anti-
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inflammatory effect accompanied by an antioxidant action. On the contrary, losartan 
did not prevent the over-expression of inflammatory markers in renal tubules. 
Therefore, superoxide (O
-
2) up-regulation, as well as NO lower availability, may 
contribute to stimulate TGF-1 production. RANTES, a pro-inflammatory 
chemokine, was over-expressed in collecting ducts but not in proximal tubules in the 
acute model (Chapter 3). Under a high salt diet (Chapters 1, 4 and 5), TGF-β1 
expression increased in the distal nephron but not in proximal tubules, whereas Ang 
II showed the opposite pattern. Tempol and losartan administration prevented these 
changes. It seems that the profibrogenic response bears no association with Ang II 
localization. Recently published data have shown that, despite the positive-feedback 
loop between TGF-β1 and nitric oxide under physiological conditions, the inhibitory 
effect of nitric oxide on TGF-β1 production was reduced after salt intake in Dahl salt 
sensitive rats, supporting our results
26-27
. We hypothesize that 1) the profibrogenic 
response (showed by α-SMA and TGF-β1 enhanced staining) observed in our 
experiments could be related to the disbalance of oxidative stress and nitric oxide, 
and not to renal Ang II expression, and that 2) the role of elevated levels of Ang II 
observed in proximal tubules of animals fed with a high salt diet could be to regulate 
sodium transport. In this way, Ang II could stabilize nephron functions, avoiding a 
sodium overload to distal segments. 
In Chapter 5, we evaluated the expression of ANP, a hormone that increases sodium 
excretion and decreases blood pressure and blood volume, in animals under high salt 
diet. It has been demonstrated that the activation of ANP/cGMP/PKG signalling 
pathway disrupts TGF-β1-induced downstream events, including myofibroblast 
transformation and the proliferation and expression of extracellular matrix 
molecules
28-29
. In our experiments, the increase in renal ANP levels coincided with 
TGF-β1 over-expression in glomeruli, thick ascending limb and cortical collecting 
ducts. These results suggest that the elevated expression of ANP in these animals 
could constitute a protective counter-regulatory mechanism against anti-natriuretic 
and/or pro-fibrotic actions of TGF-β1. In addition, the plasmatic concentration of 
ANP was not affected by dietary salt, suggesting that these animals did not change 
cardiac ANP secretion
30
. Renal ANP expression levels are independent of 
circulating ANP levels, which may be subjected to a different regulation. In 
accordance with our findings, it has been demonstrated that dietary salt 
supplementation may selectively increase ANP levels in the kidney by down-
regulating its clearance receptor (NPR-C)
31
. One of the endothelium protecting 
enzymes in inflammation is the E-NTPDase, which converts the pro-inflammatory 
ATP to ADP released by damaged cells. Thus in Chapter 6, we tested the effect of 
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small increases of salt in vitro on the expression of endothelial AT1R and E-
NTPDase by co-culturing an endothelial cell line with peripheral blood mononuclear 
cells (PBMCs). These experiments showed that minor increments of salt in the 
culture medium caused significant alterations along the endothelial cell surface, 
where AT1R and E-NTPDase where down-regulated and ROS production by the 
PBMCs was increased. This is in line with recent studies which demonstrated that 
salt may induce ROS mediated damage to the vessel wall in vivo and in vitro
32-36
. 
According to our results, it is likely that loss of AT1R in this particular in vitro 
model is a result of oxidant injury and may lead to vascular non-responsiveness to 
angiotensin II in endothelial cells, resulting in vasodilatation as it has been shown
37
. 
Down regulation of endothelial E-NTPDase in vivo greatly affects endothelial 
function as is also observed in diseases with endothelial dysfunction like 




In conclusion, an acute or chronic sodium overload is able to regulate the expression 
of AQP-1 and AQP-2 and thus the water balance through intrarenal Ang II and 
oxidative stress. Early renal inflammation produced by acute sodium excess in non-
physiological concentrations (2hs) is a process that can be prevented and/or 
reversed. Chronic inflammation may be reversible in the absence of 
histopathological lesions. Inflammation by sodium is linked to ROS (due to flux, 
stretch and/or transport) more tan to tubular Ang II, which could be more related to 
sodium and water transport. Triggering of the cascade of inflammatory events is due 
to an increase of the cellular work when it reabsorbs sodium, which produces 
relative hypoxia (HIF-1), increase of renal Ang II and NF-kB expression and 
develops oxidative stress. This cascade can be prevented or reverted by cutting the 
chain in any of its links: a) decreasing sodium reabsorption (ANP), b) inhibiting 
local Ang II (losartan) or c) the oxidative stress (tempol). 
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Future Perspectives 
In this thesis, we studied the deleterious effects of sodium through oxidative stress 
and inflammation on renal damage at the tubular level (studies in vivo). Studies in 
vitro were performed as well; testing vascular damage elicited by sodium at the 
endothelial level. Future experiments will include functional studies of vascular 
reactivity to demonstrate that salt can induce ROS in the vascular wall by stretching, 
and how this can affect the regulation of eNOS in endothelial and vascular smooth 
muscle cells. Moreover, we would like to study how this response can be potentiated 
by exogenous Ang II. The functional tests can be performed by measuring isometric 
tension in aortic rings placed in a perfusion bath with different testing drugs, and 
designing dose-response curves. The participation of NO and oxidative stress can be 
studied as regulators of vascular reactivity in function of 1) vascular stretching 
(similar to the stretch produced by increase of arterial pressure), 2) sodium 
concentration in the extracellular medium, and 3) of the combination of both. Also, 
several inhibitors can be used, such as: oxidative stress inhibitors (tempol or 
apocynine), inhibitors of AQP-1 as channel for NO from endothelium to the smooth 
muscle cells (HgCl2), neutral endopeptidase inhibitors (omapatrilat) to increase the 
availability of endogenous ANP. 
Furthermore, the ability to selectively up-regulate or inhibit AQP functions in 
specific tissues may lead to novel therapeutic approaches for human disease. Our 
current knowledge of AQPs’ pore structure and function should permit the 
development of designer drugs that can target specific AQPs for clinical use. Small-
molecule modulators of AQP expression/function could have clinical applications in 
the therapy of congestive heart failure and hypertension, cytotoxic and vasogenic 
brain edema, epilepsy, obesity, cancer, glaucoma and other conditions. AQP 
inhibitors, called aquaretics, could reduce urine concentration, producing a diuresis 
with a higher water/salt ratio, beneficial for example in severe congestive heart 
failure, where conventional salt-blocking diuretics are of limited efficacy
40
. 
There are controversial studies regarding the administration of antioxidants to 
prevent, for example, cardiovascular diseases. According to the American Heart 
Association, there is not enough evidence to whether they should recommend the 
administration of antioxidants to prevent the reduction of disease risk. Small studies 
have indicated advantages and some of them have even shown adverse effects. 
Clinical trials have not yet demonstrated conclusive assertions
41
. The benefit of 
antioxidants, in particular the nitroxides such as tempol, lays not only in differences 
of age, gender, origin and disease. It also depends on the dose and exposure time, 
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since above certain concentrations, they can be oxidants and in some cases toxic
42
. 
Further research of the pathophysiology of oxidative stress and the antioxidant 
therapy will hopefully lead to better designed clinical trials which will result in a 
better antioxidant therapy. 
On the other hand, it would be useful to study the antioxidant capacity of 
endogenous atrial natriuretic peptide (ANP) locally produced for example in the 
aorta, utilizing an in vitro model of endothelial and smooth muscle cells or proximal 
tubular cells, to test its expression under the influence of oxidants and to determine 
ROS generation when the endogenous production of ANP is inhibited. Moreover, 
the pharmacological potentiation of endogenous ANP may be a therapeutic approach 
for the management of oxidative stress in salt-sensitive hypertension. 
It is generally admitted that a functional negative crosstalk between AT1 and AT2 
receptors exists in several pathophysiological conditions including hypertension
43
. 
AT2 receptor activation may directly antagonize AT1R-mediated actions by forming 
heterodimers with AT1R. Therefore, the role of AT1R blockers such as losartan 
could be further studied in order to find new beneficial effects other than the known 
anti-hypertensive properties. Moreover, in vitro experiments are needed to clarify 
the molecular mechanism of damage of sodium to discover the potential 
contribution of loss of AT1R and endothelium protective E-NTPDase to salt 
dependent hypertension. 
A better understanding of the mechanisms involved in the regulation of water and 
sodium handling, especially when the body is exposed to an excess of salt, would 
lead to improved prevention of renal and cardiovascular diseases and would increase 
treatment efficacy. 
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Natrium en chloride zijn de twee elementen die samen natriumchloride (zout) 
vormen. In het lichaam bevindt natrium zich vooral in het bloedplasma en in de 
vloeistof buiten de cellen. Natrium speelt een rol bij het ontspannen van de spieren, 
waaronder ook de hartspier. Het neemt deel aan de overdracht van zenuwimpulsen 
en helpt om de bloeddruk te reguleren. Omdat zout een onderdeel van ons dieet is, 
komt natrium deficiëntie maar zelden voor. Langdurige diarree of braken kan echter 
leiden tot deze deficiëntie resulterend in misselijkheid, duizeligheid en 
spierkrampen. Bij gezonde mensen wordt de overmaat aan natrium uitgescheiden in 
de urine. Nierziekten kunnen echter natriumuitscheiding verstoren met als gevolg 
vochtretentie en oedeem. Tegenwoordig is wereldwijd de individuele gemiddelde 
zoutinname hoger dan de fysiologische behoefte. Voor mensen die gevoelig zijn 
voor zout, kan een natrium rijk dieet zorgen voor de ontwikkeling van zowel 
hypertensie als cardiovasculaire- en nierziekten. 
Waterretentie veroorzaakt door een teveel aan natrium in het lichaam wordt 
voornamelijk gemedieerd door eiwit kanalen genaamd aquaporines (AQPs). Deze 
eiwitten reguleren de beweging van water over de celmembranen. De twee 
belangrijkste AQPs (AQP-1 en AQP-2) bevinden zich in de nier. Ongeveer 70% van 
ons lichaamsgewicht bestaat uit water en elke dag filtreren en reabsorberen onze 
nieren  rond de 180 liter water. Daarom is een goede verdeling van het water nodig 
om de vochtbalans in de verschillende anatomische compartimenten te behouden. 
Bovendien heeft een renaal overschot aan natrium een ontstekingsreactie tot gevolg, 
welke retentie van natrium en water alleen maar meer bevordert. De moleculaire 
mechanismen van de ontstekingsreactie die ontstaat op zout gevoelige hypertensie is 
nog niet volledig uitgekristalliseerd. Verhoogde natrium reabsorptie vanuit de 
nierbuisjes leidt tot verhoogde doorbloeding van de nier en dus meer glomerulaire 
filtratie. Hyperfiltratie verhoogt de metabole vraag naar zuurstof, resulterend in een 
afname van de zuurstofspanning in nierweefsel (pO2). Het verhoogde 
zuurstofverbruik leidt op zijn beurt tot een relatieve hypoxie. Dit laatste leidt tot een 
cascade van gebeurtenissen, welke de productie van vrije zuurstofradicalen (ROS) 
vergroot. Hierdoor ontstaat er een verhoogde expressie van pro-inflammatoire 
nucleaire transcriptiefactoren, zoals activator eiwit-1 (AP-1) en nucleaire factor–
kappa B (NF-B). NF-B activeert genen die betrokken zijn bij de inflammatoire en 




~ 181 ~ 
 
In het eerste deel van dit proefschrift, richten we ons op de regulatie van AQPs in de 
nieren en de veranderingen die zij ondergaan wanneer ze worden blootgesteld aan 
een overmaat aan natrium (hoofdstuk 1 en 2). In het tweede deel onderzoeken we het 
effect van de overmaat van zout op inflammatie en fibrose markers in verschillende 
in vivo en in vitro modellen (hoofdstuk 3-6). In de hoofdstukken 1, 4 en 5, hebben 
we gebruik gemaakt van een model waarbij normale ratten een chronische 
natriumarm dieet volgden, terwijl in de hoofdstukken 2 en 3, we acute 
zoutoverbelasting modellen bestudeerd hebben, zowel in in slaap gehouden als 
wakkere dieren. We hebben de rol van de signalering van het hormoon Angiotensine 
II in de niertubuli onderzocht door toediening van losartan, een remmer van de AT1 
receptor. We hebben tevens gekeken naar de bijdrage van oxidatieve stress en 
stikstofoxide (NO) aan nierbeschadiging door ROS productie te remmen met 
tempol, mimetische of superoxide dismutase. Hierbij hebben we de bloeddruk en 
nierfunctie gemeten. Ook hebben we de intrarenale niveaus van aquaporines en 
grote ontstekingsmarkers zoals cytokinen, chemokinen en nucleaire factoren 
bepaald. In hoofdstuk 4 hebben we tevens de rol van hypoxie-induceerbare factor-1 
alfa (HIF-1α) en atriaal natriuretisch peptide (ANP), welke door de nier gemaakt 
worden, geëvalueerd. Beiden blijken betrokken te zijn bij een adaptief mechanisme 
in reactie op chronische natrium overbelasting. In hoofdstuk 6 hebben we in vitro 
het directe effect van zout op het endotheel getest. We hebben gekeken naar de 
deelname van ROS in het mechanisme van schade in dit model, welke gemaakt werd 
van een co-cultuur met een monolaag van endotheelcellen en mononucleaire cellen 
in perifeer bloed (PBMC). 
We concluderen dat acute of chronische natrium overbelasting, door Ang II en 
renale oxidatieve stress, de expressie van AQP-1 en AQP-2 kan reguleren en op die 
manier de waterbalans. Acute ontsteking veroorzaakt door een acute overmaat aan 
natrium is een proces dat kan worden voorkomen of omgekeerd. Ontsteking te 
wijten aan een natrium overschot is meer gerelateerd aan ROS dan aan tubulaire 
formatie van Ang II. De laatste is meer gerelateerd aan het transport van natrium en 
water. Chronische ontsteking kan reversibel zijn bij afwezigheid van 
histopathologische laesies. Activering van de inflammatoire cascade is te wijten aan 
verhoogde activiteit van cellen bij het reabsorberen van natrium, wat zorgt voor 
relatieve hypoxie (HIF-1), verhoogde renale expressie van NF-kB door AngII en 
het ontwikkelen van oxidatieve stress. Deze cascade kan worden voorkomen of 
teruggedraaid door in te grijpen op één van de volgende manieren: a) het 
verminderen van de reabsorptie van natrium (door middel van ANP), b) het lokaal 
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remmen van Ang II (door middel van losartan) of c) door het inhiberen van 
oxidatieve stress (door middel van tempol). Bovendien kan zout schade aan de 
vaatwand te induceren. Met name in ons in vitro model kan het effect van de 
PBMC’s via oxidatieve stress leiden tot het gebrek aan respons op Angiotensine II 
in endotheelcellen (door het verlagen van de expressie van de AT1 receptor) en een 
minder goede bescherming van het endotheel door de E-NTPDase, als gevolg van 
een lagere expressie van dit enzym. 
Wanneer we de mechanismen die betrokken zijn bij het regelen van de zout en water 
balans beter begrijpen, vooral wanneer het lichaam wordt blootgesteld aan een 
overmaat aan zout, kan dit leiden tot betere preventie van renale en cardiovasculaire 
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El sodio y el cloro son los dos elementos que se combinan para formar cloruro de 
sodio (sal de mesa). En el organismo, el sodio se encuentra principalmente en el 
plasma sanguíneo y es el principal catión extracelular. El sodio es parte importante 
del potencial de acción de las membranas celulares, incluyendo las neuronas y el 
musculo, por lo tanto es vital para la neurotransmisión y la contracción  muscular. 
De la entrada y salida de sodio y potasio se conforman los potenciales de acción 
tanto en la despolarización como en la repolarización, fenómenos eléctricos que 
suceden durante la contracción y la relajación. El sodio está involucrado en la 
transmisión de los impulsos nerviosos y contribuye a regular la presión arterial.  
Debido a que la sal de mesa es una parte común de la dieta, es rara la deficiencia de 
sodio. Sin embargo, en las diarreas agudas y crónicas y en la deshidratación, la gran 
pérdida de sodio puede llevar a su deficiencia; lo que refleja en síntomas como 
náuseas, mareos y calambres musculares. 
En personas sanas, el exceso de sodio es excretado, pero algunas enfermedades 
renales, sin embargo, interfieren con la excreción de sodio provocando retención de 
líquido y edema. En la actualidad el promedio individual de ingesta de sal en todo el 
mundo supera ampliamente las necesidades fisiológicas, y en personas que son 
sensibles a la sal, una dieta con alto contenido de sodio puede fomentar tanto el 
desarrollo de hipertensión arterial como enfermedades renales y cardiovasculares. 
La retención de agua que se produce por exceso de sodio en el organismo, es 
mediada principalmente a través de canales proteicos llamados aquaporinas (AQPs), 
que son proteínas que regulan el movimiento de agua a través de las membranas 
celulares. Las dos principales AQPs (AQP-1 y AQP-2) se encuentran localizadas en 
el riñón. El agua constituye aproximadamente el 70% de nuestra masa corporal, y 
cada día nuestros riñones filtran y reabsorben alrededor de 180 litros de agua. Por lo 
tanto, se requiere una distribución apropiada de agua para mantener el equilibrio de 
fluidos dentro de los diferentes compartimentos anatómicos. Por otro lado, el exceso 
de sodio, además de favorecer directamente la retención de agua, produce una 
respuesta inflamatoria renal, que favorece indirectamente, aún más la retención de 
sodio y agua. Los mecanismos moleculares involucrados en la respuesta 
inflamatoria renal a la hipertensión sensible a la sal aún no se han caracterizado 
completamente. El aumento de la reabsorción de sodio en los túbulos renales 
retroalimenta incrementando el flujo de sangre renal y por lo tanto induciendo la 
hiperfiltración glomerular y mayor reabsorción de sodio, cerrando un círculo 
vicioso. Este proceso intensifica la demanda metabólica de oxígeno a nivel del 
túbulo renal, lo que resulta en una disminución en la tensión de oxígeno del tejido 
renal (pO2) debido al aumento de su consumo. A su vez, el aumento del consumo de 
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oxígeno conduce a una hipoxia relativa. Esta última, desencadena una cascada de 
eventos, magnificando la producción de especies reactivas del oxígeno (ROS) y 
posteriormente desencadenando un aumento de la expresión de factores de 
transcripción pro-inflamatorios nucleares tales como el activador de la proteína-1 
(AP-1) y el factor nuclear kappa B (NF-kB). El NF-kB por su parte, activa genes 
relacionados con la respuesta inflamatoria y fibrótica, incrementando la expresión de 
citoquinas, quimioquinas y hormonas relacionadas con el proceso inflamatorio. 
Nuestra hipótesis de trabajo fue que la sobrecarga de sodio por exceso de de su 
ingesta o provisión, desencadena a nivel tubular renal un proceso inflamatorio y 
profibrótico precozmente y anterior a la aparición de alteraciones funcionales 
glomerulares y/o histopatológicas detectables y desregular la expresión y 
localización de proteínas encargadas de la reabsorción de agua en el riñón. Por lo 
tanto el objetivo de la Tesis fue demostrar la existencia de ese proceso inflamatorio, 
evaluando la funcionalidad renal y a nivel molecular, la expresión de factores 
proinflamatorios y profibróticos en tejidos renales en ausencia de lesiones 
histopatológicas. Además se estudió la alteración de la expresión de las acuaporinas 
y la prevención/atenuación farmacológica de la inflamación renal por sobrecarga de 
sodio. 
En la primera parte de esta tesis nos centramos en el estudio de la regulación de las 
AQPs en el riñón y las alteraciones que ocurren cuando los nefrones se exponen a un 
exceso de sodio (Capítulos 1 y 2). En la segunda parte (Capítulos 3 a 6), estudiamos 
los efectos del exceso de sal sobre marcadores de inflamación y fibrosis en 
diferentes modelos in vivo e in vitro En los Capítulos 1, 4 y 5 se utilizó un modelo 
con sobrecarga crónica en ratas normales mediante una  dieta rica en sodio, y en los 
Capítulos 2 y 3 se usaron modelos de sobrecarga salina aguda tanto, en animales 
anestesiados como despiertos. Se evaluaron los efectos de la Angiotensina II sobre 
la función tubular y prevención y/o atenuación de la inflamación renal sodio 
dependiente, mediante la administración de un bloqueante de su receptor AT1R, 
losartán. También se evaluó la participación del estrés oxidativo y del oxido nítrico 
(NO) mediante la inhibición de la producción de ROS con tempol, un mimético de 
la enzima superóxido dismutasa. En el capítulo 6, se estudio in vitro el efecto directo 
del cloruro de sodio sobre el endotelio y la potencial participación de los ROS lesión 
endotelial. En este modelo, se utilizó un co-cultivo con una monocapa de células 
endoteliales y células mononucleares extraídas de sangre periférica (PBMC).  
El análisis de los resultados obtenidos permite concluir que una sobrecarga aguda o 
crónica de sodio es capaz de regular la expresión de las AQP-1 y AQP-2 y el 
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balance de agua a través del aumento de síntesis de Angiotensina II (Ang II) 
intrarrenal y producción de estrés oxidativo.  
La sobrecarga de sal produce la activación de una cascada de eventos inflamatorios, 
que se debe al aumento del trabajo celular cuando se reabsorbe sodio., esto produce 
una hipoxia relativa (expresada por el factor HIF-1), con aumento de producción 
de Ang II renal y expresión de NF-kB, factor que conduce al desarrollo de estrés 
oxidativo. La inflamación puede ser prevenida y/o atenuada en ausencia de lesiones 
histopatológicas, cortando la cascada o cadena de eventos intracelulares en 
cualquiera de sus eslabones mediante agentes farmacológicos: a) disminuyendo la 
reabsorción de sodio (por el factor natriuréticos ANP), b) bloqueando a los 
receptores AT1 de la Ang II renal (con losartan) o c) inhibiendo el estrés oxidativo 
(con tempol).  
Mientras que la inflamación temprana producida por un exceso de sodio en forma 
aguda, que es un proceso que puede ser prevenido o atenuado, está más relacionado 
con la producción de ROS (debido mayor flujo tubular renal, el estiramiento de los 
vasos y el aumento de transporte de sodio), el incremento de Ang II intratubular, 
estaría más relacionada con el aumento de transporte de sodio y agua.  
Además, el exceso de sal puede inducir daño en la pared vascular. En nuestro 
modelo desarrollado in vitro en particular, el efecto producido por los PBMCs a 
través del estrés oxidativo, lleva a la ausencia de respuesta a la Ang II en las células 
endoteliales (por disminución de la expresión de sus receptores AT1R) y a una 
menor protección del endotelio por parte de la E-NTPDasa por menor expresión de 
esta enzima. 
De esta manera, se cumplieron los objetivos de la tesis, comprobando la veracidad 
de la hipótesis de la misma y aportando conocimientos originales que contribuyen a 
comprender la fisiopatología del daño inflamatorio por exceso de aporte de sodio. 
Un mejor entendimiento de los mecanismos involucrados en la regulación del 
manejo del sodio y el agua, especialmente cuando el cuerpo está expuesto a un 
exceso de sal, puede colaborar a una mejor prevención de enfermedades renales y 
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